var title_f8_49_8976="CT angiogram of infrarenal AAA";
var content_f8_49_8976=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72328&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72328&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT angiogram of infrarenal abdominal aortic aneurysm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 277px; height: 389px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The appearance of a small infrarenal abdominal aortic aneurysm (AAA) by computed tomography (CT). This imaging technique can be used to determine if the patient is a candidate for endovascular aneurysm repair.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8976=[""].join("\n");
var outline_f8_49_8976=null;
var title_f8_49_8977="Shoulder impingement syndrome";
var content_f8_49_8977=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Shoulder impingement syndrome (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?8/49/8977/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8977/contributors\" id=\"au5319\">",
"       Bruce C Anderson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?8/49/8977/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8977/contributors\" id=\"se7143\">",
"       Karl B Fields, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?8/49/8977/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8977/contributors\" id=\"de97\">",
"       Jonathan Grayzel, MD, FAAEM",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?8/49/8977?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      SHOULDER IMPINGEMENT SYNDROME OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Impingement syndrome occurs when tendons of the rotator cuff and the subacromial bursa (a fluid-filled sac that separates the bones of the shoulder joint) are compressed between the bones of the shoulder.",
"    </p>",
"    <p>",
"     Doing work with the arms outstretched overhead can cause shoulder soreness but does not necessarily cause impingement; shoulder impingement syndrome is only diagnosed when symptoms persist and interfere with normal daily activity. Chronic impingement may lead to bursitis, rotator cuff tendinopathy, and, if left untreated, thinning or tearing of the rotator cuff tendons. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/49/24341?source=see_link\">",
"      \"Patient information: Rotator cuff tendinitis and tear (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/27/44467?source=see_link\">",
"      \"Patient information: Bursitis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The goals of treatment for this condition include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Reducing the degree of impingement by increasing the size of the subacromial space",
"      </li>",
"      <li>",
"       Preventing injury to the rotator cuff tendons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Treatment typically includes stretching and strengthening exercises and limiting overhead reaching and positioning. The chances of recovering from shoulder impingement are excellent when these treatments are used.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      LIMIT ACTIVITY",
"     </span>",
"    </p>",
"    <p>",
"     Eliminate lifting and restrict over-the-shoulder positions and reaching until your symptoms have resolved. Avoid overhead reaching, reaching across the chest, lifting, leaning on the elbows, and sleeping directly on the shoulder.",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Lift objects close to the body",
"      </li>",
"      <li>",
"       Only lift light weights below shoulder level",
"      </li>",
"      <li>",
"       Do sidestroke or breaststroke when swimming",
"      </li>",
"      <li>",
"       Throw balls underhand or sidearm",
"      </li>",
"      <li>",
"       Do not serve overhand in tennis or volleyball",
"      </li>",
"      <li>",
"       Maintain good posture with writing, assembly work, etc.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Do not use an arm sling to limit activity; this may lead to the development of a frozen shoulder (stiff shoulder joint) (see",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/21/37201?source=see_link\">",
"      \"Patient information: Frozen shoulder (Beyond the Basics)\"",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      SHOULDER IMPINGEMENT SYNDROME PAIN RELIEF",
"     </span>",
"    </p>",
"    <p>",
"     Ice can be used to reduce the inflammation that often occurs in shoulder impingement. Ice can be applied for 15 minutes every four to six hours as needed.",
"    </p>",
"    <p>",
"     If needed, a non-prescription pain medication such as acetaminophen (Tylenol&reg;), ibuprofen (eg, Advil&reg;, Motrin&reg;) or naproxen (eg, Aleve&reg;) can be taken. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/13/2262?source=see_link\">",
"      \"Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)\"",
"     </a>",
"     .) No more than 4000 mg of acetaminophen is recommended per day. Anyone with liver disease or who drinks alcohol regularly should speak with his or her healthcare provider before taking acetaminophen.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      SHOULDER IMPINGEMENT SYNDROME STRETCHING EXERCISES",
"     </span>",
"    </p>",
"    <p>",
"     Stretching (range-of-motion) exercises are recommended early in the recovery period. These exercises are intended to help maintain joint mobility and flexibility of the muscles and tendons in the shoulder. You should not feel more than mild pain with any",
"     <span class=\"nowrap\">",
"      range-of-motion/flexibility",
"     </span>",
"     exercise. If you feel sharp or tearing pain while stretching, stop exercising immediately and consult a healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Weighted pendulum stretch",
"     </span>",
"     &nbsp;&mdash;&nbsp;The weighted pendulum stretching exercise performs two functions:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Gently stretches the space in which the tendons pass to relieve pressure on the tendons",
"      </li>",
"      <li>",
"       Prevents the development of a frozen (stiff) shoulder",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     This exercise can be started almost immediately after a shoulder injury, or after receiving a steroid injection into the shoulder joint. This exercise should be performed after heating for five minutes once or twice per day. The exercise is performed as follows (",
"     <a class=\"graphic graphic_figure graphicRef50148 \" href=\"mobipreview.htm?12/37/12895\">",
"      figure 1",
"     </a>",
"     ):",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Relax your shoulder muscles",
"      </li>",
"      <li>",
"       While standing or sitting, keep your arm vertical and close to your body (bending over too far may pinch the rotator cuff tendons)",
"      </li>",
"      <li>",
"       Allow your arm to swing forward to back, then side to side, then in small circles in each direction (no greater than 1 foot in any direction). Only minimal pain should be felt.",
"      </li>",
"      <li>",
"       Stretch the arm only (without added weight) for three to seven days. Progress this exercise by adding 1 to 2 pounds (0.5 to 1 kg) each week and gradually increasing the diameter of the movements (not to exceed 18 to 24 inches or 45 to 60 cm )",
"      </li>",
"      <li>",
"       After a few weeks this exercise should be supplemented or replaced by other exercises to target specific areas of",
"       <span class=\"nowrap\">",
"        tightness/restriction.",
"       </span>",
"       The pendulum stretch may be recommended as a warm up for more localized flexibility exercises",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       strengthening exercises.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     When performed correctly the pendulum exercise should not result in more than mild discomfort. If more pain is felt, consult a healthcare provider for instructions.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Muscle-strengthening exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;Muscle-strengthening exercises are necessary to improve shoulder muscle strength and help to prevent further injury. These exercises can often be started approximately one to two weeks after beginning the pendulum stretch exercises, once any acute inflammation has resolved, or after having a steroid injection into the shoulder joint. Consult with your provider or physical therapist to determine when to begin strengthening exercises.",
"    </p>",
"    <p>",
"     As pain improves, the level of difficulty of these exercises should be increased. Increased resistance is necessary to improve muscle strength to a degree that reduces the risk of re-injury. Mild soreness is expected with these exercises, although pain should not continue for more than 24 hours. Sharp or severe pain during or after exercising may indicate a flare of the underlying problem; stop these exercises for a few days if this occurs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Preparing for strengthening exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;The joint should always be heated for five minutes and stretched with range-of-motion exercises before beginning strengthening exercises (see",
"     <a class=\"local\" href=\"#H4\">",
"      'Shoulder impingement syndrome stretching exercises'",
"     </a>",
"     above).",
"    </p>",
"    <p>",
"     Rest after stretching for two or three minutes, then perform 15 to 20 repetitions of each exercise slowly, holding for one to two seconds during each exercise. Flexible rubber tubing, a bungee cord, or a large rubber band can be used for each exercise (",
"     <a class=\"graphic graphic_figure graphicRef70846 \" href=\"mobipreview.htm?26/2/26656\">",
"      figure 2",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Scapular squeezes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Lie on your back with your knees bent and feet flat (",
"     <a class=\"graphic graphic_picture graphicRef65309 \" href=\"mobipreview.htm?37/24/38287\">",
"      picture 1",
"     </a>",
"     ). Your arms should be straight out, 6 to 12 inches (15 to 30 cm) away from the side of your body, with palms facing upward. Keeping your low back flat against the ground, squeeze your shoulder blades downward and towards each other, towards the spine. Make a conscious effort not to shrug your shoulders and keep the neck relaxed. You should feel the lower muscles between your shoulder blades contracting. Hold for five seconds and repeat 20 times. Do this exercise two to three times per day.",
"    </p>",
"    <p>",
"     The difficulty can be increased by performing the exercise while sitting and then by holding a piece of tubing in each handing and pulling the hands apart while squeezing the shoulder blades together, as described above.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Outward rotation exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hold your elbows at 90 degrees, close to your sides; holding a towel between your torso and the inside of your elbow will cue you to keep your elbow by your side. Hold one end of a rubber band in each hand and rotate the affected forearm outward 2 or 3 inches, holding for five seconds (",
"     <a class=\"graphic graphic_picture graphicRef53514 \" href=\"mobipreview.htm?36/14/37089\">",
"      picture 2",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Perform the exercise through all available pain-free ranges of motion. Keep the shoulder blades squeezed down and back while performing this exercise.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784889223\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3705979\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/35/26162?source=see_link\">",
"      Patient information: Shoulder impingement (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/53/29522?source=see_link\">",
"      Patient information: Rotator cuff injury (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3706005\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/49/24341?source=see_link\">",
"      Patient information: Rotator cuff tendinitis and tear (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/27/44467?source=see_link\">",
"      Patient information: Bursitis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/21/37201?source=see_link\">",
"      Patient information: Frozen shoulder (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/13/2262?source=see_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/7/35961?source=see_link\">",
"      Evaluation of the patient with shoulder complaints",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/36/36425?source=see_link\">",
"      Radiologic evaluation of the painful shoulder",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/50/21289?source=see_link\">",
"      Rotator cuff tendinopathy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/33/32280?source=see_link\">",
"      Shoulder impingement syndrome",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Physical Therapy Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.apta.org/\">",
"      www.apta.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Orthopedic Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aaos.org/\">",
"      www.aaos.org",
"     </a>",
"     )",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?8/49/8977?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f8_49_8977=[""].join("\n");
var outline_f8_49_8977=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           SHOULDER IMPINGEMENT SYNDROME OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           LIMIT ACTIVITY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           SHOULDER IMPINGEMENT SYNDROME PAIN RELIEF",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           SHOULDER IMPINGEMENT SYNDROME STRETCHING EXERCISES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/37/12895\" title=\"figure 1\">",
"           Pendulum stretch exercise PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/2/26656\" title=\"figure 2\">",
"           Shoulder strength PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/24/38287\" title=\"picture 1\">",
"           Scapular squeeze PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/14/37089\" title=\"picture 2\">",
"           Outward rotation PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f8_49_8978="Plaque sarcoidosis";
var content_f8_49_8978=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plaque sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDhb+XbCAGIYkr71DARHF1OCfw9qbeMXlCjJUc5I6nvU3lnauORjGR1rzVoesyrOm5cE4JOT9aegCZZvTH4Ul/IIsklSFGOO9TwxiSKNnHDgUwsS26szKSnHXJP61et4unOTnBYjmoYcBTx8xGKuQIdpJbG0Yye9SUWI02Kg4A6HHP5VetVwu4nGOMe/rVQRlyu0kR9sd/8Kv26LubIChs9D196EVFEkRVWOBkr39/erURbzFzkEc/U96ghJcrlcfwj/E1MC52BdpbGNxOM/hRqaWuTAiBGwSQBkH1zUlsSnznDSL0yMFvqKjgj3bfMHy8qQv8AOrEcW1ewbpxyc9qYxzsrJuGcLw2f6DvTQoU8klDkfQ1Jt2sWcfd4B6inkbBtfnA69Qaa1JZk3FnHJKWdtyKehH6CtLT0+YKBtRenON3rXOaneSGZkVlBU4yKtaZeMUJkkZY0HLkZJOecU4yi3ZGiTsdUAIpIxCqyI43HJOFI6DFaNkhUom7cUKsSG5b/AD6Vn2jRS2zSxshdGCgEnJ9/pWrbRtHKHSMFc5d84OD04rT0JltqTEs8i7UXzFUvuHy5Gchf1qwFkZ/7zMAcnjBpm5GkJYhQvzLx92rdpkSBmTcwyAinq3/1v51LRk31CMR8HJxu7n71W4fMIdFRFjGSHbsM9D7k1W2yea/Voj/EOdpxV2AOsjh4yFyN2OQo+tESGySK3RZWGGYZGdh544P0zU62rOrSRrEN45DHg+1T2oVtqsD853kL/Fxjr2Ap9vbo8cSxjZvw5T7yg9vz/StLGTlYpJbkINuSuD84yff/ACKjRFQgyOq5IC8dffmteSMpH88mAo34TBI7BRVaS388OrQKdj4DtxnPp9KloSncp4WTayAlujE9Pr/Ko7uLchVR5zKFJyQpJFWGikUFGDlARyq/KB24/Wq8nmC5AWQMoGXBGSR/hRYtPXQgijYsVclmYkjAB3e1WI412ncjbg230KZ6fUe9WZdycEDdjALAbRnjt60LAZiRIo27NoVGyPr70WByuZ8AkSTyZs7wRuY8K4+vYe9Kyp5rIyNvUBlG3A64696vTQqls3lMuFG3y2H3eevr0pIrcmAFizhuUDN/D6+//wBelYXMUWUoWi2FFHVsDH6U65SNUyF3J2bHQY5FWZ4hFGoMnlmPg/Lk81lS3AVl3ylW5wG4DH+WadikuZ6DjuSHGSq4CrkcqtMj8vaEORu4Xb2981ZtwZ1XaijI52nO5vSmmGSEuCMHgZJGCD0x6GmkPyK8sKiXcSGzgk57j/8AWajuIiq425XH3hz0q0SWQMUZQSU24C7T6/8A6qgbJAWImKTJx796kRntEVaRyE+UZDE5+tRtjPBG5xgd89+Pwq60CrIWcZjI+YKfm/L0qCdQsLeWVAIBU7e30qUrFXuQN864Ck4JXOO/pVOYBZTtyX4+VT/Sr748tsBfKIzuB4PqKqSKBhtoaQjggcYpSKRUZXZTwgJJyB2H+NKN2QHKjA5APWnjJkHysTnDA02YBIyd2DnBz/L60kxtFST7m0k57MRyfYiqbAgMM5Bbv61PKgAYAlnABB6CkkDBlVzlsbgB3FDYIzTGQ56kA9+c/Wq04KHJbC571pSAAEABew9xVWRC2CRnBJAPY/1pAzMnDFQdgCkf5xWbdRbsDZwffmtq4jBdXbAA64PHPtVO4gw5IIPGDzQZtHL6haLLE8Z+VuqP/dNYQJDNG4/eKMN9e9drdQApyOR/OuU1KIxS7lAJPDe1dmErcsuV9TjxNK8brcp9qYevSpFIKgjoRmmsMmvUPORuGE+eo5HHU81Oj4GM8Dgf409wM98gcjPrULEBmHAxXz57pBMisWVuQOenerCPkjHUDOB6VAwBUMSQc9PUU1CBIqgYHcjvQO5o20fQjHHIHvWvGPlz0wp6day7PA+dj7D1Fatsu98jg9j70WGixChI3sMAjr3FWo4uAUYAqMnA60wRkc4bcpGSOM1KgYLgsygHJIHUUjRFiJAoKryccgVOsZZ1wwChvTP4UxN7DK7V7r/tD0qeDiTdgEcHAouWh5LBiMEAENn1pPtCKELS8EHju1G/duPJxwaoXEhlIK8j72RxQtRpXNW2dZI9wOeNuO4NQXEp2fvGB4wV7k1FDc/KEYgbeAAME1OV80ZG3pwR3rRbaA42Oa1GAK5bdtJOWz3qTS5U+0rDM5SE/dx0LHufbNJrER3d2QDt61Bo8am6V5H2SFgFB6Cs1pItJ2O00e3uYrgLLEGCnaUIxjj7xB9K12vI41DJvUMVGOvQc/hVW3YPBJlpEZ0xknrz61TuJ0LPDu5VOT12/WtnZENcz1Iptbmn1PyrZB5W7aP7xPUfkefwrp4dRjSwS6kkLkSCALGfnYt1bHYCuCubZonkdfmDH5Sh6etddoMkbaKi3CA28cjDgc7iRh/fGMVML9SqkUoqx0OnO8sCzbVjmZy+RkYUHHzepwOlaULozfIokQpwo6AevuaehWRHFsRz8n7zjI6lT/iKro6xSbYwxeUhok6AdAR9P61ZxbmjEBtcIWlJTJTGOucn8elXIZc24IjRIgCQi8kHocY/Kss5mD/vAhZgEIbGMHOPxp+mz7oJgy+WXYle4Y/0o5jOUbo1rlyQrIUUhlZmVcsFHBH1qWKJo4CC0bSYbfJjGR2warvP5MCmKLzWUIWQLgsDn+VWZ5iQWcurDkr2Cg9R+daIxdxwgjLBzuKEBEAIx7/yrPuVjKpNGIw6/dbGQTnkY9v61atyN7Snc5b+FvujHYY79KL8eW+UO3ywSyBsZB4z+HpQCunYpLEg8sRhRGdxHOCOfvUjq+fNAdeMyAcF/Q//AFqmZfkAdAEjXZ83Hyt0H19qEkVIgyuoIwoA+bJ6cg1DRd+osECmRmcAsco74GAPf8aPLjCnauIuBsAz/wDrqWAgqVHULnC9+cE+9RyxlXbB8/I2MQe2c8/T2osSVDE7sU2orfMwk/u/T19Kw/scM8kks0pAhcr9mEZO8+pPoa6RJBg/IgcYIAGRjPGailtXnkLrMNi4ZzjJGe49KpI0jPlKmlvsSESwNEHOWKgH+HA+lNubdDOuVVZHUhsHJAHI9u1a0YWVZ42kwoBdv9oYHJ9KjuLeKWLzlcFJsFMAggAcD1OTTJ59TFkjUMuATuGRx0YdvYVBMm6VFCuVYkt0JU+o9a1LiMiWSOPeNjhSpbp7/lVWaFoog0XKO4UYbnOeTWbLUjPuAInAOWJJ/eN1/H19KrOq7GI46DDLkkZz1q1NGxdgkgZxyzE8dOCvYc/zpH2lSxi+YjjJw2e4x6/SpsaXMzZ5f7vylj5I3ZxyeTjtzUJiIgAkUhFYlSuASPTH1q/Kh2fKVZFG3b13DqPyFVrofuVcEbJGxv5wp9KTVxp6meFGWPsQ3HINRugf5nGSG4C9h3zUy/O2SVDKCNw7/jUBJYZ+8hG044P5frUmgyWEKx2jcDkgd8d6qzZ2EbflY+vSrjMUi9SvBPbHtUc6Dy1GwlTyRnpQBmyRngY6YJJ7VDcpnDZyeOtXY1V+gOOwP+FV5gCRs+4Dg/T1FJqwyjKoKlQBjr9apTIy4HHTtWnIg5yCVJAz71WlXKKvYZGfWgTMm4UEDup9etc/qUAdWUqDnt2xXUTxFWyO5wOOayb1OThc56+1C01M5I4oAoPLb76nbRirWq25jmEoGADg4qDbkAjp6+tezQq88PM8itDklY3pmI2kAEkY471WflTySe2e1Wicbj26Y/nVcjA3HaT3rxj2LDGPyrj5qUITKp4C4yaYSd/BPsMU+V/LiJIwcUAPluRHIis4AXtnqK0tKvvNuVj6YPy4NckWLSZOfUE1taegjRW+6z8KQaGawtax29qf3e5nBPIXFSRxqJXlyxYrtyTkAVBaIREjkjZtHAHf1zVmJMSKJAe5BHT6UMtIsQTGWHcgAIyPn4waliyAoxg43EjIANGSpGOhHWnISG4+fJwQDUsoapOQjMA5GcAHkVDMibclSGPAA7Zq7FEdrZbcRnJx+lVzFuIhLEPjhiOaqI0V7SAGdpZjkAFQrfxfl0rXjRIdPihRQVYEuxOWznI+nHFVpIGjCqNquw2gE9TV+NYjCpxtKZLAe1WtAk7mNqNoXBdBuGRgHjHtUWnw2guIQWUzSnZGoGM89/Stxod8B8vGW+YFj2xXM6haT2krXEZO7G1QBxz1FQ+44u+h1sLo0cjDBVDhmxxwP5YrltSaQu0hICudx2nJIz3/ACqSK4uU0Ro/mO6QOVz0x6fXvVW0E15KSTkjLMX5z3/z9Kpu+g4xtdmjo7TSt5EasxlGwLu6knjFdtpS/uws/DAbAoX17+me1cjpVj5Uiy5OzackjrXW2rTOCU5QhWBY5Ix6Y7VUF3FU1Vjo1DCHzANwCnATqRng4PPFTSeYrByVUZHluUBP0H1qFJEktAzEu/mDJ7HA64/KnuYUVghIUKGG0fmcGmzi6kaEqzRkKFc8gcknJ/UVPZSLbFt8TojSFGUDJye+P61VQ4dlB3lRu6e38P0q1E4MTZLeYF5bOTj0+tTcGjQmuGiR2mZfKX5ieSV45z74q5G6XNvDNFvMeAQwGCyHnbj8Ky1KyjATcjjcT23eprQt3CgugDEfcJJ7+lXFmElYt2wVCW3r5e9iSBwST/MGorlvLCxsp2pz8xB3LjmpghVjlAoIbAX5evr+dV2Krp6sYwSACELZyR71ZmtyFXYg7lVxtDBgeuPX3qOQMgaVcZJDNgcso5OParHmiUAojoAwJ2Hrx93B6f8A1qhl+bakg+VW5I+X8Pf6UmWtx+5BHlwUyRg98dQoxTk8qUTqY9nVQQOv07ZqOKMSFEkG0KpY/MWyc5/GrcVsGiRoZTucY3rxjPUgdqLCk0ijDHJwY2Ef8JzzuB6CrmXhud+UNuIzviQZJJ70C2WAPK7NJJk4wNoC46Ad/wD69QqWfMUYMb7VyG52Lnn8cVWxLdxHSSKb5Vy4UNuH3mPPU46DpQzLAIpZdq3MxG/DEjp0/A8VJd+cRDEElJ3hwexA9fQe1QTq0jLJApUlixyMlwOhA+tAEV+NyCUPKFUsGcnOcDofrVCZo13KY8q65G0nr04GK0bg/wCjoFKow688Hd2Y+n0rL8/ELEqwmB2Yfvg9v1OalmkVdFG8U+WgC79mG5+Vvr+VRSZ8hm2xBSQSrcgc+vX6VZZS7KoY7SCSXOc8Z/zioZPuyM2QCy/McEk9Ovf/AAqTUQeWxjZSEy+0M2fl/wABVJo9+T5bY3EqueGP8WOxrRODG7BxtPRcZzjsP8T71DPtRNrZUO5Y7hhVbgbgO39aVhoxZEVXZlVWibjaQSP0781FMHlCpjnbhSW6/lz+daEkTHKhNhyWOOFwemT9cVT8sqVWOTBBySRgnHXH0qLamiM1nYTAM2D0ZW5496pXeqRwkoO/Q+9aGrRTNC0sGHdz0xt+oFcDqqMhZXcSbuQUOcHuM+tJ3RrCKepuLrWZSB1HXNX4WSdFePPOGULwRjrn2rgUdhISMllAyAcmux8OuPL2g8jkFjjHtURk27MucVa6J5IyWJcg85HoAahcBVwABzyfStCbGR8pKsQM9gKrOmAQeRgn602ZGZcLtYDqD3rPuomZZCNxzxjpWyy/KSQAaz7khUZjkJg4J7etNESRy+o2pkQjNYTqY5DG3UfyrsJ9khyuGUnt6Vh+JLTZAtwg+ZPmB/pXTh6ns35HJXpc68yRyPLKZwWGAcYwKiKF0TLHPt1I96mUMYkLHCtknPamnIYLkc9McVzHQQumHPUn1qlfS/uwm4lQcGtGUMSdgyxyOvSsiYtHLIGOeOtNDIYHEpIUciuq0jT/ADUgOckZYZrndOt/OvC8fRyCc8V3thbNAiIctnnJp2NIPQvI/lxqhxuC9PWo4Llmzt4C5BGeaoawZE3eSxHPc9Kl0tdoOc7xhnPrxU3uzWJuW4Y7FYblA4KnrViGMFfMVcSp0U1HbnMGSDtIJ3Dj/IqaN1LMnzBAvDjv9KHEq3YsoqOnDEbTkj3pqAKSJnyrkgEDkZ9KfFIpAiON+MkHjHp9ahCP9pVt5MbYCjHCmlsKxLOsckiKIg3l8h8+1SJuXIyHcc7f5ZqNoo0LBRudskrnqPWn4IbYWA5DblPIFLmAerAsygcg7jjoKrzDdJJvQFc4Qe1Wh9/CruXHWnXEZMJJH4561SYGQ6o37pXwQCAAKrPi1B8vaWPBJHWrAicyiXO2TIwSKragqi5TAcNIf8j2qnc1S6EsF85t2t2LyGQlmGcHgYGK3/DiytYuGG9EBYegHA49OtczEPOmA3KkmSAT2rqrCCS2h+zumwKd5PTqKcW2KaSNyKQxIqpvRowBzzkE81eMnLsmCD1OcnPbiseBy+xCeVOBg/zq7FKEXa5J5z8o4PvUylqc8o6lhbgmRRK4UZKqev5/WpYpAGJxz0GT0PYE1Uj3DLcgYweeoqyhRwgBI3cYYZP1zUolmhGzKiKSgTILQEjj1x7VpadcrP5ksZjdF42k5wM8cd8VgwIrMCybScjcevFaECCN8iNRJ90ZHQEfrmtIysYzimjYlIG1ZJsxOMqPvHOckH/Cqs8wjQuB5u75GVR8q+n0+tSwt58eXCJnoGUcN6j3qC5RnYM+Q4GB5Z6AfzrW5jFWY5hCsQa4Kp5fzRlPmwRk9e9Ys+rOTGY2m3AZPB4B7n0qbWJ47K1WF38tdxIKcl8DJHsTWdplnDcWxu45ZIXWEu7MC/JYgAjvlQcYoSb0NoJRXNI1bHVGbCsFcbcIVOMrnnB71v24MkMnynayAIytjj2rjbGRbeOaN/J2ArIsi5JRGGQAPrwfSuosZywVAoUhN20dvb2prQzqxXQvSFXjDSB1jRV6jBHt9aYCZN8c/l7znDDjjtz9O9OLHcgddwHAUjjPUk1EzvncyxeY42lQchiOP0pnPYjk37N/m7mlJBO75VH09Pf1qK4ZUXKybiGKqq8ZwDwcfic+1OuskhIokaSID92mMg+/161XuXWXI3KhU444znnC/wAqRSRnJbeQYVt41CBC20tgMMcn+RrF1MzFGeCfyXT5XTOSTkBQPfn6VZ1q4WO0drQBpMYwecNnHHPXFZ9xc2Wm6Nbzwt5yXpIEj8fIBiTdg/e3Himlc6Y3WpDb3sscxW/UrIshj3L13rxt/EY5rYt3MwjUugdl3ZZdyrzz+OK5CElr1tu4i5d3DO2VCLx/30MA5966eyxNC4ydhAUSKQpYA8Y+uMmpasXO25MJQEfyk3KAWKjAPy56VJN88AS3ZydoLgtw27p19OenFK6BrkGMqvy8bT0/GoIYJ4rG1FxIpdWOW3Dc6Z46cd6kyGTRRbEDqzANjGc847H0JGCKqGJtqLiM7fmLZ6ccf0/WtK4VwkgDlY9uWaMZB59O1U5EBQt8uCcqAcKe/H60rFJkMqRzwvCzFpHUOY3OPlz7dx61zHiXQTePfX1rEcuv7uFIwoAA+ZuOBgDp1rp9nzCURIZh8m8HGATnv2pVnAlkRmATOEKDLKpHzMT+lUrWsyotrU8ds7cm5jXk8fMMY69zXT2Fqluvy87+OfapzpSQX7H7y7goH8RHbmrgChQHAUhSCM8Y+vrWFjqlLSyIygB+7xj9KrEMGUbMAHHPtVraqAMyn5RkE9vamZMm1SB0zuJ5HHH0pEFF0BfaB8uOCTVLW7fzrBijbWHt1rT2jfgsDKSBk9zQ9sssE0aMd2O/SnHXQR5ha3r2l2Uk5Rmwynt7ity5jW5sZIxy+Mrn0qhrunSRXIOCzeuKtRs628bYw4HJpxdtCKis7oqEnKrjgHgntVNziYgfdAPXvVqVsvhsYByMd6hYbpsgHOc+1ImwkMXmNlg2TwAO9QXdoA4YjIPXjNacKjPynEZHQdc561Zwm457Y3D60FLcXTdPihiDRqGk+8uT1rbgGeC7H5uOMbfas+OTy02qc9VOO1X45CYgYxkgYwf60XsWhZ13L9wAE8A8/iatQxgKrKRlhwPXioVG4ncecAEen0qxGm23BPy7M5AqkXEsQyNJCUdlzjBDdKsEsq5Xb8o7dqox5VQoA+Zs/N6Y7VcijBYvwrY53d6NWWmX1QPtOTtI/h4NPkQEkqxZSOBnj/8AXRanciZAX5cN396mlQIFO4kbgOnrUyQiokISMruYknLHuO+AacY0P7xlDFeOecj096ezCJ1Dswd+AcUoyp6AKDjOKzAWFiNoUEKx5PTAqeQgoNo7dz3qi4kbCfwNknnlTViMmQB3BGOMEdKaBorFAJG2jk84bn8KY1kZsF2Ltu3Zx+NW0bD5/vHHTn3p8Sqx3EEZzgg9qtMpMyrW1VbgnawUtgkdfetvSxKsTKx3jOcnr/8Aqpv2Yn5gcDPNW7f5dwRWyvH1FGw5SVjQtwqgFcA8ZLDrn+tKx+cEDAGQDjtTARsJPK9D7UZCrlc7RkKQT0qb3MCxbEKgblj6nmrSMDjBUgHsMVn2shDEEhol+6ccjHv357VeJ/jAU4HTPJ9yKBMvRFQuDuYjoCcA+5qaCQL5YYHfyMYz9MVRR87d2FJOQf7vrmnwlxtUbGRvutng+/5VVzNq5txSr5OAE3MeSQeMEDNLIyRgrK6u2CfMI4P4DvWUZDuVVG9c7WIYgAdsfjVnKAOnlACIkAK2QW9K1TMnHqcx4gWWORnjLYwcBn4x/n8aPD+oWsH2ma4lkityCRECQjOB8q467eSSPetTWIPtMDiQFRjIxyQa44xFZW2hnk3Z2y89O+fU0KfKzqjBVYcrL9vdzTXdkYpA6oGDvIgVBk8nPuc49BXoehRK0alVYluWGcfia4TTrC51J4RdLGscWSMKQF/+tXodmwsbFflKycjA+fdgDH+NVF82phibJKK3JUlVJFG5Y5HJJB6Nz1/AU25mjcMAmQEz5mMdeu2uOvb0O/nNIZJpZjEm18KueQcfTOfStbT7kSweZKjJGhMmMgjrgZPpT5jKVGyuWbqUq48oImzl88ZJxyffFUJ3W3jbz0DEc8Dn2wPSpJnCnKhV3nMmM/NjucVTlnAeXcSzjAV8gbR6Y9B7dahscYmTqeyKFmitoZIWy0kak4Ga8/numINuNkaBgxIBwTnoQO+B1Feh3MjyLtBTcRgErjnuKwrvSBICVA5Pb19KnmfQ66TVrMzXuJYz50M3Mny7UXhW4OB3244/KuzjkItYVkwqqo2oo4TPJJrk9K0iWK7LMcIOAO5I9PeuqtoCSgcEAD5OSA3qSDVKVyaiSSSNNVjkjYJtjlJ/iwOuMVYdIX3oiFC37rco64OeP6/WqsYQOdsaEHG5wv3h647nkCrZfHmxI+x0XBOep7DPvVJHK0VXiQx5jGFLYOTjjvVB03OwVlwcYIHBI6kf41oNC7BsqyEAkAr0A6jjr161UcncSRFlcff6kfQdOKBooXSlc7ypQ45DHjjkH3qtLIojwN+SM4xjPpV+bYd7BSHbAHTkfT9Ko4BkJAAZjsyOcc8DNQ9Gax1M9wcqrAMDn5gMZz/WovIWSEKyuo+7t9/rVwqN7YGCSTj0NVzvjU5OSW4Kdj6VlY1KdzGUXPAAG1yTnAHANVZBIhCMAx28tnGDWi/M0gUqZMcDtg9KgwxXY/JwOf7x70tBlZiSoBRRjA+lVmcxlioXOexwAf8AGrzRgOwUbvXPOQarzRcJt+8OoAyMen1qhGTdos7MGwSOOlY91FsQoq8c4FbtwpSRVAJGMbie1UJY94JB+f0P60ES1OTb5mY5G0cbaLTLFyx4B7eopDKN+wjHc1LCq7s/Lwck+1AiZTggkEnjHvUlmPMCuWLDr+tM3McgYX+6PaprRdkvs3T39qComjHGGYHPzDOBnr6Zq2qbtowwBbPHb/61Z6ZiYbO3r9elaUbYQlAeTkk9qTZZIBhjndknINDXBDhVGNuDkd6TeQh3kZxziqWTvbCb1xgYP6UFxNy2xIyMQu9c7fXHpVoMQjbl3lhgoDn8qztLBkkTKsVTjHc5rRiRxc4UDaB94dB7Vr0uU9C5CykpCcsrZ6Hp+NTFmjlwzF9xwMdqqKJBM/kMckZHotWYvMKAkneDhyRgfhWcmBJNGzlTG5V1yQBznPrUUZYkITv2DcXPc+lOYhV2BgMHAYdaS0k8yMBlKMrlSrDlgO+fesxFhhjdzjgZNOjAkJCE/I/OOO1MD5VgFbd06ZFOXaUKggknOaAIyhLkLn5s/Oei1Yt1VjgZDdMH0pr5ReCNvT8+pFSxkgZUZPf6VQMsCNcjkk/XipV2qx9Dxwen/wBeoogFY5xvBHTjNOjVllTBypOduM57Yp7kltYVCjbkgZJB6g9ximKR8o+YZy2PT2pQzAg4ySMFvT0H50uThCxAYHO0d/WlYkYkUn22Py0BRlILsMbCMYrU8klFLLv3c8Dbj61TjddqndjngDvzWn54Z8CUHjByOv0PtVJClcaYymWAJVj0HYVGsaJggEDbtAHQ++KtBuF2li3GHB4J6cVHINpZctk8EeuO1BFwidkmZFwMjG3HBzS+aNxJJyODxUBWMsuwMPTd/OkLDcADj0zyKNQsTNNvVgMsu7JPOPwquLWIOJGj9RgjJBpRIQ3Y45x2qaPZnJ39efQDHNO4fDsWbSQWoZ5E8yNSAQG+YY/w/nVrUL6Nbh41kVLeQEBs/wCzxj3JP61nXcyvEFI+Tge/1rnL9/KdvtHzWpOeFJbAz0xn8q1i7ImNLnd2Iujtcal50U2YFbzCg48vt36muwsYwkI3uzgtkbgFXNcDFrFu1rDEm52DIv3x06nP6e1aia+bclbn/SYNm5U3YZWzjP4D09KE4m04TkkjppXB3bdomyQ7jjIx0B9KzLgRKc+Xv4OMcgmsaw1v7RA/my7nBwAOjDOfrV4S+ZlgygHODjAHsazk0R7Nx3JlZCq+Yyj5fwX2pjos0eD0LEDbyDx3qNiiocMCMZAJ6E+lIZW8wAuHAGSAMZH+ApJ2FYaY1QbmbcGPGBnaTx0+lWrfazRncfN3EHLZ2jjtVdAnmbiOWG04Gdv4etPJdw4yoJGNqLncfSqTuKSLcE0JvAMFV4VUySgxzkVK07MCSFjzlgO3uBWcW+b7yjOdy5IBP+P61PEWAwyyKqtuQAbguO498VojNxLca7UQbfKBYqcZOSf17VGzyTRsFl+bftcyHAUen0/xqWMpkshyVbAGfvc9fpUQGWZY9rOWOT7dTinYlEHlOkXmONpI2nBAJHqB9PWsmeeGO4kjcKrAc8ADPYittozcB44/KWND8shfoMHt1J+lcn4jaKXToZLSYfaFbOzacyjOMjHTHvQ46GtPV6mi4TaNpwpGVk68+1RMrPEc53A5I75PcmsK2vJolVJJQJCeRnH4H0rfgYSAqrFsjHPQe1ZNG7hyldowyL5gHA69sioChMhwuFOCCD1NaNwoIGfm2rnBPFQFFZPkH7xccf3fc1PKRcz3G0q/G0kgjPA9xVSRMD5RufHykt1Gf51oyId2GxuBGMenrVeUYbJ5K8EL2/HtSsxmbNiVNw4wTz2NUpoflAHBDfnxWmyENjnjoTzkVXuUPkMc4AGc5yMihITR51Ht3YJKgjHIyafEyhgo4B49RTAC6rjBOc57CnKmyWNE4UDnj8qVyC7syE3DkHp2pbiZLaAGTOwnGR1FIzYAPBHf3qVohNEnGM9c9vakUi9bKxT58Mo+6R3q9GMjnnA4qvAqoqYIz6jipGkCqS3c9qCkx0yED5iWyRjHFV41JdVdcEtt4P6mr+xCrFiccd6WOJd5Z1A3enehFxZf0+AQqxXCuQBk9KuZLRuV3qQc8fxVWgJCbdpIxjGatxLtBznnqf6VTl0GEau0odCysV6HgfX606W5Cx72O9R1YdalBLMThA3RST1NRDzNzYAcY4Xpk1DGhtsu1d2/cz4J3dQPWrIjBiGM4b7uDyafEg2gYxjqB1H40ggMDFF3bmGSRyABSsFxVI8sMRtZAQRng+9SxqCW+b/Z+v0pFK7ym3OehppAMyhVyU459+poAV2kAUbeDwCegqyqtsUl+Mc5/iwagQ7shlwi4wc8/TH9aUB0T5juboRk8UwLKuW4GGcn5sdT7CrMLckgdOc9CKz0JBUAlfTHUjNXVlY4JGCTzx2qkSy05xsIYk9CAOAPWo3ZSwUfMoAOSKMl0C5GQevtScKuR90d+maZJJDI7spIxjuT/Sr0blAowN2Dz2+lZ8XdmbaauQHb93IY9cngUBcviTdggbVI+6vYfXtTmdivUYOQVz1qAAbSAW2kYIB4NOQrGVJJC4wFoM7DSCmQXAGT+PtUSlJCSuQO+amYbyTIAAQRk9/eoPnUkArjtgd6Bji5J2bh83AwOo9KUOwk5XdgHLA8H2FRMWJAI6nkk9vpUsbgKFBwoGc9qAY2dR5TEgY67u5rjNSkWG6JZnJbJTBxjPU++elde53sDwSOrZzj2rD1OKNpSRHvJGafQ1pOz1MfTYPtDKWw6hiduNpHP+elVvEHmLclgWUsvODitZbL7jLlSB8pzii7sTMAsr9ufQ0NaGymlK5neHAdzNt3Z9fWulDKcgqN38qoQ2kVvGQhwOhzxzThNt2kPk8tyM/nUPQipLnd0XEkQMr5LyNwWAPyikVghwS2w8g5qorkMcMMP0x/D9KYkmQQHLnkAnn8/ShMzsXzM4Xd5gY5OTjBx/jQJlk2ruTy9pwmDlj9f61SQq3OxiW4Pbn2qWN2Iww5HUE9SOwNUmS0XY2fywAilQc7d2Rj69v61YhlUKNsb792C2ccnvj+lZnG/BByRkEHAIqzAQW4wWHUk8Yz61cWQ0XYHZAXYqxVicnoR+H40l3di2iS4zujBO0KucHBNVEkRZsBjtPTuPU1j3lyxVw5D8lk4IA77Rj1rWLJ5C9dkXTwX05d/MBkMJO0tjGCR/dOc+4p06Jc2BmNrNI8YwI41QLgDPU898/41BpdxJaStfWn724kRoPJkj3E7ux7KPukEccYpJJmsrhbW9MSTQgL5TEFt3X5sZ5747VtaxN7uxlajp9rBqr2tqZJIiwUPkhjlQTkdAByAOtdDpMbrbJuJO5Rlm6+38qo2NgztO88ryKsjSMG+XLH0A/X1roYoXjgYsG8wHmQYx7AfSsJau5rKdlymdJFkEHb5Zc/e7j6VE4G5v7zLhuAMex9a05V2cr8wLbic8BvbvWfIsp2ku3970yfSpsSmUpRnG4quAVbjBwKo3R2h1wQoXJI9a0ZcGSRvldiOR7+mO1UpFaRgrjkEEgdM+hpFlM+Yxc+XtBK5IOPxqN9oYoCuPmOcYB/CrbqxBLKME4IByW7A57VSn5ZwvrsHGe3Wp2A85jjC5wPc88Zpz71KOOp6jFJCyyoSSM7tq/XtUzRkpiVjzjOOx61kQOi2kojfNyc+mavIGJxxtyDmqqD5coMsTzmrkYHGepPr+tA0WIyccgAe1THIbCDPTPpVQfNJhwckYwOhq2W2xgk7Rina5SJLYo6nHIJ4B7Vdt1DNuKhhjnnoazoQQ3mIMHoc9xWhZKpkCEkEElVz1osaRNCPGRxtxzn3qyudoxwh5I75qizKGx9/wCbBHpViJvmIGc9KQy2nHG0EDv15pS44X+HOeT0qvJKqOEGQ7A4J6HFOViTkEZHXd2pgaMRXegJO/IwQpYZqSV0toWkuSsaMpbD9hUFm8kcDnceOAo9fWp1ghkQxyxhgRgp6+/51RDI49rRqQR83zE4xUj7DGQOnXdjp7U1xhlZCSmOuMD/AD7VJGud2F+YgHP9akq5CkY2ExjIUcikPyktnLjk4qV5FXcEAyRz/s4oyxXLYx6jvS2C4xCjqrfex09TU5BLEHB74HSmQl1kXJ+X+961OijH+zjgj9aZI5OOCeFPA9qdED8xkfg84PO32puHGd7Y4yCBipVwV9WOTk/SgBVO4FzGVycYJqxG7AbQFHqCc1X4wxHXP14qSJhnkHBzz3PtRcVi3EWY7UPCDJAqRDucEKTt7se9QREFc5+uR/KgsgwwZuu7HeqJLIJV1AcA+h6//qqOVBtU7tpPOR0NMkcFiRtZ+5HYGgkZAHQdjQA7J3bu23jPUVGwBIYqRzwM4/Go3JLEFsnqR2HpSb9xyWyAce1ABITk8AZ5OOMCqz5CkgjcM4H9afNIA+MHpURbluNzEYxjFCeo7kROOGQt0OT6+1McpuAZTljmp33Ajbjjse1VHdhknOSOnpQ2MSaRiBgHng5FQSEqMjBPQ54pHkwDkjA656fhUZfdkALx0LdKhlJgzqScnLdsdqDIMHOFjxg8+9R5yV+cAkcYH86gDrnIYYPBwO9CC5bEhJ3HJYDk9Pxqe2c7QGHzBeFY8YrOEg2hshhz83Tb2pY58Ek4Knjd0z/hVoTNFXZmxHld3cHAP19KmjcBgu5mKNjGeD6c+lZUVySxDPucHB2jGfrUySB2O8huOUTqR61SEy7O4LugJLDkZGBkViX4mgVWjmXdITtGcE56/wBa1DMwOFIXgYBPX8PUVHHE2EEpQjODkcevB9a0BOxUsL2GWYebELYwpnAYsXIxluep9BWnPAv9nGRot4nYJnYTJkH73HBYjjnoKz10weZKp2MXONzA7sdxmkjsrhWEZaMxiTan3sgHt/n+VaXdrC5Ve6Oh0mMLDHJtHTCRq3zdep/D+VbVyf3ZIVmkRRtVcHP1qhaB4Y0jRQu3MjMe59/8KuwzKUUM22RhuLKvy47n35qWZS1d0VZVcyAhjlRtAHQE+4qhMh3PnaFJA3Zzj2+ta0oZYwPMZjkk/L97057VTnRCw2qVVMHaTnHp/wDrqQTsZsyIEk8xQCwLOAeo/DvVTaPMUsTtJyMdOK0ZEDgk5G4gH2x9O1V5Ig/m5J3A9CfT0qS0ytPG58s+Sdkhwr9i390e9Z2oxiF5AEkjZceYG6hv8K25kjurS386QxSQpgLsLr168d+a57XrotfMYhJhEVP3nDOAMZI9f6UOPUcdXY86tApgA9TuGB1xV1CJIkkQ/KRnkdapac5R2U9QMEAda0zuRQMDbnPTjHpWLRJBlSSi8FRkE0+2DKAVLEqMc04Y3HPDe/pTwoUccj196kaZaQ/IGxy3OP6VA048+NfmVWBYhhx9KXzNqkjJz2FLuRQC7HIHIIpjLdu3zMSM56EdDWhAQeTuBAzgcViwTqsihMEkZVfUVpq+7HXIPzVSfYtM0YHDDKYyTzmriNhF+YcnAHcfSs+IBCjYAw2TVuIhix6EHA5pMssYCqQM8cgelFvkJlue+cU2RC2ME47U9TjczgoAR3zmkBatmZjkqEA456irEbkscbjjjHrVWMfNk8k9M+lWEI2HgAr0z3qtxWJgd0Q3Jhskkg5x7U53wqgELnnPXFQZxCowAM5Jzgj6Uo+b5iQq9s9aAY91wW2t8qnoeaWLBwxGAM5bpgU1QNgXpj0HOe1PQHBY7fMxg9h1pPcRIgJBKAEd89CKdlgSAckHIz2oLhVATnP97igHczA4A2kY9fekIcZlJADnd93JHWng7m2kjPpjtUOQVUHaWBwMdAalRyCDjn/ZoAdFjHzY3Yxx0NTREIuSRzxj2pMkMctjHJ9801mIC/NxnkjrVbE3LKvtVR97HTNKZGUF2weenfNVFlAfG1yeo9CKkDDeSFYr2B7UXET+ZyCRznrTdzBvmKn1+lQOSMHdgd//AK1I0mVKtnJ9O1MCQyEscdCMfUVBKzlsYG0clQeRTGJ25xkr7dPc0yN9ylSAGJzz6VNh2HSyM20bxnPOO/0pkLYQ7GyhOevQ1BLhckLjHc9hVWWYoxkXaSB0z2ppDWuhqupBzsyuOueaqXX7tQQ2PRTz+NVP7XCM6TBVxyCCc0yS9iuCCCD2AU8//WqrFcjRG5w2MjHUrjrTQd+FI4zkDsKgkfknzDwev/16fEd2dpI2jqR2/wAazsAjyfN1baRwV5wageUByd67xjcuOlPkZlL7kCrnaR/hVOVsngcZwOxz6mnZibJfM+Ri2MZ5A61EWKDkEg4GP8apmUoTzwDhuc02aYBmUE7epHfNNE3NOObcTuBAHygD+dWo5WUY+UZGD6k9sViRT7mHy8D5T6sfX/69XFmQKAFLlPu8Z/L/ABqhcxpiQD5cglR8w71VGpGMqHKywkkDuc+/+NMaU+W6pw+NwJ6Z7ViXUpaf5wrL0YjoD74qk7aouNjo471rmRvJcZjydxbr9f8A69bFldpM2x5VjmIHyBgSenP6VwttGkjx7ciUEA7iCCM8V0mmwvHcMSY8k5DBuenp/WtFJg0uh11rcPsVWZSmSWwAS3OB9PpU4lMm9FbBZdrY5K46VlQ75CrsNjM3Py8t2/yasNKRyjgIcADGckHqTRcycUaQUNas2CNmBucZYjoBVW8ZFUshHl5wD3+tUbvVMKjj53UZXB+6fp3qJZ9wSIsZO7gjBX69znr7U7CUGWiE2KckYbjsTVZyhJyOAcsTzg/T1p4YsXwQeflwPu+uP8adDI0RLJt3r823Gcj396iw3oWJXb7PAsd9FAAoDqz7TnPX8a5DxBbtNfOZZ1uB8rFg2c45Az7V1FxfOS+Irccg4aMH9axdXzcTl2EavgAGIbM+xHpTeoQdmeTQLKrRSK4RycNWwJjIODnnp7VlRHEpyGHOW9OlXYCwy2cx4yMDkVz3GiyB82T07CpGGEOAM9fpTCpK5T9aXJUkMeDz15qRkattyTjKjJA7/SpbcMWPHy980oCsucdf5VIqAfMDkY6dqBjYgDLyBvzgEVeTAxu25PXPeqTK29SGwVOTVuPDICo68/Si+oIvxnAyTxnJAHt3qeFcKDuAB5BzyKy2lKRfIec4C981at5nEaCUn73JA6fWncpG1G+SFLHPvx2qRWI3ZIyOg9qorMrKAuHIIJyelWI5N3y5B3d8dKBstI5GAeWZuAvp2zVsAnbk8/pWem8oCAA/6fSrYbcpIzjI79atAWR+7+6yqwPT/Pemr8zZH8XJNRu2EyMEDJJ9KEcvsaN90b85HT8KAJwSuNpDenvRKWO3DAN39FpArO4ByMHgKf50jwllUEYC9cUmAqlQ4BYtkccdPxqRCQxJIJP5/SogSO3zZJxnI+lEeQdzZGOB6VIE6n514zUq/eIDfTsQKgVsN3PNOj5bCHdtB+lNEk6EooC5P16mntyAeAQOCe1QjlSTwxHPfFI46DB4GabFYkLKVwS2Rz+VKHOcEnnOarhgAeASevPemMxwAR06k/ypBYt7hvbPLdOajZwoOzBPBJzUfnHYMdSccelVWk3K2S20eg7UxonkkDx53ZGelQNKSWw3AOFAqFyx3bVyR0JqGRiVKyDO4H8aQyad1dWQksp4IrP1C7htoGVg27HyhSOvvntTGnSIMHYhBwOM1ia/MoULkrg56feppjTsyleXcayttJUNjgnPNLaXpWUOs+CMg7B6+tY8lx1AdsEdcCi1mG/AGWyMgDP50r3LcjsWn3KGI3f1qIXLRSjbt8rPU53D6UyNgIxkY+Wq0jF1IxuHf3p9TLmNAXZlGSmxc4yPuk1VnuNzE5X/AGiO5qpGCqkLnAGSR6VHLJtU5Iz1GaoiUhZpdpDEHJ6n0qrLdYXk7u1VL26VV3ZIIHQ1SluQ3If5hjJH9Peny3MnI1xeeWQm4Nk9AKvRz4CKGIXBxzkD3rkluwZdpIIBwea0ba5BxzkHj2FPlBSOphuMBSC3HHI+9TJUD8ogDdfb8fes6ynLkjK5I6kcitBGLRjYCzEcHNSnY0jIsQgyupZVeLquVIIPatqw3RlMfeXrz0/xrJgyVAbI3Dk55/OtSBzswAAw4BJzj8apMu9zbiuAUG0FskjdnO0Y6Z9KRJgWIjcLGVPT+I/4VQWRVJZRwFwxHX8qHcbVXapjXBCg8g1SEgmPmzKJAxVTuU+vqAB3+tRLcbh5igrLKv7vzQflGcDgdKjktt77huAPLdiM/wAx7VMseHJkVuxBJ4xnqB2960TLuXlO4sgdtu0ZzwcZ6cVOshDNtRVwSCcHGfT8Kr2yopDSAsSTnacD8KmYfKRtEhbg46fT61LMpWuK0MsrKI4tySDhiM7sdcdqrXq+Wxie3MbYG/DZ/wD1fhWtHOGsSUjuG2x+TuRflUHq2fWs3UtslyQEZVRFjAf7/Hc9hSsSm2zyWIKwBQ5B4qzAgUbSfmHfHGKhRQ2WiODxnb7danQ70xjkcD3FcxQ0jYPkUZHUZ7VMpVSWGTz0xyPpQqqQMqMHg5606U7OVAwvP4UmUKy4QgMD2PHWlgwpUEcAY68U23YSqzKQQeQD1/GlMK78knLdBnjFLUZPlGywyDjHI6U6EkPIucgDp/WkVfmJJBGMdO1SxghmB4x0FA7CgJMQrKGUc8jqasoMgZxyeuKYVwuRjpT1BGFPYA47GqBaFkfKP3eAx454q5GCu3DA+ue9U2ADZbJBOVPoasR/K2OD7elCRVy8p+YhTyOcDqKsQbt3P3Tjj0x/Ks9rhYxuPQ/zqlHrOCwC8Z5YHkmr0WjCKb2OjUNznI+n8v8A69SfdG5wAQc5HYVT07VoZmkBwmcFcrnj0q9NuwMMpyM8fpVOOl0J3T1GPJskBXgdwOeKGuAJgrB2DDOQPl+n1qDBAVkHzf3jSu67gq/KSenPPvUASEnb8pYHGeaRHLMw2sFB57596iDDcAc/NzzU2MAcjBJ6dqkCVGJBDDtzn9KcrZAyOnpxUJZflJPI5x6U4OSwxxjrjnNOwE4Z9pAwf6UxSWkwHPXkt2qN3wBnIwODUTvv6MT3x0+lAEvmkH5cMCOT6VCz5AAYqo796YeQSSCe65xTS+MlQWIGCO9ICTIGMZfgZPY01pgXyW47j37VE0nB3kEntULSgN29/rTEXA37v5hjb2HaoZCMYTIxySf1qtLO0WSAWIzjH61TfUN77SrIx6kGqQ0h9xgAEg5IzjpWTqQVkG7BHfHar93KrDchB3evpVKbd2AXI496kTOWkWFJGzng9PWoxcrAqnbtAOSAfvVp6hHLHktErN0OBu49qy3AVR/o2G7lxnP0FMLm7p159ojI27H7DvirEkmGycZJGAOKytIRv3jyB8d8j+VajgbSMggA80EPcYzAFvlPuBWfevlQVJwvQe9TOxAPqecetUpWODjGB1HXFVEykZl8/wB8FuScg44z71hTXXl7skgqcFc9RW7dIpyWYq35A/0rj/FZkgi8xwUkJ2qw6N9a6oROacnuLDq21lIkwd2COhzW1Y34JwGOc5yOuK818wjoavWWpSwsmSWVT0zVuncyjVsz1zT77DqDgk+vQ10VtOWwzDOeT83SvJ7LWlbA34ycD1rrtL1gPHsc5xwCO4rmcGjrhUTO3juM5wTxx1xmrkM/yoFQcEFiT0965a0uVyFQkp27/ma1kujsUoT/ALRBrM2TN+O4IDAsevABqQyI5Kx5wT8x6EfWsmKVSpyQVIyPWrSyZjQtlQOvGDVJl3NGMgSKzKGYDOSeasRdcZ2vjIHr71npMI2JGWbOcAc/hV2KZh91/k6dAcmrTFqXYEICiX5mJ5JPFOk3MuxnAXOcY5Hoc1EgfzcjkN97C5IHvU7SKiOgXO1c4Ucn1GaZDLkckFxZqHuY0byTD+9PGc/eAHXNZ1/Kk1wphcyRqioZB/FgdcVpwG5+x2yWSxFRHht0a5DZ5Bz296bqSiSGV28siPaEKYXD/wASg9xTsQnqeMblVeCFHUbep9ae0i7DKBhCmMg9qgjAeQblyeqmpGTAO1c98dia5DUuxBZNuCSVAwT9KcsKjhhkc9T1zVeI+WmRuYg+vrVqLqOp78mkUMtoYrONtgGCe57elWFWNnXdyc5UU2VUaP5uV45J61FGdk23K4zgAdfzoZSLSIUPynC9CaeAMkd8YPrQsa9G43csD2qXAYDdtLDketAxIsHby3Ixn6etW40G3eAQB0JqtCDngnGM1biDBAHIKj0NNALGd+dhB9/Wp5IxgbsbfQGoIso/y5HfgcVNle+FwM4x60xMo6i37ghSx759a5xZirHrzXVTRj5kwFUAYOe1c1eWrQyEdzzSmuqLpytoXbO7ZJAwIz97Fdlp94t9AmDiZD8/PX0rziKTDAk8eo6iui0Ccx3GN3DA8dqcJ9C2uZHV4YLgncTznpmo2mCgBTgnge31oRtx5C7sZwDwfSs7UkaQRN5zJJFIJcIm7PYgj8abMjR80K3yknPdqdvxu2n5COpPBqr5nzZIAz/D1zUsTkNg/dYY55wakY4uRuBzwe9QQ6nDDMWuQXXOBt4wPX60y4lPlSDldvGT/OuOuLl2nYOxB6dKHLlLppS3PQDcQzMVt5fNX1HemMRtyT1OSc1ymjXqpOuXwp65HH411A2lC6qQCMjntTUubUmceVkZfJZ1GR1Oen4Uin5sN167cmkJyDkc+3r6U1lIwE5x196RIjuAw78ZNQPk4OefWnOzAHCqOcY6fhUEgyy4HzY5waAGSyEqcKGweOcYrOkzlhz/AHif8KuT85zgg8fWqzghQCTnPPPWquF7CtJ8mO5GRu4/CkLZPIGcdqj4zznPp6VHIx5yME9R2qepJVv7vG1VZfvdQOT7VlTXytiMLuOckjj8BT9UdEYM4yw/unArOjzJL8zNvbp3wPc1auGhqLenyo0yygdgOPx9a0EcyQKw49fpWPAiE45YE43HitmKMpHtDbgen0o3IZDMGDHnA7CqkoUAnJU9zV1jjAGSAOhqlKVyc4wM96qJnIoTDzEIwpH5VwvjSGTyEaFGMKP8xPbiu4lYDALYBHJHX6VRuI4bjS5bd1O5mLA8da64bXOSor6HkueKDU99btb3DoeinGRVXn1rU5ixE5GME1s6ZqjwONx49R1rCjPPpUqk5waHFMFJrY9L0vWElABOB2rp7O88xgSeF5rxmyvHtpMoxA7122i60sijLEHp9a5Z0ztp1r6M9Hhlbagz26gdq0Y3ZcFMhTwa5W01DzCACMgccda2LW6ACkHgdyentWB0pm0hdlL8o6nHHJFXDO0YwrAgZO0dD71k28yhXxkEHHXp/wDWq1FNh89F79sCg0RrQ3TCPcZmOWxjJwfy9qu/aMlCcFeoA4x71ixzqMlPuZz8g6H0FWVuAGCpEBEw5yDzVJ9yWjprZVMEYe2WfzYGk8xifmYH7ox6D0qnqMC+f+5UIrRqyx9NoxzwehpomggtLbEdxIxBkLo7KqtnkYA4P86bcuru8ypIVdekuSxP/wBetdzI8nj45zwO9TZDdOvaqQlCkbiMnof6VYgYCQKSpGOnc1yM1Rct9uCCoPr7063IDlfvc81XZircZIp8LKxO/wBePei5SRoxKsi4CAwkc8U/yEBY7OAcj3NRW8rMgYfKM4IPYVODjOOuOpo0LJVQt8/OW7HtSMmHVlHOcc1InKEE4GOMU8oNylh05XPrQMjYHa3TpjFTwqBEh/gApxjQAHad2Rjjj3pGO3kbsegH607CJI26ng9eR3qZUyOHG0H061Siny6pIVHOM9MVaO7Z8qZQc5U9/SrSuDQ540IJdsY655H4VRntRIiunzleh61bJfcQwGOPl9M1MUVWO04Uj5sDvRYnY5uXSy0hYcEn8Ku2Fk8I6HzOgz69s1peWMg4yOh7Yo3FZCrAbSO/B47ZqeVXuVzMnhZgNrHp+OfpTi3O7ceTzn1qES5fI4YYJA9Kb94HOOecetJiuTEjZkEbvrTlk3MGY/L0OehqqCN57Y7dTj1NKH2kAL/gKQya5IlXYu3ceuc4rA1HSPMYtE2JPfvWyr89ccc0dSoBGf1osnuJNxd0Y2l6U8coabgDoa6TzMLjjAPJJqqCvUbs+p6U1pUKlcZB42kDHvTSS2KcnLcv7xkDqWHTP60wv8p2ckfpVETNxgEr2HSmyXAO1R+XSqBK5Y3B/U7R37VFIADtOAOvNRibcwDHucijzMkZO7tzSsJobMpxksB3zVSYHeAQBj1q40gbOMnHUe1UpWwAoHfik1YlleZmTkfhjsKY+SMjgY4pxJHU9OPrTSd2OoY8dKklmVfwM5xjcOxIzWTJvjLfLz+X6V1DKrjGAM+/WozbRyDJQH04q4sVzFslnllTzQBGh3D1HtW7uLL8wKHjgc1GtsqY+X3JFTbRzgYPv61QmyF1PyjOcdjVKcZG4AAnjjv71ZlYKp5IOPyqjM4IOcEHn6U0ZyZmX+BE3Ax3NVXx9j8rPRck+p9Ks3bh2HJDKeKxtQufLV0JLKDzg4x6n611QV0c09GYGpWqyXjZIRPLyQy9z2/MCuVcbWKnqK6x5IreNnkkLSNkBSefbPtXN3hLXDB1CsOCB/Ot0c0tyuhxU74wCv4iq/p6VZhPzcigkaDxVq0uWgkDIeKrSL5bkHoeh9alWLeMj86loadjttI1RpFzuyeM811NjfbhycA+leTWkz20u7nFdfpOol1TBOehFc1Sn1OyjV6M9EguwSMkkHv61owXGXXLFk9MVyNhdAYY5x3HvWxBPuUg5I68dKweh0pm8J2A6jP54qzby/PGXJCH7w3YBrHjlIKlS2QOO4NXLK4EMkcm1GHOQ43L+I70i0zrItRVrS1RdVhttqlWUBgWPYnFPa6IUk30c7PtHmAFhjnk9x9Ky7fV3MqjyrCKQnILQcf/AFvrUhMc1088sUccJ/hQbFP5evrWyuyeWx5kpBwqgDPOexqe1UIg45XPJ6iqULgsFAOVPB7VeHKlRjOfmHqPauZ7jXYnyNwPP93NSxKGjKxgMnTr+dQRrJwuAcnt1xVm0BzlBgdx70lqWaEZAiVnAIK4wB1xUkRLEuW+QgHB7VCeFQ7QcfdxTxIEbkbgB19vSqerKRoRgArng44NSbclcdR61WjmwmTzu6Y/hqVJcElgxTtTGWSwwpJyBwfrmnMFIIyVUDOaYjfLnp/snvTig6YPXOPX/CmIqSopYdn65x0qZXURkEDGOMdaJlyvUgYx0qJ4yFJQANQFx8lypAyTlSD6CkN9GZB5sqkdSV42n0OevNUpSdpK88cnH61mOp3lZF3gnbk8fjT5mtilY6xWRkUZG4DDEMCM+o9ajcg7wyBlJxwc5rKsXMeA67lHYHitPgpwOcfSh6oTQkuQvzE4BPXioyx7AnHccVM5Un1OO/aq8q/wuMj1zisyWgDHLZLnBznoDTg+4nJ+buM1AznC5A/DmgfeXA7dulIRZ35OPTr7U4SDafu++aqknJ2knH6UFv4gOBVodyQtkgncfT3qKSRcn5SBnnHP4YpJHxwMjP51EzbjnGMVLC5J5g2n5sdwAaiaZskMeAOoFRyOC+QwHP5CoZnwBycenY1SY1Iu+Zu5LAEY59aSSbPylsVnJOSzFsA+melLI4k6NhvUc0x3sWGmIbhxwPXvTjIT978T71QQMSOnuferAUls4xzwetJkNjlIDZ6fzo2feJILYx9RRzuGCcfSlIOOoJ6c1AkxSF2nORzjOODRgEegA6CmA4DZztxjFG/B3Agt0PpiqQmOYkgAD5j1HoKinZkUDJx0PvVe8vDEpK/Q4GPxrLOou85DHKA4FWJ7Fy5kySFOQeeR0rOnlypyACfxqw8vXjGRjpms67bapdfmx2xVRRhJlK7nwGkJJcdvSucvbkblAb5pH++f61o3RaVyp3ZY469q5nXpzBcxJCwDxAn1APSuyC0OSpIo3swlLDduJbAB6/WqIKkNuOD2prkkfMOelC4J2s21RnHHf3rUxEPvxTxIR0qNjgkZz70v0pAPMjP94k1ZtZtkgLdD1qmM5HFThG7KaLXC9jY8tZ1BGAccGltt9s/GdpI71mWlyI2wxO01txlbhc+vSsWuhrB3N/SrwnGXK4966Kzux0DEgc5HWuDjEkDDaSR19a3NPvfu5J96xnE6ac+jO2gn3Beegzn0q4t7HCwlMYlKnJjc4Dfj6VzNrdAdCd39Ks3Eu+NiDkEYJrJRZ0KR1CzyX1sLmLS9IiVl3L59wyNsBxuxn7ueKx9Z1W8j1I2U7wxBQh8uByyK2PU85xUEIuo109rmwmeCSKTT3lRhiZGPylM9CCec8U/WNNeXUADHJbJbRJBtm/1h2jGTjrn2qmm0VGaTM+xyE+fGfXtV1f7oA2VmwNlyWOR1HuK0MZjIBxjpWEgRPGwO3a5OKsRMv3hu6YKjvVKMhQBtI78VajkJyNuAvII71Keo0XonTAbIBPQn2p3C44JbkgE9KhDbQCFJPUj2p2H2grgknJJ64q7lEwcIcjJyOcdBV2PBAO7A7c9az15O3PHpjr+NTxcHafuL700O5oREAKwZioznPNKTkqWZlyMj3FVgVGGLEY6ip1KkDdyM+nSgZJwD97OOqt0P40keB3JOMH3pZdvOcfhzVOWTYCA2QD1poSRalgLH5gcMOMDrVTyPnXAA+Xj0NVI9UlEyxux2qMKCfu+4rUiuPtEbsu3bnr3B7iqVnsOzREqqrYbGV75/KrKAkDccN9M0xoyCWKAAdVxyDT1OSMZw3Oe1JgPEZByTn1pGxv8ALZhuPO0elTKAq72AA6cU2QliW+TPTB9aXLcVyoY/mByQev8A9aq0rbACAeufrVlnTaATtbGWJ71DIBs5yT09ePWosIgEvzEF8+vvS+aT1JxjpjpTDCDwMbccY4NPEfvg4xx1pgDnIALZqItyBwB3C9KkIXOO3oKikPzDaDkcgmkJkZJP3hjPAA6YqF8ngSbccj3qYAnlicZ6VC0Zxjr7Y5ouCdihds6kgKVAOQRzmrVhuaPDgZHVu9S+QQQCMge9PigUHPzKDnnOKdx3ZIFwM449PWnqSV54PYUg2gE547UiFlLBiDu6e1IkCD6kt2FNdguRjPPFSbcBlGQM8c5qKQDblug96AAsGIOT9emRQx5x0JxgVAZCDjj296Rp8KTnnoCe9NCZDeqW+9yOcGsnyMOSVGPrWjLcBxgf5FUZH+XPfPIrSJnJiTPjrkGsq6lJBCgAdRjmrUzZ4B6Vl3RAD5bt931ramjGo7IpzSmMeZtDkDIT1rlZt0kjSzKHdiWYdiK6+ODfY+aw5k+VR34rCuII0SVm+U5GBjpXQnY5ZRZzbnZlXXJxge3vURIzng8HJ9amu0MUhVuO4z1quaszFOOMDpUiAYqHNPDcCgTLSYHYVYjbjOaoo1Tq4xVCC4jG4si8dx6VY0y6MbhTnH1qFWBNMlj2HfGeOpFTKNxxlY6yFleJMdT2x0FSJHg5jPOeg7Vh6XfDiN/vdBW7E6MGAOT34xzWDWp0p3Ro2jtkbs8cnI6itezJmZY4lZ3bkKoyfoB3rnY5NrjJBUj+IZH/AOur9lcSW7rJDKY3Q5UoSCv0NQ4msZHd28UOp2dm119vheCMwqYrZpY5FySCMdD60atcb71GSKSIRIkSiYESMqjgkepqpBf2dhplgLq/1ZJZofO8u3mCoE3EZXPrjpVjWYbcLPcW15dzyQxxSt9oIYtHJ90568ehqHc0TOehZdoHc9Kuo5HJUkcCqMZUjeoDeoFXot2MYyp6+1czNrlnauSo5Oe9ODBG4yW4zj0qJDjCkNg9T6U9GyWIyoHHPGaRRbiOQfmOB69DVyEBlHfnGfastZGVzgqEzxnoDVyKZRG3y4AGc/XrVoEXWhAQhTx7d6jKkyZxyCeQetJDIsqqdxxjA3cEfWpFPJIBOT19KYxARjliD055qSOUqW6lcgH296gfB+c4Bz0Pf3pF8zJ5J54yeSfrSYJl/fkHBO08dKrzSfLuXAJ7MOhpgkICn5wfcd6dMHAYcEj1NCY0yhcJtJcqGJOSB1HvUttcPGyhGbyzg7SOcepHrUioSCCc98tUkMJjUh2Zx1LNziq80Xcu2908g+fjnJJ6n3NNluQqEH5Qc+/NQsnyYC9Rzk8Y9qoX0v7sDzADjAB4pMm92RT6myzAJIVUDqPmGfp9a0LDUnuIj5jHg+n9a5CTcjEkYOSQD2rS0kyP9/eoAwFz6mkpMt2OgmCyPHIvzMpBxnHNSoylTv6AgHNVUG0DaBnPI9abdElG2cHGef60NkXTLb3Ea4BwPlyB60gVJMFJFKkZODXJSX0sVwXB2kA8kZxnjoauabqbhggVSrEc9DQmU0b7RYJK556gUjR7V7k+mc1MrqwRscEfTipEjDI7owAU8kt+Qo5SbGcU8xcnB7fSjy/lUAZ/Srrhct93I+8F9D0pixljyOoqbMmxU8tsjGcHtTpI2zgc7fyBq95LDnn86Yyc8AZxnjpTsMrMMDOBnFR8Fepzj0qbHP8AEB0I9PaohjdtfBIPGKRIx1PlkRkgsAeOopqjaoVzuxySe9WCPlBOc1BKCVILdB0p2AryjcOByT3qCWIhM/L9D2qckRx7t2B0AqpPP7cY7U0iSpMArd+KrTHAwxJ74FTO7SFiScdxVaVmjVto6/pVpGbK0zgKQRwO9Y04M8qxoDhjj/Grl3IcdBg8Go9OhBl3kDJ6V0QVtTCbuaTRRugiyCqgAVz+rwhI2QjIOdpPU10MbblJXIJx+NYmsYeVhkkdapPUUlocRrSbL7bk8IOtZ5rR1592qS99oC/pWca3WxysKKKKBDlODT1aoaUcUA0WUapPM7VVViKehoJsOf5WDL0/lWppuosjqHI9s9/rWcACMGoWBVzycik1ccZW2O2tLuJwA7cZ5wa04VhZFxIAW6HpzXA21yQME4961IpjIixyqSOxB6Vk4nRCoetWGLDS7VdTuojG4MlvC9mLgxIT97JIwCeQOap6vcX0E81rNdxzx3BW5MypjzlI+T6AD+HtWBoniKOHTLe01GxW/S2UrFIZWjcLnO1iOorR126nkv43nEK+ZbxSRxxZCJGR8qjPoKzkjaMkT2kiHAB+8OKuK4jy7bjx09axI5Utwu3AAGPpmtNJA8OYySeMZrmcTrS0NGMgrvTr/OkwCx/unBA9KjiDFCyrhlH4U5iSxzwMdKhiHgHBGAfY81KDtdQjbxnIOOvsKrodmEjzwvU9AfenrKropIJYDPy9Ce9NDuaET5+9uA9+9TGXcw6EY61SjwFUK3ykdjmpYm4ABBUg9eKYXLBdfOKxkscfKxHUDvipeOp3FgPp+NUkY7g3VQMYAwCc8mp4pOCADnH4Uxkm3BDsSRjGc8ZodlAHPB6jvimgBeQpYEAY6ge9KzHllCh8EZIyAaSQyUEZ3KAdwIyeQPepUcgDfsYn171XgyQN6+WR1IPWrSorbiDhQcDI6+4q7DI5JSikMDt4AGc1RuZFd/mRWB6N6D1q/KgY7ivAPTPJHrioWtwzcpuAPHqKWxJm/YYw8TuqMrEkZPDAcYNSQWrLK207l6+gq79jCmUsTgnoMHbiraQHyxtDEDAGB29aHYLsrqQmOME9DUdxCGXcTk9MdKs7CpyByvIAprZbGRj26j61DA5fUrYxuzNg5OOajsYmN2vkl1bPDeo9q6C5gDLggMSTgEVnSW4jkBCg454P9KEi1LoX4ZJfJCMSV/Iiql1cSLKrxhiBn5ScCrURxgAduTVa6hYvgEDOKqSYJl6yutww23cfz/GrTXCRcuQB09ce9ZVpH5PLdDzzUWoySAblY4PSgG0a9xrNsuRAowTjnnGKljuIZ40IlUs3LKvauCmkZZFDuCMZAU5/yasQ3G5wY0aMHoAf50OXcrludk4XkqetQ7dvPX0qC0mdoczHnAznpVhjhsLyCOp6UrGbVhpPJHXnJqvKeDjJpxUqW98ZowfMwfu/XrQSyo65AGcgDAqnOpI+YnHatGXGATxzyay7idmcqv3fYZqiSFyoQ8jnnrVCdw2cfhzVmYEqCRyehqsYy7HniqiQzPkUyOMcY4+tPwCTGONo+Y9xVnCAgY59fWgXUU1qsQtvKnhc7pMYDZ7j1FbIyaDdtQ9to7dhXOarceWJZXPyrzgVqzycELn35rl/ERLWpReD3q4rUyqOyOZmlaaV5H+8xyaZRRWxzhRRRQAUUUUwAU9W5plKvWgROpp5XevHBHSoA3OBUyNTRFrES43fN0zWzo8kC3UT3kcktmD88cb7WYegPasl1ycqOKtaNaTahqltZ27Kkk7bQzHhR3J+g5qXEpM7qC98NH/mDanyP+f4f/E1Nq2ow6herJaRNbwpBHCiSPvICDAyR3rHtp/DQzE2oatKQcecsCBT7hSc4+vNWr61Gn3UcaTCeCWJZ4ZlXAeNhkEg9D6ismjojIt7WIALYFatiwjjByGAPOaz9hRjtIIz0PWrkBXbgkY7AVzs7ot7G4CG2uj/ACDgntUdznehjyGH45qvaDC8n5Rxtq26iWIgZHbI65rGW5TDG7r1zk896kUHI2cAckAcYqBR8oBOCRz7VKjgOUb72QOtSBKir5WNyqCcBeefenxsI8BtxPQHvSPieckhUDc4UYA/DsKdMVEojUKCBtymcH3pgPhmw3AXGcEHuPepoZlSXLoCqtkITkH296qbkMgAKhugI64qUKVwBHyOg7/WqUgRbDoSzDKYOdpOSKRmGWAI47nrUQb5TluaY7AlVcZ+hoW9xrRl1JSCu7gYx9DVq3lGSuSdp5J9fQVzd07HIicgsckjua0NMuJVjUSn58Y55BqlLWxdrq5rxpEAeilsj5snP+FWCTyWZGC4LDGMf41USZVK7lGMdj39qhOoQpI5BMYBB3Hk/Wq0JNVIlcDfgKeMevuacV2KVUgFc/N3Y+n0qKwuTc2ZuZQlvEcmKSRhhiPp+WPWmrcJMDhgwA7+n+NVyW1QgIIO4Y6fN7VXcANhjyeh71akUEDcCvAO3pgVBIm1GPLHrgD9axaGQvEpUgk8daqyBS4wOenTrVp87NwbhcZGcHk1C37wk4KkHABPNIClhkYoCMcn3FSjLgZycnoeop11EHjZWO31KcYNOgOU+cc9z1BphcYQM7cbj29qhuU8yNlBwMYHFWyjMhYEKW4Ht7//AFqZsO0ZChh1/wDrUkBzNxYN6Z4yDilsrOYzDK4x0YVvPCCTjrjPWmqmzG1Tx/PFMOZkkaFBgnj+LjrUhICcgkZ4pgYAE5yenNG75t38K80XJuSPkJjgnvUBf5sHOMdqR5DuO7OT0PrUbEDdyQT3pXBjZfm79M5rOkxuODg1cYblPOM1WkAB7jPtTRLKsoGMsc1Xd8gEg4HpViTgk4/+tVV2wdvUY9OtWmSyBzwD6VUmkILc4B4xirMrbQVxnHeqLDMjEAYBrVGciGT5Yy5PvjNYF8N+SfzNbF25wcH5R+tZF0Mxj1PNaJ2MJ6nM3KGOUjt2qKr+pJ8of0OMVQrVGAUUUVQBRRRQAUUUUCFHFSK2eKioBwaBNXLIbr71Ppv2yPUbd9M803quGhEQy24eg7/SqQfHWpYJZvPj+z+Z524bPLzu3dsY5zQJJo7MPrEjeZJ4JtJJjyZPsEgBPqVBx+lUL+81KTU3bWY3iu2A3RyR+XtXHygL2XHSruqaV4o1K6E8qLb3TIokjF6iO7AYLFC/DHuOOa5W+F5a3skV+JkuoztdZc7hjsc0mrlp2PQWk2rvxnI4Peq/9oBcSKoI3FWXOCKgluFeAdcYwcf0qla7yWQ4cevYiuSx3ueuh09leEqCTg+hrVt5SyjBAwOcmuXspCpEb4DDpnvWrHPsCkE/n2qWjaPvI2pCd655+XoBxQCHVR0AH4ioreUPF976D1pYcxgruU4xjPJIrJoLWLan+LHI4+v/ANal3AOWLZIHOKgMpXJKnafbvSLIAw+8x9qm3QCyxDrjJAHde3vU0MjMUDEsQuCxqsH44xx+hp6EbepI65J5ppAXiF8sKOWPHy/zoeFhxtOCM8f41WimMZDZznHAHOKt2twJeC27JyAKtJMCsYQZN3QHsR0NSQRFGJU5Bx9KsTHJyq5XoQSRmmlN2Cow47Z4+lPlsO4+ebEDE7c/3v64rl76RPMfaw6ZHGCfpW/I2ZRbyZO9ciQH5fpWDq1gbfdIuQmcc0pIuErEEV1sKhS+08kHgZrXs9c8q5yVBwMAsOD9RWArGV9zueFz8x4+lPWTAxsTGQc47e1F2aWvuehw3K3ESy7ly55C1KGB3ZBOOBnqfeuc0OQyR5HmbAcAD+EdR1rcRmwBIcMep/oaT11M2rDmXfJuAG9eCcA8U0qCd2enBJpd7m4CgDA6+o+tI4A3CNs7uuKVhEcqo2em4diODUbqY9xJJUYOR1yO2KsEK2S4APqODioVyXZAQMdSR1+nvQA0uFGSxCkZ24zSbhnIPygZ3EetPj4UrJwW4yDz+FR8qrHduGeB2paoBkq7g+eQSDnPX3pjDHyn73Y+oqZskgjAB6gio9vXPXHNJgR4CsM5OBjnqKQttx3XPSl24b8MCmvnOTzgflQiSORgc9Tnn8KjDcdwD0Jpsm/JOMA1Ez47jg9+1AmySVwox+dUpHJwSScevakncluuRVeWThvcVRIkrkDr7mqjvg5P0NLK4wfrUAZmYd8nvVREyKZmPAGfYVWmJRMH7xq8yhM8jPWsy4f3Ga1M5aFK9bjaDznFUrjkE+tTyndKAwPA3YqJyCcelUYGPqEeYWz9RWPXR36DyGOPwrnCMEit4PQykrMKKKKokKKKKACiiimAUUUUCCr+gaj/AGTrNnfeX5ggkDFc4JHfB7H0NUK0/DFzbWniDT7i+A+zRzBnJXcB6Ejvg4OPagZp3OmaAJPMm1bUYA/ziOexzIQffdg/Wq3iW/W/1OJkhnigjt4oYvP/ANY6KuA7epNaU2sNLeXWk+J75dSspG+S9jbzTA55EkZ/u88r6e4qn46eI6tarBcw3SRWVvF5sLblYqgBx/hSAluJQWKqcNjgdqt6dcBMhsBsdOxrNuIn3FlHzJ39R6fhT1YJGHZMr3A7Vg0dEWbihJmjcjaw4zn9K04vmC5b61gWQaRAVbKZ4Pp9a1rc4Uf3hw3vWbOimzXt38oAAnB4z6VbXLksq5wAST2FZsLY6HJ7j0HrV6Eg8gkD+dZuJq3csJnzVdW5I2uOzc8fQ0ZwwYZ2HgrnIzSbBkMCRnHSpCqliytjoCB3pWYhSRsIADbvU8mp1beuWwjAYIPUVXdlDrvIHYVNGQQqlQSfWlYBVj3PudQXx0B6CkWAxzeaHZFHXnipgpUE5B44x1x6U6Pc5UgkZ6o3pRYd7FxZnJH3TzyD0x6ipElDMw+UqeOOMVSWQ89AB3pS2GALjceSMc07iLpKlv3YG3ru7E/SopEEgAdMqwzg/wBaqmQRfLDkL/Ft571PCx2neQaakhmTe6XhiYTkg/c9vaqcNhNLjGQM7cEY5rqgBJuRVPQcjgH6U9oFJj6Ki9Bnv703FMtVGitpVp5EOSBnBJBB4/HpWkH+UkfMMDdk4A+lRKMMxI3Y4Pse1KCVQqXx3wRnIoemwr3ZICXAwCcH7p4z+PpSPtxuBxhcZJxzVcF0LsrMVbszcfhTg6sh2spI60PYZMshEmHAK44LdzUbt5TqBuDOD06DHenqQh+b6nrgVFvKgADa+ep6YqGBJuMik8/U9vem7iCu7IOcYHGfeozIcKwyB1wO3pTZZTArvjceyqOcUrATNIDuDYxyc+pqsUZVbBOCe5zTH3bgVwMDpnpmlJBAGSfagVxkUpAy2WI4yeDTXlHBzwcnFEjccd+MCq2QQegboaQmxZZQyEjPXP0qsz4OOp/nTioJDc5xjGarOec//roJGzMd2M4FVZWyduetSyA9agK/jTEMbnjtSH5FwDgVIoAAJOap38+TtBA47VcdQbsMupgg9eKyt252eQ8YzxTppOCWOaoed5jEdVBxj1rbltqc0pXAOXDyMcFzwv8As9qcibsGmuSxIzknirUSbUVQKlsSVzL1cqkarxlq5qcYlYV0HiOJzcwkfcC849axmiaWcqgycV00lfQwqblWipWt5AM7eKiIIzkGtHFoi6YUUUUhhRRRRcAooopAFSW0EtzcRQQIZJZGCIo6knoKjrR8PXUVnrNtNcMyRZZGdeqBlK7h9M5/CgC//Ytikpt31NzcBSxeK1Z4QB1O/OSowcsFI4rH1CzmsLyS2uAokTHKnIYEZBB7gggg13CWU66vZagq6g81tFHGiW8YaCQIu0bZs7VjbGTnpk1yviWaKS9iigkWVbaBLcyp91yo5K+2TgewFAG3gOTuGe1ULkmJgU69Oe4oorBHQdDZxrCkixjaDg4q/bIpkJI74ooqZbG0CRhtkXbxzVxGIxg9RmiiszUnickADgHsKn3FVGD0JoooGPjAOWIyelSklSoHQ0UUiepYDEsoPQkU6Y4GcAkdKKKHsMdAPlZu+aZcAAOf7p4/OiipewxyKvmbdoAIycdetSxqIwNnHNFFIZJCxMpB5AAx+dX7M+ZKI2AxvAz+NFFbIBVYmV1JyAxX9ap3MrpbSMCMjOMj0ooqWBFDIz2UcjnLFefSpdxBUdi2KKKQy1KoWbyx90f41HnbkADAPT8aKKUgWxJIAokXquM4NQN93GB0zRRUjRVkbbnAHUCmOAwGec9s0UVLEMcnLfgKrEky4zx1oopCZG5wD7VEwBycUUUxFck7l96jk4bA45oopiIJeAMVmXJPP0zRRWtPcipsY15IwTg44zUVqP3anuFz+NFFavY5VuTwjPPfrVrODRRWZojK1tzuXnsKwUz9qUZI+bHFFFdWH3Rz1dzpUiRbfYFGBWFequ/oKKK9CZyx3M09aSiiuKW50BRRRSAKKKKACiiigBwlkEZjDuIzyVycH8KbRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Well demarcated, red-brown, infiltrated plaques are scattered on the back and posterior arm. Hypopigmentation is present at the periphery of some lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc. Original photo provided by NYU (Tisch) Department of Dermatology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8978=[""].join("\n");
var outline_f8_49_8978=null;
var title_f8_49_8979="Applanation tonometry";
var content_f8_49_8979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F59419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F59419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Applanation tonometry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 410px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwAZoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDliSHbk5B9abuYZGTj608/6x+cEZ5PpSQwyTybYIXlOOiKTXnqnpdblDAx3A7m496Cxzyxz9a04tC1WReLGYD/AGht/nUi+GtUI5t0X6yqKvllfVCMkMwON7fUGmMx6ZOR71uDwxqR6rbr9ZhTj4VvehltF7H97TcJSewXMIMxyQzdOu6kLEj77D61q3uhy2UaNc3NqAxwNrE/0pLHRJL4OYLq2IU4JJP+FTGDkrW1DYySSf4myeRUc6JPCUmHmI3VTXR/8IxMOt7Z5HHU/wCFZuo6cunuiy3MLM3QICaTpyWqVgOJ1TQpIVeewkZogMtGzcgex71iWt1NBcJLE7BkORzXod0kUERFwwWKT5dzLxzXJeItNtbOOF7MgZJDLuJJ9DXdQm5LlnuS12Nyx1SO/XdG22UDLIT/ACqw7tngt9CelcJGxUhkJVxyCOorp9F1Rb5RBOAtyBwez/8A16zr4V/FAakaW9/U8e9S6cx+2RZLdfWmFeOhqWy+S7gZzhA3LHoK5FH3ijprEsznaT6Vv2iMcZJz7VR0ybQIAGn1JpSx6Rx/4mtuHU9F3fJdcD1HauhJiJFQnHWmSIeeT+dXBqWmbQI5E6Zzzz+dK2paeVAVoBjjqMmtIpCOeu4zt4zj61x3iDcu1mJHbOetelSX1m/Bmt1A5yzCse6n04XMcpk09zGc7JlV0P1GeaUqfMnFDPNg7EdTjr1pVYiReTjr1rpL+y0Z55Z5dShDO24rG6hR/ujsKxbz+x4QRFfMx7EMp5rF0JWSYXBrd5tSiu1vGUIMGLceaZ4miN5Yx2wn8s7t27kjis7Qb/Q5mun1jUr2HYcRRw2quX9STuGKh027/tGaUKjRov3GbqwPQ1cac+YG1YpQeH9x+fU0X/gDGrI8Mxj5v7ZTPp5TVfgQqiiRP3g65AzU+1f7oP4Vopyu7k2IY9JhMYE+pRuVYFVCsP1/pRqNggRFjugfvbgc9+mKVIJFuJRPGQufkYjgg+lPu4kwvyj2pPmk7sCpZQpBKjG5BAIZsLzTokhE08l1K8qvnaFJXB7GgJHjgL9RSFEJwEH4Cny6oLi27xwxBDcFu+fWnB/MyY3Yr7npVVojO4it8Da2HIAwBViHAMi8HB444IrGtTdtAT1HMXO3LH86TLY6n86d9BwR0pQMA9ue9Y6vcoiZm/vN69c0B2GSGPXnJ6U9lPJ6n6UmDhs459KdlfQY0SMM5J+uaUOw6kn2JpMZB/lRt749iaGgHF2HO8g4wSTQZGHAZue+aTYAwB6HpzmgcLnbmpkrabAhQ7EH5jn3NG9h/E30zSDjt0FKckd+f1p62uAm49mPB9aN5B5Zs+meKUgrng0KMDpkk0t9EAis2R85/OrxLbVwxI+tUucjoSOlaABVBx7gin7MBgLcHfwfeml25yzdPWpABu+X+VNx8uCP0qFDR3C43e2fvGrke7y1wzdB61VK/McjNWY8bF+g70JO4Hb6J4WtlsP7U192WJyTBZrw0n+0391f51HqviqDTkMVt5VtEOAkYwKPHmrSRAKmWmc7UWuHhtEDl5v3055LtyB9BXbKSjtuI05fGvmMSolf8CahbxZMVGy3mPOfummDg9ABjtS7jn+Kl7RvQBw8TXjD/j0lHuVrd8OX0upRrK7JGjHAZj+tc8FeQ7IlLu2cADJNWrSHWbK2Be6trFAvyxvt3GqheTsB2mp6bpM9kTcXM8siAn5FIWvPLoXqziG11JrWzZufJjPmZ9ye1Pm1fUWRh/aM+McgbRx+Vc3Pc3O757idsHu1XGydxNl4XXiO3nmW2vGvIUYjE+AW+lUf7WvdRvQkuyK4jP3JW2nPtmtLSZ2mjnaRy2GGCeT0p9/Z298FW6jDkdH6EH61Eqii7SQWKt6mqXMRSVIivB4buKzdSa5WxeK7gx84dXOOB0OPrV5dNuYDttdUlSMdnG7FWLTTFSdbi6mkupxwDJ0X6CtI1Yx1CxyN/b/ZZ9obejAEMKiO5SsiEh15BHb3rp9X0oOjSQAqo5dAOnuP8K5u4gktJAsvQ8qw6MPauilUjURLujsdHvV1Ky3H/XJw49/X8avKmR0GPT0rh9LvDYXiXCZKfdkT1FdujpNEksTZjflSO9ceIpcsuaxSZYl023YjECYwO2MVatdKtZGwtugPQnFZoeUlissgwecGmSatf2s4WN0ZcZ+ZRWd4vWwzqYNAsjgSQqfbGKtL4c0sjm2U/ia49fFOpoMfuT/wDpUi+LdWC/KYen9ytEkgbOv/AOEa0nGfsaHnjJNMOgaXGoIsYG9QVrj28W6wPutDz/sVBJ4r1tjtWRSzDG1UHJojy30Qmzm9c8MXtjrEtvb2s08UjkwtGhYMD0H1rqv+EXXw94fga/VTql1ukeLr5SAfKPr1rnz418QRudl55Lg4OxQDmqFxq+q6vcbbq+kkdx95jiupJ2sSZUIKOGXGQc4NdF4bmedp/MOdoAAxwBWTPYyQW5lZ046jvWxoUcaXN2bcSeQwXaZDyeOelOTXLoBrt9M09Tj3+tMxt9cdAaFB6k/nXHfUaJ+TtBye2M02/J2OR0x/Sq73sERXdKA3tzUN1qlsy/KHx6kCtIqy0C5FZEizh3Yzjn86nBwRt4/nVC2v4WgVQCMDpiq11qLKNsQ/Emq1b0CxoW+PMuByBuxgn+VOWVA5GcMD2Nc608pZvmIDc49KjLSN/E3pnNU6XMtx2OrE6Z4OSO9BuI1X768+9cp5sigDe3HvTNzHJ3H86y+q+YzrkkRmwG5xml5PB6A/erkllkU/K7A/Wp1vrkAZkJHvTeFl9liudIDnqM/hSkHdtx+dc+NVnUDBwQODUw1RsDO5j9aylhp2Hc2VwuT3zThjbnPTsaz7a9R1UjCk9jV2OTnOPw61Hs3HdASnrzSY64B570oY8jOPYUANwCax0tqMXbjJyOnNGMDHX3oGBgcj+lA4J5/Oq02QCYPTv71oHJUAc8VRBBZQTWgMNGMnt9KFFsBmcZPfoPal2jHOcGjcVz1OfSkIJ6d+9C27gJzxgYPfNWUB2LwenpVfrz37+lW0+4vJ6U2kkI2fG4P/AAkDKfuJnGPyzWISqKWLKAO5rf8AiM32S5a7ZWYbipAHr0rzHUNVuLzcJBsjxworo9m5Tdg6G3f63Hb/ACwKJiehHAH41oeDrTUPE91K58q00y1A+03Z52+iKO7H0rhTBPdzW9vAC8krCNV7bicCvTvH17H4T8K2HhfS3xJsLTuvVnP33P8AIewq3SitHqIq654ws9OklsfDsCoicPOfmc/U/wBOlef6pqdxdT755GlbOckn8qrxbVAYN8+ck4zmmPyS2ASTzW0KaC5d/tq8OABGOP7tVpL2aR/nY4PoBUUaEnjAFSLb7ssHUrjk+lbOMVsSje0TUbKC3ERZ0kJ3MzdzWzDJFKB5cqseuAefyriJrV43AzkcfdPNKjTRsHQlXB4PcGuedFTd0UjuQvAOMjsKXgn/ABrE03W1JWO/BR2xh+x9zW9gnnO5c8Hsa43BxWowT5e2AKomxt5WltbtQYJDvTPVD7VdU+uCPrVPVlJtd+OYmDZHpVRkt0DRx+oWMljcsqkyQjkPjt71c0PWBZbopwWgJzwPun1roBcRvJC0kajjawPOQawfEmki0JubZSIGOGX+4f8ACutVIy92RNup09vNDcxl7eRZAR0BwRTZbZ5mZ0XIUc46iuBheSNw0bMH6gr1ruvA91NdwTvO28owUE/TNZSw8Yap6DUrkJhX8cdKVYRzzXTmGORsFFGf4tvNZd3rWlaZeSWtxdtHKmNyiAMBWaT2AyJouM49qpTs0GHiIEincuela114h0WYNm8kbPpbgVgX1/auGa2naXIOFdcVpGN3buJmNPJ50rykAMxyQPWrWnyPayrcbEIX/np0/wDr1TWTbyqAe/U0bi5yTn3rstpYm5p3+svND5USIqE5b5epqz4aZpJblpGySAeawyhUA/3q2vC2d9yfYComrRA3Z38uN3wSFGaytFvpb2+Zp9ojjGfL9a0L6MzWkqDIOMgg4yRWVYyvEftMcRK7djYHf3rnjaS8y46amnJZ26uzzDceoXoAKzp5IsbYYQM9ABxTJ713YK3I/uj1pj3CqSFGSDls0rS2KSW41/KXGVBmJwAOgomtg/TA9SaW2cFjKcAngZHX6VceJYlySSX6inGfKUZQtiTyRtH6UyVlUbYQee571NLL5s+wDEa8ketQsMAuARuOBWyk+pJD0JwQaaTn2FO2HoOT/OhV+8X42irvYljSMcUgxjinxruycHGOaYvLgVV+txC4/wAacqnI7A0+cFAo7kUgcjaeOKG76oZMsiRjYRgk8+lOF40RXynyBwRVZ2yeOo7nvTFPUbRUOF9wudDZX63ACt8r9896vDAJB6dj1rmYJCx8tydo9ulbkc21Y1lbdkZVh3Fcdako6oZcGSGBxilyDxj6/Smq2cEbcdaXnnOPrmuZKSWoxwwXHr6VoFemT9Kz0++AOuavnIHAzQwAnI4zz3pOS+CR06UpOQBzg+9Yeu6u1o32e0x5x5Zj0X/69aRjz6ITZt7SMnnnsKtoJNi49O9ebm/ui243EmT/ALVXo7678tf9Jl6D+Kt1hpLqK57F45tP7U8NXGBl3iJH+8P/ANVeIwII0zLMEPpjdXvto6XehpgBgQfyNeE6vG1pqt3bnCCGQgAHqM1pCTuB0/wstBc+MLeRyskdsjTZ9wOP1NZfjvUX1DxRfSrJ8qP5aj0xXRfCbET61dDHywBQfrz/AErz64mMtzK5GS7lifxrSycgF3nkH/8AXTOgyOaUHkdwOlCkgDgCtU0IkXO0qpPA7GljYK6t0B4NRq4GSOtIzYUZ5NJ6q4EpID5DEEk/Q0m4g4BIB754zSOwMIHcHioyRjH4GmtAJHIkJyST1ya1tF1Z7XENwxaEnj1SsNGwc0pbJJ9aicIy3BHoFtcR3MXmREMg4p74dGXaDuGCK4zSb97KYsCWRiMr6118NzHOgdD1GcVwVKfs3ZFXuZE8biEjoyk4NaqFbyxXzFJSVMMDT2gE6yR4w2Mj39qp6M5EM0LdY3xz6GnJySUri8jkF8zTtTAP3oZcfUf/AKq9H01IovNMKKu5gx2DAPFef+IyBrFzt9V/lXoGlsVg5/uqT+VbVFoncSNGNiXXP5Uz+y7a+vHe4s7eYsBgsmW/E0m7D7hg98VqaTNLG+77JvYjgiYDH5isIyvqiiK08IWpkuDeWdkse4eUscfIGOc+9cv4m8PRWjSmQxRWZcAFFAKp3zXpC3M5AzZ9fWcf4Vj+J9B1XXNPmS2sowrLwzSjLH0ArRtvRBY8ve0soQrRxEdlljl3/oRisjVoJoJo3k8tkdcxui7Qw9x61vtoGr+GHSbWrWOCylJQ+ZIrAnHYA9awp7hZLaWEsZBu3oR69/zFdEL3te5DRQH6muv0y2hsrVdq5mIzI+c7hXHngenFdFYatE1vh4/3sa8/7XpTqXtZCRZ1C4RYhkgvkOpB4H1p+j3YlWSLC4Y5x71z0kzOxLbeTyKn0a78jVIXlOIycGsoqUE3Hc2go8y51dEGoxtbX0kfQZJX6GmQjefmb5R0966/x9ZxS2Npf26gDcUfA9a45SMKvrwaVGpzR5iqkeWbSNG0BkkPUDsT2qe6nDR5GMgY4PJqsXEUBKvgsce9Qq/dse1Pl5ncRKU2KzMOGIAHeluSJNoGAkfC0KvmFBnn/PNL5SYcAjJq0hFaAKzkMM4/SmSnjIzknJNW1hAR8EAEgcGkurdYoNwOT29Kd0G5Au1YRxwRgVAg+fr3qwynyzu6L1waggUmUDOPSqvpYnqOuGy2cAex7UxsE8elLMDu9ecfWgDJwBTi9bA0MB9elKeAOKNhB6c5qbb+7Y8dc9KG+gJEalg2Rj1rVLj7KgLDH06VQijEsbZx8tWUm8varJtVRjIPBrOWoxY7kjKsx+oNTpKGBw+4r1waz7kCJiU+aN+nNLZOplYngHoB1qZxTjohM6VXWOBZZThVXcT7Vmy+KGMh8q2XYOhLc1Lqu46LIUGRgE4PbNcqretZ0aUZX5iW7HVy+JI/JXyoHMh67jgCsO6uEmV2aMea3O4VUJz04+lNJ4HaumNKEHoJsdDE00gWMEsela8dlceWv7rsO9Y8bFDlSQfatKOd/LX5m6DvVtCPXPh9d/avDqbjkrlD+Brzv4m2n2bxL5wAAmjDcdyODXSfCm6LRXkBOAsmcexqr8XLfMdpcD+Fyn51yxdpFi/DLC+H9fl77QP/AB0155GPMfgHJPNeg/D4FfBevPkgk4/8dNcfb2u2EMBg9s1bqKMrjjG5U8pscqfY9jSmMbhkEA810NtaAxYddy+lMa0yxBDZJ6CsvrMU7GvsrnPrCxBZRnFMKseccV0EWmkuOGx1JFXX0xDGQy89QRTeNj0QvYs5I5HUZpnNdHLpI8rMfX0qsNLKjPUEYIq1i4NbidFmJz2FLmtSbTmUDaMDpVS5tmiPqOxrSNWMtLkOm4jLYbnHGT2966LQX23Do7DawwoHeuYV8EH0ro9HiL7J0aMYPbrWWIXu3JTOijYi4jbt0NVdqw6xJzgSJuP4VIxwAQTwR+tUdemNu4nHB8t1x65FZU1zUwe5ys7/AG/WmIHEs2APbNei2ZxcMq8/LwK4DwvF5usRN/zzBeutvbiW0tJbiFh5kaFlyM/nV1pJWiC7nUQQ7yGIOBWha/LMMdPQV5pb+N9TtxtkitW/2SpGatnx3dQ+VJ9itnDjs7DHtU+ykug7nq5J8vgYz3rjb/xdeadeyW8u/KHaOOCKwR8S7jbgaZD9TIaju/7R1m0j1aa0S3juCfJOeHK8EjPvRKk7KTDmKXjvWLjxAtnMQ5jtwykEYAJPWuTRivAyD0NdVb6adQv7eC7vkhjeQB5JeEjz1JAo8WadbaPdXdjY3cd7bRSAR3CD5ZB6/wCfStYVYxWhLRzCAY+b8KmjQIh6ZNTwCKR8ugbAwM8U2RcycKFA6CtJS6FRiRYxgAfNnmmbSPmPHPFTtGAcEDnn6U1mAOFAAAoi+jGaT6pc3lg1q7Apt5X3HesmIZfnnHGKlt22yAj1/wAilZFWdtqnBOQK2lyummuhK3JHzjA4wOTTLhtwTGQcDINISpDcdOlR7s8EZwMDNc6L2JBKV+793H50nnkEEjOPzpgwAfSmehxge1V01E2Wln2rgg5J65p/mgwsCc5qpngkjIpUPQYyB0pcqeqHcvoBLEUQDdtBpqxCMFiNxHvVaOUxkkE4Jxj1pzTFgdpI9KXLpoA91XcxwTjgAetIIzHEWZeeBTN+CTjv0FPkYbRtB3H1p3d7gKI1ZSON3pUqgGDc3ABx6VUVjvznOOCKkd+CoztHJBp6J3QD4+I+pAJIIHah22xgDBwM1EkgVehwDmmFgf50loAbt0ZTGQecYzg1GGww+vFOGRgjqeAabL90HvVJdWJs6XSrhJoAj4I+6VPep5tB05nDiJlzztVuDXO6VcGG4Q7jtY12EcodckEgiuGq3TlePUDI1jRLdrZ57RDE6KTsHIauUDZAr0uzt2uZCDgIo+dj0A9K4rxBpBsb2RrYNJascqe6+xrXDVW9yZIywCSABzV+PHlpx2FUoEZpQoB962Y/IWNR8pwAOprrumQb/wANLkrrN3FgAMuQPoa3viYnnaFKcDKMrdPf/wCvXH+BJGi8UAbjhkcH+ddv41PmaDeDqPL/AJc1hJWkaIyPBOI/h5qh6F5W9+wrnjnfECV5FdJ4cIT4X3LkfelfPp2rmIGD3aZ3YA/KuesndM2pdTYj27uuBjPpVkKuAcZ45qquMAk9RVgHg4JI6157fY6kSquewH9adgAAHIx3pgcZG7IH8qkjYAfLnJ7mhloa0aFflHzAdKrmNNvoBz0qxI4CZOPWqrNnOeppq9xEDxBO/eqlxErIVZcjp+NX5ELDoBVSU5zjqB3rWMpJ3TIkjlb6EwXDKRweQfUVpeGnb7aFx+7PfNLqsO+LIHK8ipvCwDTvuPAXPI716LfPSuzhlHlZ0cpxGwyMmsfxWC9iuOTkAAVryj5W4rI8VD/iXxkdmHNGFXNCViJbmf4TKw3kxnKxkphd5xnmtbxJJt0lmhkUfMoyDnIrkQx29c/Wl81mTaTlat0eaSlcL2HJcSAY+Un3WpHu5GXaEhUe0YzUH0pD0robtoTYa4yc1v6NeQywwWcwYsmcfNjvnj0rAanx5EsZAO7IxWdSPMrDR6DrI0q7jC6fJLEgABaQAsT3Fcjq+E22kRL7eWNWtVkMckahkIKhjs/r71WtQvneZIcs3H0FYKGly0NWFYYHcn524GaixxkYI9Kml/eHGSUWoWYgYHb2pq9yyJyDwO45pjHjC9emaQk9+Pel37RhRg9M1q9ESKQFQ881LIysibTyF6ioHb5QM8dAKaDxjnPSi2nkIkVvlJzj14phb0pVztI54prct7VUY6ag2OJ+UjP196FwAxOfamMf0pRxipsgH8BMnjvz3oUlT+tNOOfrSk8YxyaaTQBwW4H0ApdwJA6474pOME+lNTiktB3Hqce34VKzYVct0OfxqEDJJPApThiq5468Ck12Gh8eVKnOATTyn7wg885zSRJuG4k4H60BSZCSe3WhIGIflVwAM9s02Pl+PrzSsudx5GO9JFxT6CBsY45APFIep44pxUYYZO7vxSAcDOV/rRfQCEcH0INdbo1x9ot1z95eDXJnGSDW14YuFhuMSN8pOcf1rOrT5kK51V1cCztfKXJZuTXPM015cBIyff6VZ1e6SZmKtvz3zU2mw+Vbhj99uc1y/DoFzJ1m2jtjboqjOxyTnHNZ0Z/dp9BW74ghMtj5seS8DbuOu3vWJHCDGpWRcEDGTXVQk5R13E9C74Scx+Kbc9AWYfpXpPiGPzNIvFwMeS348V5foJ2eI7N+T++x19a9Y1GJnsZsAkGNs+/FKo7TGjl9OJi+Eu7PLO+P++hXKWIPn5Zv/wBddV/qvhHbAsTlznHu5rnNHsbueU+TaTye6oTWNR3RtA01bC8nB9D3qVJR02E8elaNp4Y1OcZ+zeXnvK4Wta38GScm71GGMD+GMFzXn+znfRG6nFdTnFckgAYPfntTl34JOz2IPWumTwrZJ9+5nc/7OAKuwaFpse0m3L9vnY1rHDTegnXijipGxje+CSegpqhnYbBI/PRVzXocdjawkeXbQqc4HyDNKSVGB8o6fLxW6wt9GyXiF0RwyWF5Iu6O0uCP9zimXOgalLl0tHH+8wFdx5rqeW/OkM+c5PP6V10cvjLS5lLEPsebz6Bf4bIjXIxguKq6NYzaRLMb7YoYYQhs13GpLmUlRjNcj4jQiMH0bNd9TK5U6LmmYOtzOxZnu4PsssiyqUUFjjk1g65qkF5YpFDvL8HkdKqq5TeyEgYxiqU8YWNSOOKzw+HmqcuXbdkykrq5FCplnjjOBuYKCe2a1b3QLu2jkkDxSRoCSVODge1ZVqcXcJ9HX+ddP4svZLdkhiJCyq2456jpiuecpppRKS6nNtFIsauy/K4yDUPars8mbW1AK/KMZH9ar3UDW77JCN5AOPY9DWqTa1ER7ehbIU98VswQ2Vu0MomBZhkZOSPwrPnmE1tDEHACDv2NJHEkcyM8kbKvXtUSXNHQFuaE6PcTEhPxamXCGKNAmN5Oc+1all5N1EqiNzLOwRHVsY5x07mqt5bLbXDR3MrK8TFSCMliD0rnjJ3sWjN5QAc5zk+9QuxIZiPmJ4qe7xuZ06MeBUBTAb1BrRK+xQ1RubGP1pDnjkc0+MAHnAx0xSuoDlR0PIq5apCIgOORzQqkngc5p7ZA4HHamoct0yTT5brQVxBuBYN360Nkdqd/GCOfWnOhDHp+Bo5ugWICTkUvJPWnY+bpSEc1TQhP5UHIwOMUdc+tNHByO1Q1roFyRicBR2oBNR87utOB/Cqt3FceegycmkU4Gc80HJGaMEgtQ1comRiqgk5OM0zcc4U/eHNM5A60ik5yaXLYLkzPiNgOpIwaSHHmAk8Ux2Jx0oDHg5HtRLuO5ccYhLdPSq65JQE5A64p00oaMKBimKcDnrjilYbeo2UDzDx07Vb0KXy9Sj6fMCKqSckYOexpbOTyrqN8DhqJaok3rmFZ7yNehz24rbbGPQdqzLMB70PgcDNaExKoSxya8+ovsgircXTZ8tSCBwc09NFsmRWKkEjOA3FZ5zuyTls8V0EIJhQ7v4RTi3HYZx2jWq3upShpjCYkeVWUZJK8gVd+1ztqsUbzSvCwz5ZckflRpUGNXldfuPHIpx2yDUE5CahBIB91STXZKXNsJqzOp1nxWul6dY2VhZ2xZF8xlI+RM54A/Wuo8N+IH1zRVuMPEVYxvGDwCMcj2rxi/m+0XckvJBPH0rt/Dut2Oi6FBbku8zEyOEX+I9vyxQ4csRJ32O/Wcjnt9aXzi3HOa4STxiZCfs1oSO5kfFQP4nvWGN8ER6fKuf51ktNy7NnoqMSOcHPaiSeKE/PIi8fxNgCvKrzV72YEPf3Jx2Vtv8qxrj97kySSMf8AbYmtE09kHIz2OfX9MiYl7yHIHQHP8qzrnxbpSN+7kllY/wByM15daMYpMIa0YZWZ2Ynn3qZScdkVGmnudfP4vhZv3FlO3puwtU5/FkmCPs0aeu5yf5VzsszKuB1HUHqKpEGU45/qa9rKMHiMfVUaWn5E1vZ0o3ka974pvWYhFiAPfaTxVSzvJ9Uuvs92V2PzkDGKZfafc2EwhvraW3mKhgkqFW2nkHBqxoNq73puCP3SAgH1NfSZzl0sDgXWdW+yXZnFSqKc9ESXGiELL5c+RtJwVrn7hwbCE45JOfzrt52EcMkjkgKhJ+lcQVLafGQynJbgHkYPUj8a+SyrFSlSxEZveOn/AIFE3nHVf10KsRPnxf7w/nXS+MLW4neKaGItHGrbyO3NcwnEqezCvafDa6LYWb6t4mnt1tSTHBFL83mkD5iF6nHSuOrzKzRUdTxRW4/+tV06ZqT2C6h9hu2smbaLjyiUJ9Aa9z0698A+IZ1toEtw7H5Y2Xyd3sM/yrudO8O6fa2nl6e93ZpEP9WkpwB7DpR7byHynyMCxbaFbd6Y5/KtTSPD2raxcpBY2UzO/O51KqPqTxX0pqk50K7gljEd07g4eeJCyY9DjPNSxeLt6gXFnE30UVH1jyDlPHIfh/4httOEBtrd5+iss424PPPuKyb3wtq4IFxB827BZDu+pr6Bg16yubhQ9n5ceDuwcEn0FYUeotrOnXUwsGtomnaGNG5LgHlqyctWyloeCeJRCuoC3tFRYYECAL3I6t9Say1OBxnnpVvXA0OuXkTAZjlYYPbmo442KFwoxng1vFtRTAYsZYEuQmB3qMq6kcZBGcinz7yWJ7imRyMvC96pO4O4jHexwKAvXg5B5FSZIJIPJ5zTgQdyYyScmm5dBEB5J7YqQMcfMOMelIE5AB/GlcbUHZs0tLD1CaMh+MjuAaYFOOnvT2chVHcUocDaWGT3I9KfM7hbuQkd+/tSEcVNKgz8tRsML2pxfcTRGeAMUDPHSgrmkI4xTae5Auc96fu4xUY6UdTRe1guOBzxRnFIeuBTj7VWu4wJNOBywPHFRj60o+7SW4XDOTUgOOfaogPenHNJvsNeY4HIPXPamfxdqXr1ph657UPazC51WhMZMsTggVdv5P3ZG7k+nesfw9KFWUE8hR/OrMrl2O41w1Y6jQ3tW5CzeUnP8I71h7fwregP7iPk/dH8PtWMrsdjlLO6l+2vIuQQSPlHY9aTVZPLEbjgFSq/jV23EatJjA5IGPSsvV5GlKrGGaOMfMwGQDXTDWRdWNiHTrd76byIYgxQGRmxztAp75LhCCCOuetXPDXiGXw+9zNZxRtPMgTe/wDCOvFRm5l1S8e5m2mV3y+B6966JppX6EU30ISWU8HFQMwycsVXPbmtWazYEuy8dc9qjWCIAFSCev1rBVF0NeVlFopBCzjeqLzlj1qBJWBIPNbDvE8LI8eRjna3Wq0VtE/CRMPVmPSrjUS3E4u+hUiY7/kP51uabAJxy2Dnkdc0y2sVkTETMU7nFaNvEsF1tX7oAwRXNiKqt7ptTg+pXv7UxQsVIYgZHr9KztMt5bidVSeKOQZIMj7cEe9dRexK9seDhuOa5V4FiYA/Kexr7PhbFRhhm3vF97b7fqcmNouUlY6z+19MfwRf29zG9x4mnukZruceYTCB91WPKnI59R39OCa5lE7ESuuDxhsYrQ3fMQME0XGm3EkhltkUsq5ZcgfiK9LiHE0XCn7OTcb3ae3RI46NFwvcv6PeTXdjfw3LmTbGWVieR7VlaVYyXsMiRSIrKjN+8cIOBkjJrU8PWc0UFzNPtCyxEKM5Nc0o6jsQa+J9pB1Zcmx0q9tQXIlUA85q5qM89/dotw27YoiiUH5VUdh+pqtDE0rHYMkdaCdzZJJP1rR3as9hIYylGwco6n8civTNE+L2qabocVlJZQ3lxENi3MznJXsCB1xXmeNzZJzSngdaycLlJ2PU4ficms3EEWt2qWe3IE0JJTJ/vA84rpo9R04MoEpZSPvheK8GK5Xmus8I3++E2syyO0ZyCq5O2satGy5kO562y4QPbsGQruVlOd1dDf5zCucYGeK43S5ktZIUlMojuFIVXAG1uxH1xiuuupN8meBhRWLi1cpHi/xZ0I2utDUoQBb3P3/9lx/jXL2+1olwSFHAyele763pcGp6ZPaXOBHKMk+nofzrwi806fSNUms7nIaMnHPDjsRTi7+6MZcLkjy2BUdeKrSYEi7DgU/eFY85OSR9ae+0+WMDjqa6FewEO45yckUR7vmxwTwKkfBXPv29KYWAznGfr1qr9wHQjzG2qpIzyafOMzbQfu9MUlv8jKVPI5NRynMxA6EVNgGOcyHmmZ5/pTm+8T09Ae9NYFWwRzWm6JZYiYkYI3D0HWmyKoI2/cqSArE5Jx60y5YcLt992aizKKp4Y/pTWqTrTCeavZGbEFH160YwOtOHTinrYQmOaO+KX36/SkznFO4WDjPSl/GkHHWl9aFtcABxScYPNH4mj0xRfsAZJ6HmjnrnNB+lOx0xU2GaOlkIjZ7jk1o4xnGapWsexRkHkd+maugAjp9a46zuxpB6YrcilURIP9kfxViD9fWtqGOMwxkqudo/lUU47sZz2pD7OZ5YyNjEgA9jWXa3rxoUZS8bHcy5xk1e1uSN4hg8+YeKyoI3nlWKMZdzhRnFdNCLa1KrPUYx3MzYAyc4FXNKlMcze/NQLbTEbtvy5xnPepbeIxPuY54xgVvNJx5SIX5rm/8AawyCMkEMM/hUcVk7MRC2VHIz2rPt3G4jkk+ordsU8tdzHBbivLqL2eqO2Nmyp5EycGPc/qKlispnfM/7tMfdU8mtPKg/OSQeaZNOoGRjj0qPayehqoJEa4iYRqAqD26UFskYA/Cs65upJJSsQ4J5FSW5kBCuDjqKmSursOY2lO63IY4I5rAYqLsxuMq3PI4rbjZ9mONpGMCsTVozHIsy5+XOQK9TKsU8M5eZNSN0QmOOzuw0ahl64J4rRsZPM1GUrnBiPUYrJvJA6I+Oehq5oBM10WLNhYyMevavUxuLjOjyx0ONq2hqWWX09R/sN/WuGTPHBPzEV3Omf8eKjsN31rkdPYAzqOv0968fD252yJbFSN3ibKEqehpWVlClgQCMjPepdWAS7fbwCA36VbvdOuVs4bogSRFAfl6gH1FdDnHqyLGYAMUdTz0p2zCB/wCFulBPFWrPYBRwCfatPwzdG01ZWDHDoUNZO4Cp9OVnul2OE2jJY1M9U0B6Fb3zS3MKsWYFh3969RtJFeCP5snABya8c8MMkmpxpvZ/L+d2xgD0roU1drVniZyp3Egk1wt8mjLR6DcN98g8YzXnPxItomt4JggM2/G7vj0+lacetlk27+o9ayPElyL6KMF+VPTNZy0KWrPPdn7xuuQD+NIoBxgHOO9S3A2TuCSBzUaYWQc84wPeuyLvEYSAZKgYAXqajOCBnjB6VLOy9+D7VXVgBVKzEx6ttcHk+ppr53gnnikz0546U9MOmBnI6D1FUlZ6CFwGGT17U+QKY93HAqMOF+79Kj3Efdot2C4bsjDc/wBKQnPBpGbcfemFsdOarRE3HU3qTilJ4pB6UN20JFHP4Ud/ehe5pDjPenuAp64xikOc5PNLx0xR6+1ADQfWnfypv1FLkDPeldAgPWkB9Kdxg5pBinYB3bkU5c9TyKbnA55pwYHA9utD7DRsadJ56LGQMdxmrZiaPkjjHWsS1lMbqwByCK6qznR15AcEcg1y1Y3lcq1jOzyR17jFbsODCnyj7o701LKynRipdTjgLzVqKGMRoNzcAVzp23YbnnV2xaVsnJya2fDOmPqTOiKWVQX4HQ1huhe4KjqzEV6z4DsRZaLGdvzy/OzY/IV2yfKJanB31p9mQho/LyehqicBucfjXofjS2jXTZ3SNVJ+Y8c5rzxTuAwMAdDWMXLqaxJrRf3mMnK9frWokx7dOnNZtvkRtjg54NT7sHjp2rKouY1i7GgZ++SVHeqlzcnptBJ6VXlkYKQM8dc1JZ2+5hLMDnGVBrNU1HVmvPcaA1m8cs+CGyevQ1LJqkLDAf8AA1PdRiVAhxjsGrNls1Xkp8p96u0Z7hJtbGzb6qvk4BAPqazLu7Ex8tCTnnNZLK4dkjb5R6U+0XlmwSRxmt6VFJ3Ri6rejHzsRHtYYweK2/CXPnk9Mhc4rBufmGcc9/aug8OlYNKnnlJChyxx6AVVS6i0jKTuX9LAMBGcHewriomKXMmDgZPPpW7ba9Dbo6rEz5dmXPHBrALAyu2OGYnH1oo0pJ3Zm2iXUSJHjcEZMYzznBrSh14wWMECQBii7SzHr9Kw264rovD+nWt7Yh3gDzeZs6nmrnZK8kJeRnzxrqCPc2kJXacSRrzj/aFZxwODjPpXc6iYbGYR2MESKgw+0YyfrUNvrFjboTd6eGlbPzgBv51lCs72S0HY5BIJZMbIXOeh21tWenCCA+aFaVuTg9B6VpiSOVUaLKqwBwR2qB54w+zOfXHNZSxE56WsPlsavhaLbdsI1CqUNPvmBJ3KCM1Fo+o21rMzyZyw28DjFQxGQJKblt7vIxCqOFXsKzvpZsZFIdjHyen1qKO8d32OgGTtIp5gl3DYfk9+oqN4Ctwm9hnd17daXMknYFuZ+pRBZFbBGeKrkZAYHgdc+lbuo23nQyqByMkVjW2AsiNwVweauhUvHU1lGzKU2ACSeM4xUIbn3FTXB2qwIHJ4qsDjOa7IdzKQpwMZpUYBsjr2pn0pB61o2RcmdgxycZ9KjJ5oXkYNFFxiE880HjmkH/66WmnfckTrTgRTad35GOKAQse0nGaGX2ojHXJ5pzgEHjvUSkUloRjHc8dKDwaTvzQemK0RIdTSdDR2oz6UhDs8Ui+1Ie1L2xQA7r7Cg43UAZX0pMZxik1dXK2LUI3EAjqO9aNs7ogK89qrabAZm4P3R8xroNLtUMbvt3HPHpXLVnroUR2t2VIXYyr06YraQ5RcgHis68uY0hZFHzdgO1V4pZvLT96/QVgkpivY5Mt5N1v64fNe16EVXT4McfIMH2rxKb77+uTXtmgc6Zb89Y1/lXRWY0UvFqb9OnGOdh/lXlEWCQpyM8fjXr/iFd1pID3U/wAq8fdQkh2+vrSps0iacaqqAenQ+tPXBzn/APVUMLDbxz7E1MjKXGScY/OspNts1RPIqoqtjjvUL3aHA6E8mmahIFtuD9Pes+C3kZdxYgmqpw5k3IUpO9kbCy7x/dAGeTzTCyLEzyMRkkZPcD2rOaFwC27nPUGoJgduCDjtznAq1BJ6EtvqSxnMzlvlX71OaVQuQoBPJw1Ujk4FKq7sA9K3V4mTFLhpCOgHSunjkSw8L+Yylt4IwMdW4Fcs5CuRwcd/WlMj+S0e9tjHJXPGaco86syb2IFP/wCulzgUHFB6CrWhG5rsit4VLhVDJPy2OcGrvg+cpazkdUkDdfasJbyZbN7VXxA53FSO9bHhCJnF6Qm5FClqxq3Sdxx3NCWRZZCd25mOcZrIuCRICBnGcg961wbe8Z0VeVGQRxWXdKRncclWx9ea5Kemty2bsESi2gYA5aINj05NV7yNVUYA3Zzmr0CbbG0YHIMXp7mqt/xDg5zkZpSqSvZjVjOLAP8AKOAQMZrWdxg5HesnoR0/ya1CTu5OAe2OlKo9BIkQ/N06VXvVYzDptz16VKDl1GT15p02T1xjPWsZeRRM5ypyODWBqEQiugRgK+cnHSt0sAASRkjpWPrRX7KxGRg8UUZNzOiW1zCuZN0p6moMgnpUmwlGfB2jvUZ+8MdK9dao5JPUUnr/ADpC1OcA8UzHOO1NtpiAnnPT6U4Y/GmjnNHSnckdkY6GkPOfagkHoKQj0pXYxB70/NM5+tOzTWgIemME0bgcimZwTxThn86V7lIYT8xpCaG6mnYyuaCRpIxRxikIxS9vrRfS4gGOuKXPNIpAPSl78URlfcdhynB5B5pYULsAoyc9KByQOmTXUaRp8aQeZgbvXvWdWp7ON2NIr6VC6I4ZGGe2Otb1vFsQIuRx2ogSNWO9gG6jNYniTWDBI9pZsNwHzyDt7CuGEnVldFbEmrS2sBJaT94eqrzzVWLUo/KT92/Qd650HJJYkk981fjH7tfoK7qUORaEN3Klx9+T3Jr2bwyQNJtiOSYl/lXjE3+sf6mvZPCbA6PZ/wDXJf5VnVXVFlrWV3QHrk9celeQXYxLIh6KWwPxr2TUQDCVI5ryHU126pdxN1Rzj1rKHxXKiU4Zdh3c4rQicOvyt15rNf7xx+IzU9na3FwD9mwSMfKTjP0raUblXsT3TDABBJznpUliSVkDZB649a1tI8L6xfOPtUH2SEf8tHPX6Acmrus+FLqzVpdLBnj24ZW+8MdxUbKwc2tzDWIPnDZPUD096VrSNlPnOxPXANQW5kluUto0d53basaL8zH0x9a3LrwprNtF51z5EIP/ACz37mUe4HesrSve5pzrqc68Vuk/QlcZAzTRGo3BWUt03HpWhJ4fuSE3SYyT8u3nFaNjo1vBGXu1JX+He2Aa2U79TNyXQ42ZSsrq33s8H0pD0rU8UeT/AGy32VESIIgCp06VmN93NbxMXrqMz2pDxRgYoP1qnckOtdB4KupLPV4/K+YXH7tkPAPeufPQ1reG226vpzHtOBUS2GjuZEt4pXe206U3T9Rtwufr0xXH6gsoumRyPM3Hfjkbs16NJnAwO+OK4PUrU3Gtyxk7SZG571wRaNGdBpsRl0C35JdEJ/8AHjWdeZEPfGeM1v6EvlafHGG+6pGT6bqratZA20jpkcghamS1TA5WUZbjpmtP+EgD9azZOOqnIPNX1PTPWlNaCQ4MNy4Oee/rROwMmM4GelAJ3Lz9KjuM78AnrUNPqMlilV4vlxtyRWdfxma2ZQeR196ktX2N5bEnPIFTS5WQEDKnr7VEbwldHTH3onNH5bVkIIYN83FQxoXcCujuIY2LKRwR2FZ62CpMCJDtwevavRp1VLRmMoFC4TyyvcYqDvVq7YMEQEErxUG3oegrZNyM2iM5A70nU9eakYYOKQDHQ1SXcmwmMUEGlHJGO9DEYxnn0pgJjFLjgc0g/WjAxmm7MSA8d6XnHvS4yfekAGDSs0xhtJxUkUZcHAzim46ZyKk81ohsB+VuSKHboNIrsMMfrQF3dOtPk5cn8hSohC7s8dKWyFbUjx2PFS+WGXKsNw7UGN+659/WgBlAx2oukgSGjIPtW3p2r+RblZCc4wMVjoGkbAyT0xWta6O+0G4O3PYVlVcWveKSNC01mFw7XKLtxgL61z+on7TPNPBCUjZsYHOK24tGt9wLljnsTWjBBHEgWJQqY+7XLGpThL3Bs5CPTrtrZ7jySI0/vcZ+lWYx8i5GDgcV0t+T9mfnj3rnPtDnkIuDXXCs3ujNozbjh3Hua9g8GndoVnz/AMshmvILj78mPU1634JcDQbMd9n9aVXbQs6H7N9pwu4KO/rXKeJvhxcXWo/bbOZkSUZddm7J9RXXh9pBB9jUq3c5GPOl46fNiseZdBnAQ/Dlsjzri6YdwkGM1rW3w5sdjB4bvd2Lyd/pXUtPM4yXkwB/eNMZieSzHHYnNEnfcd2Yh+Haxf8AHreyQHHUy4x+tTr4YvYpRJJ4lKbRjYgDD8q0u4BwfekbjqBUWjugFtre208NMJo7rUSNv2jyQjKD1xiqkq7+XOQfWpzjnPTv61A49M8/nV7LURWkRDwgAxntXPeJ0AtYDk4DEden4V0cgz0HP8q5/wAU7RZoWbHz8Zq21YR57qXF37FelVHPBGatao6G5Gxgw2847GqhOQa6IfCSM+tJ2paOM1fqSJ25rT0ONhqFmzkKBOhGTyRntWbiptP3DULVhk4lX+YqGtBo9hk5LA56muLvF26+2CMGQ/niu0nI3MAOT71yV0B/wkYBAwJMkfhXn8q6lm/pqlbVQw+cBuv1p97n7FJuOOmM1YEnnsHZQDsK4XjpisW2urm4ivY7xCrR4wCm0kZ/zzSteQ0Y1/GMFlxuHamg9PUfrVi7Hykfjn0qoh4B70VEmtxLQshsEHAUE/rUU/Mh5pyNkg4+pqC7Xr5eUY91NQld2GxPLUyhz94CpQ4YAHhsYrI+1zxyhXww6A4wa0d6kqyYxjkCnUpyvc0pyJ9oJIPUdTWLqhkT5SNqg8sO9bSuGGfWmSIkg+cA+hIqabcXc0aujn4bfeN7naoHA7mmXCc8H35rbmjG8Edvbg1QuYSQdgPHfHWu2FVS8jJxsjMIyTTgPWnNkH5hj3qS3t5rmQJEpdvbt9a35l1M7WIMjPy/rSrGzkkAmt3+yFt4w0jb5P7o6VdsbDey5TOepAqJV4bILHM+QyrktTEjU8nPpXYXmhMAGZSFf19KzriyjhQJEpIHOaj26tYLWMN0KjoBUQUDAI68nFa0qfuSEQlj1JrMAIbDA5/nWsZqe7FYUDaQMjnv6VJ9mZ5Ru4FWLeykZCzIcdcnvWqlgXhVh8oHGGNTOpy6IDHaIKNkse5fXvTv3UK7lhZlbvnpW2thvh+Z1G2oFhNu5GQ6Hrg/ris3WUtEBDBanuMIeVb0FW106FlzLGHB98Gnn7vy8jsPap452jiUmIsvTjmuedSTGhLeyggIMUSr/SrIGMn1HXrUMV9A5wW+b0arKsp5XGccisndatjIwOPUGnBcck/l3pQe/fsMU8EBcEYPpUxlfVAZ+uSLBpjkkZf5V+tc1Hny1+bsK1PGEnFqnOOT+NZcWPLTnsO1enQV43ZEitN99/qa9W8CLu0C0wwPyY/WvJ5v9a/pk16B4I1K0t9LjhuZUjdc/ePbNFVdLFXO8O1P9Y6Rr3LMBUL39jEcT6haR+zTLWNf6/oxgKy3EEgI+796vLvEDWkuos9kpEPv61lGm3oFz2B/EOixff1W0BBzhXz/ACqCTxhoEfB1FG/3UY/0rxXAyDSBa0dJLdi5j2CXx1oKA7ZrmTH92H/69Urj4jaWv+qtLuT0yAteXYyOKeUAQcc01SiF2d7P8R88QaWAPWSX/AVm3Xj/AFWU/uYbWHPQhSx/WuRGM0HpVKEbXFzGvdeJtZufv30ijHSMBR+lZk801w26eaSRv9tiajGO9Lxn2q0o7iuyzFYXTxeZHbSmPGc7ePrUbRSRkiRSpHYiurXV4m0SGNtu5G5cdT6A1zup6g97MrOei7aXPJuzQ7WKPJNLt9wBTo9hb94SB7UoaMYyuSDVW0JI6s6dN5d3FlQRuX8ORVdyC2QNo9KfbAveQqpOS4H60mtLjW57DNgMckkduK5W/P8AxUKN3Lg/pXUSsCo56frXManga4hPZl/lXny3LOisW/dgHrkj9KWVVaOTjJKkf1qPTzktjrkcenap2AYlT6EfpUacw0c7cKvPUD0rLOcnHX1Fa02OeDgE4xWRIQsrgevOKUo8yTF1Hoef8acyBl53AY7Go0cbjUoI5PTjgULuO5z19MyTbcZxg5qe3voQuJlZXJzlT0qnfZN1znPaoJCM9K7Yx5o6ivY6FJFPKNvGPxBp6vuPB5qHSSGSQEZ6dqisA0lxdJI5+Rvl9RXNKkrlxqPqXztZWxxj3qqyqfvZ54qRgycn5h0PrTVQzzJHFl3c4AFZN2ZqncLbTmvn2IDhfvHHQV0tlojWagIhQnt3P1rqvD2ipZaeqAHewHmMB1NbMcEFsRtXLf7XJrW7+0ZN3OUs/D8szCSdOCM8ituHTIY+CB9cdBW5Ywvfz7FBwOT6UXllcQTENG2O2Ka0V0iSoLSDCgrk47+lZeqeHrO4BPl7GPda0Z76OB18wZYdEUZY1BLHqF9nIFrAe7feI/pTfYDjbvw/FDJ89woGPu45/KoR4cDsGS2crjO5xjNei6LpVml8qqnnTfxO3P610r6NE7FjhFJzgc1UYN6oDyGXQrhLNWw2AMbQMCruh+H2vLC5jbb5y4KEruJPpxXa+JltkhEUUZGDjmrngm2lSKVol+VmxnFCinJXCxwGgRRpfyWd1E+WOAuzBz+NYfirSxZXzhUYRt8yBlwa9k8ReH5bydbmJovOjbcB0/WsrXPDq6taxpPuhniOUcDP4VUoe7YLHh0cxEbKPm2jIAoS6uY0GxQc8kHrXseneAtOWXzLiJXYdxkA0zxF4AsLuINpo+zXQ6DPytUOlK1xWPG3vY34ubYr/tKKarxbs210UOM7XrsJPCFxayeVfTGFycAyRkof+BCotR8GXMOXuLYvHj/WQjePrS5OjQjmheXUWAdsijv61NFqyhiJYyp7GrY8JSXBJ06Zmf8AunKn8jWZqGi6rpzbbhHX/ronH50/Zxe4XZR8TXUdzNb+U+7apzx05qtEB5Sdeg7VJcROVPnQ5z0K9velih/dp88nQfw1vTmoqyE1coSD53znqacoGF+nemOf3r/U1IPu5xW6ADgg5zxTJAMHjPNOHOeRmkYfKQD1xVWERY5oIoP1ppJzxU6ICeLaAS3NNwAG7g0ADGaaw9DRfUb2Gge1GM9vxpcHvQ3ftTZIg47U5VBdF6AkAkU3FCnDqe2QandDR1Wo+GXe2RrDYAgyQx5P1rmJYJYjiWNl969PssPagdQVx+Fc/qFj5cxRx8pOQT3Fc0q/J0Ktc44KT90HPaniFyOgHuTW1NpaElgzD0GaiGmLuALnGefp9a0+sQauCj0M0W7EZDKT35qzols76zbKw+UPk81rvbxxLtjVQvTGOtaOgi3E+wqqyr9wgfe+tZ/WU1Yt0mjo2OX3A8Vy/iC6Wz1JZpAzKNrEDrXWLatIV2tu/Cua8aac1tqn2e8U+Z5attz07jNYq17taEvYs+H9WtNQvpBbLIsnlH7wwu0EH866EAB2HU54NcL4XHk+I0XACyIwGB7V2stzElxHHKwDuMgHocU5xad4oaMS5ASRgBjGax7jiZwBwRmt3UhtuJBnBycD2rEu+Jx06VEtBEO7pkDj0qYHKk/zqDH4fWn7uGyOMetRbZgjEuk33GTx3xVWbGfXnOa0XXc/TnFULriQ5GCK9CmtBXNbS7mKOCaSRtuMcetOscR+fdTYRX5O7gADuah021ildpZAWK4wD0/KrGskHSb0f9MJOn+6axqSs7AIdVsM8Xltj/rqv+Ndb4Bl8OiWXUNT1rS4XB2xRSXcasPVsE1TFGK81YlX2/H/AIB3rB/3j0BvEvhxOF8QaTjti8j/APiqdaa54dnJ3+JNEiUnndfxf/FV573oqlil1j+P/AD6p5nrZ8aeDdCtj5GvabczEciK7jbP4g1jXHjTTdYLCfxHo9lat/At7FvP1+avPPrSGr+t305dPUPqnmei22seGLYAWmv6Ep7vJfxFj/49T21nw/KczeKtCIPX/T4v/iq81zg0xuRWkcQnpy/iJ4XzPZtN8TeEbFMR+IdELnqx1CL/AOKq4fG3hZuD4i0PH/YQi/8Aiq+f7kDnsKoXQzC3t1rojVutEQ8Pbqe/6lrvg+/dDJ4n0RAOy6hF/wDFVZtfFXhS0gEMHinR1QdB/aEX/wAVXx3qCeW0i453mqdbSsmc9mfao8Y+FlbI8UaKx686hF/8VT/+E18LtwfE2hge1/F/8VXxQvB6U9WApOQ0rn2fL4y8LKMJ4l0Rs/8AT/F/8VVc+M/DB6+ItFx/1/Rf/FV8bs2SaQ/pS5g5T7Jfxh4WZdr+IdEYHrm+iP8A7NVf/hLvDABVfEOjBewF9F/8VXx7n8qcnUccUOQuU+vj4o8Juu19f0PPY/bIuP8Ax6om8TeFJEKS69orL0Ia+iI/9Cr5dsT7VpqcJWMsS46WNVRv1Po6x0DwnrStd6abO5UPsL20wkTdwcHaSAeQce9XR4I0fHFqMfWuQ+AqhvC2qE/9BJuR/wBcYa9NCNgfMa3jyuKdjJqzsfJD581/qaevTrTJCfMfH9409SMfNwa6UrGYY57ZxSMDjninfKc/N0prMMcEGjqIiNIBlhQaVetS1fQB+BTGHI64p5GKTORg00khsaKTr1zQeTRQSKRSEUUoBZgoIGe5PFPSwHe6JrVrPAsf7xJEX5gVyPzq9eXtnCiSTyrsc4GRk/lXI6fayWwl81+WXG3GR+NWrSD+028i4lCvG26QDsvoD71xVKdtWXH3mkjYzYXk6C1mBP8AEq+nrV86bbsuzywEPBx1qHTNOjSdEs4QqnGM9T9a7KPT44Y/MILMBzgZrhk4t+6d1KnyrU4640WOMAIGDdgTwazG02bO5VKkchvSu+mhSZFLIApHBxgj6is27UplWAODz7ipupa9DR00R+EL+1OpWy6rOsQRgXz/ABEdAPrWN8RLxtR8S3F3gBXUbR7DgVneJQYdkkfAJ28d6ozXXnwRM7bnQbPc46V1Q96NkcFRWlYTTm8rWbGU9pACR711GvWBvYV8titxH91s8VxunzpNeqM7mi+bI6cGu/kPfaMdcVUrtCiUdRx5gz12jPvxWDfHDj3rf1MEFDjtz+FULC1jv71beUlVYHBHXPrS5eb5iehjA8DByPegH5WHJBHaugufDbKGaG4XA42uMGsu50q9WOQRxbzjgpzT9jNWVthKSZlKuT6jGTWZfjEpB61fkd4QVmikjIXGCvWs+9fe4x6Z610Qv1A1dG/1Mh9xzS6xxpN9ngmB+Mf7JqXw9A88MzBgFUjNTazp7nSdQCOSwt5XI68BCT+grnqu0xpGvRilz7UfhXintiHHPFFL2pDTQCHp06U1uacT3prMMVaENIpp60M47VDLOqD5mAHqa6KauSyK4HU1RmAMcgz/AA5pL7V7WIf6zc3oozXP3etOcmGLHXLMf6V6MI2RhJ2MfXQFuW98GswcGrc8zSvmXJ96rSDDnH4Vp1OOS6jV+9QaBjPNBFJkoBRS8Z+tIPzpAGKfHy3SmgZHFSIpJ6GhlJGjZ5GABWmv3RWVakitBG+XFclVam8We7/s/j/ilNU/7CT/APomGvU1C7R9K8r/AGfmx4U1Qdv7Sb/0TDXqgJwOld1P4FY5Zbs+QJB+8fp1NIBzzRLkyt9TQuc9a3vqZkm0DGR1prKQCKXPPH5U1ySCQaq6QiOnoOOKZmnRng80XQIcxGKRe/rQeTx61LIcEAde9Q2UkV2GD1oxxTpOgJ5puacbEsXBqS1aNZczqzRH7yqcE1Fmmk9cU7iOptlnvfJ3MS7JsHOcKOg/AVr2dmLUiONN00pwx9aoeHpTHDDJgHdFtFdrpFiMiecjceee3sK8qvJ3sjsoRTVzT0LTysYbBGR1962TEAhJ49qLRgkOBk/yp88hC84rl5ubdHckZk+RlQBtGOvesTVFbGV6+lbV7IWXKHBPQA1zepXOAec4/ClvcJqyOc15fPhCE8gg1hEBEAKhQTjGK27m4yzEkEdiRWTrD74lIXnHbvXVRle0Tin3JvDraVbax5mpKwg8o/LGM7m7V1/mFgdvAB/GuN0myayuUvLiWORiuBHjJ5rqLdmEX7w/MeWHoa6KklLRHOJqjHy07cmqej6f/bGsW+nrM0JmyN6HkYBNGszYjQZx1q78NHRvGEMsrqscETuSfXGP61n2F1LN54Y8WaYT9juPtUf+0c8fQ1kS6lrVkzC+sCOeSoK5r13UNZkVtmn2/ncZLtkD8PWsyHT9Z1qdRJbtIjcYA2qv1ram59GDSODsNQ/tBdsllMqjvIoKkfWp7nwzY3cRma1CoeQ0ZwcV6cngG9ZSkl3BHGegCZxWNqnwx1kxOthrUbIeRGylRW/M7e9qRy9jzOXR7fSIvtNvqAVDz5L8k/lV7RLWe98GeKtWuUVYVsLmGAAfePltlv6V0OkfCXWZdTWPW5Y0sBlmkibczewFd94s0O00b4YeIrWwgEVvFpV0FBOT/qm5+tRKKlqlYpX6ni5PoaTePWuXk193z5ULH0z0qpJqt/JkLiMYrwlRkezzHYtKF6kYqtLfQxgl5FH41xU0t7Mf3lwx+hxSLZEjdK7N7E1qqKW7C7OnuNetI/8AlpuPovNZ7+JCxIhtyx7FjWbHaxr0ANSRxqjHAH1q1GCDUkk1HUJl++sQ9AOaqtHJIR5sjyE9ieB71LJIBnH4VXEm4lAcE9+5rqpwctiZWW5DMy5KoMMBWZO3Unp0960JUChiOAR1/wAKyZmLHA4Udq9Sjg5NXscNWokIxPzDOFzUEw/eGpTx1/KmXIHm5BrOvD2cuQxT5lcjAOalCZxUI61qRR5Vc/yrmm7FwVyn5Wf6U5Ysmroh56U5Yuc9R9KzczTlK8dv81SiDHPT2q2iDHPGKcVHtWbmVYrxptxg1YTp61G2AflNOXg1L1BHvHwBJ/4RPVPT+0nz/wB+Ya9UUfKPpXlXwB/5FTU+M/8AEyf/ANEw16ipO0cmu+DtBHPLdnyM4/et9TTTxTpOJH47mmE81texiWBE7RCQAbCcDPrUU6lCmf4l3cVdtjmwjz1EuPpVW7Y5QHGFQAYrPqBAenFPjB2EioyeOKljTCbiap2uCEFOUk8dR3NIV4HBJNOQ4Vh2qXIuzG9R9OtR/wA6mYYxjvUTfeOOMVUWTJCY4pD+lO5Pemk8Gq3EdP4ek5s0c8YG0dsZP9a9PtATDtbtgfSuH8IW6XsGnoYVLod2/vgdvpXpJjSJeSpODk+leLim+d2O/DK8dRIso4ySQOgFSXM4ZMsw2k4PtVGaYryMknjinmYtFtIB4weK5nJ7I64qxXuyoiLBgPrXEa5dLvwDnnjnvXSazOY4/vZGOmK4HU5zvbJHPXNa04czMa89CKWcOOCCB2qvI5cgHj6VA2SMjkY7d6dAGEWD8pHY16UYJI4W7m9owQQBgo3g4LEcmpJ7l7XVYjvBhlXae+OeABTPB9jdatqi6dZJvllIIz0Udya9+0HwLpOlRQtd26Xt4nJlkGQD7CpjFttrYk8SttA1XxJrUdrp9tJ5X3WmKnYo7nNe6eD/AAVp2g22xbdXlxh5pFyzn+grfW4itwsMaqo7BBgVcV9w9DWtOmo67sQ1bWBcAQxj/gIqYHC7RgD0FRk89aUfnWyExkhIFJGxHJFPYZFQnI680gJHPHB965f4ksf+FfeJsd9Lus/9+mroy/HB6VynxIfPgLxKMn/kGXP/AKKahgfJdrcZ4LewqwZ8biOp4rLgcB9wHNTM+TjOB3rzJQVz1Yysiwr7nJ/Ae1WFfI4yR2qgmWGCMJnvVhS2QA3HfFTKJUWWMn61G0hB70EnH+RVedcsPmB9hV0qfNcqUgkkGScis+WUs429R6U6R2Z9ifiaNoQf1r77I+HnVj7atpE8rFYuz5Y7jbmd5OuF+lVtuFyeBT5JEQZGHb9Kqs8krZPXt7V0ZjXwuXrlhrLolt6t/ovwOWPPVd2SzAG35+8DVRug4p7bwOQQKbL/AA4PaviJSc5OUt2dXTQQdRWzb8QLxz61i9K2bX/UjmsapdMlLUu480zJweT60meOawsaEm7GMml3H6e1RA4x703PPc96LDJSc8mnrzn+VQqelPyOCRQ0CPefgA2fCepe+pN/6Jir09X+UdeleW/AAkeE9S4/5iLf+iYq9TDDA612QV4o5nuz5HkH7x8epph5NSS/61/qaZ1rocUzIvW//IPPqJlqLUEAkX0Kin2zf6Kw/wCmqZpNQyZc84P+NSlqMpEEVZiUnABGMcioW9anVQylWyCRnim0khx3FIAzuPyqetJEm5uM7SeOxNSRhR1X5QcY71IxzIznsBj0FZPlLtci5kX5l2KDgH1NVHGHPetLeJBlhnGT1rPkPzc1cGtiZrQaBwaRsGlB4oPP0rXR6EHd+C7ny7aDySCwBRh6V2kEjMhYngjmvMvAr7dSmHbYDj8a9GiJfbztHoa8TFx5Zu534d+6XEG4hTvUnrmnSj5MnIA6+pFCkgdCw7nFNvCywE55+tc9kdVzmtdnAjK9vU9q4W+Z2clPvZ4z2rptdlKrg8AnP41zyRGSMuWO5jke4rrwsVHVnFXlco+bKP8AWgMOmQKs6fbtqN3Ha2sfmTynaqjqTUsdmHly5bbjP19q9Z+HfhVdFsvt80QN/cLhcjmND2+prtbjKJzGl4K8P2fha24zPqEuDNIp+77LXWaXqEi3jRySs0EhwpbqpqhDZXDNlIWY5xjsK2NP0V/M825YJt+YKOuamK6IZtw2qqcucsDwatHKkEUI6PGrxgEEUwsCOSK3SXQTEeQqf9n0pY5g3GeR1qKUgqRmqcjEPlevelswNUsM1DI3tk1SFyxHzfhS+eDkk1V0Ie5PO0VzHxFBHgLxJn/oGXPH/bJq6C4uVjH3ua5X4gzbvAviP/sG3P8A6KalYD5IXJx7VMnGO/rUCk+tWIjnnrXCz0kWIucknn0qRB8wxmhBgDJOcZqVEAHOc1g5GqQ1icZBP41TuZTGN34Cr7Dge9Z8vlNdHzydi849a9fJ4wlOTqbL/NGGJk4wuhlpCzpvYqit03Hlqi1K1mgVZZFLRN0KngUxpWnvH+8GGNoHTA7Vu2E2mN4X1iK6+1f2p5iG32keSIwDv3d92duMe9fossZHGYOVOndcr3ez0vt2/I8CSlBqb6nL7AzqkaszscBQM5PbFaP9iaxDKom0rUEJ6Brdx/Svef2PfCVnqXiDVfEF/Gk0mmrHHbK4zskfJL49QFwPrXqvxp1qTw34UvtXhYi9uG8uEn+DJwuPoAT9a+XhQ9viFhZL35W26X26PpqbTqOmuZHxTqME8LGOaCaN+DtkQqR+BqlMGG3IP5VsX1/Pc3Dy3Eryyucs7nJJ+tVmLOpO6tsfkmBwd4+3ba/ur/NGsK859DL781r2n+oGM1UupWPyDA4/Gqyuy9GI+hr5atCLdos6YO25r7sAdfpSbueM5+lZguZR/GW+tTx3PeXIX1UVh7NmnOi1u78/WkD8dSaiRw6hh09adk0mir3HhyOMVIr/AF61AG7c0v8AnNKwHv37Px/4pLUuDn+0X/8ARMVeqrnaOO1eTfs/E/8ACIaj/wBhF/8A0VFXqa52jk9K6oLRHO3qz5MlJ8189M0nvSycSv8AU0i9K2VupkWLckKR23oT+dTaom2XGOA7Dr71BAB5UxPVdrD860PEce25lwAMSnH4gGk2kxmT6VYlOKrIQWGeBnmpyhVCN2Sx7+lE3qOLJVP7rGQGPIFEUmAiMrMWHbtQqqV3D/WEYqza4jhYcZHAIFZOyNEmyrESiSELvcHAxVaXJkO7g55q6u2OUsD1HI7GqM5+bI7mrh3JmN4FHGKBQTxirW9zM3/BBB1lxznyz/OvSo41xtkYknnFed/D6LzNWuJMErHCc49zXoYYBlyRhSBtHuK4cRh6lSreEbnRTr06UffdjSjO1fvkHoMjtVW+mABz3Geaie7zsVgAvPv0qndSB4/mbJ2lj3rH+z6907FLMKD0ucj4gcF2xj0xVMjYioBgBe9XNagdJULjKlwNwp2mWS32q21szbY5HAZvQd6OWVOPK9zOclJ3izq/hX4XOr3bajeL/oNuw2gjiR/T6CvXLi7s9PDE/NJ6UzRrOBNOhttOHlwRrtVV/rTL3w/JNuJ5btXVGLUdCDPu/FnlACFcDvgVAni87wuCQep9arXfhy4hOVTI9qzn0i4iJYw8d8dKScuoHYaZrO+RreI5L/Ogz+YrQiM4O+Q4z2NcXpMk9pMjeSXaJt27phe9d85aeJZVwI2G4GtIO6GNMuOW6GmNIO5zUTOF4B561XeQbzjqKpsRNJg5IPX3qNpCiHGSRxUPnEk4+79KQTdmouBEzlmyxOf5Vi+OsjwN4iyP+Ydcf+imrcLAk1g+On/4ojxCP+odc/8AopqAPleJfm5NaEECuPeoYYiOcZ+taNsBkdu1ebUn2PVhEkhtDkf5zVgWwUglMH1NTRq/boOnNP2Eg5zz0rilNtnSoIoywEck4qpBZWNxcOlzepbNnjchII9yBWs6ccnisHVlEcysV5YYJr6jhfEUaVeX1iN42/pnDj8PKrTtB2ZY1XQzZRtdW13ZXcZ4JgmBYf8AATzWOqvJGUAEUOcsWPLmnu/yDkVE0nHAFfotWlhMZFSo1LQXRK1/+HPB9nUpPlqas9V+AfxTtPhxrF/FrEM0ulagq+Y0IBeJ1zhsdxhiD+Fdt8aPGeieN/AMZ0DUorlrWdXeLO2TbyMlTz3FfNM3LDPNOtFzcrkc+tfMV8zp4XMfrPJfla62208+ht9XdWKV7DpcrLzSs+OMZFOvGxIV6845qOUCFgpOQRxXn5li6GLm6lJtX6P+rHRTpyhoytKrZL7Tt9aYOnvT3HzkjoeeKZ+deM0WPhXe6ipH5kwT7dKZbYMq7ulWXjARmwOuFwe9F7IpK6G6cCUcHoDVsR9eCBTdMiOyXAOOOtXPKOORXNOXvGkVZFUR4pdg44qz5YwaRk5HcVPMVY9u+AZ2+E9RBI/5CLf+iYq9NEgx90/pXmHwJXHhfUQeo1Bv/RMVenL90c9q64fCjmk9WfKUvMj/AFNNFPkHzvz3NIBg10tXMkS23SZfVOPzFavinP2i4I6GUf8AoIrMsuZyB1ZcfqK0/ETrK05H/Pcj8his3HXQZhR/fH51bHLAkkYqvbrulVQQPep9m4EdO/1o5RxHQf67DHChskmpGYN/qmyp4PbFMgCiQAkFOhHrUwj2hhGMBBn8ajRbl6leSRZM7NwxVaQ89OBVqUknpz7VXl6DPUVaZMkMqWyt3vb2G2i+/K4Qe3vURPArqfhho8+seKo1iVjHAjSSSY4QdB+Na6LVmTvbQ7bQ9EMEIstJgL4HzOBgs2PvMa7Gx8D3MmHuLgRZIbCDOOOnNdXounQWUCx26AAdc/55rXCcd6z9tJ6LRERw0d56s4oeA7QD95dzZAIGMDr+FZmp+BwkbG0vGPy4AZc16My8HcKpXS7VJX6VLqTXU09hT7Hg3iPT7zTiwu48KSSGHKn0rEs7horiKeIjKnNex+KbQXFpMsqFkI6f57141JALO7mgYjarZU+oNY4mTnvuEKapvTY9H8K+L30y4RLhi9tJ0f0r1bS9etbyMFJQRXzzollNdwydVtg2EbH8VaMN1e6XMAHIK+h4IqKdVmh9FCSKQY+U1Xns4X7CuH8K+JvtlvtkP7xeDW3NrIjXJOT7VtzJ6gWrqyjhlVxgqeCp7ioNPukCTW0jY8luAP7vasa/8QJITGH+b0Hasa5vZhqMEwf9zJ8jYqet0FzrJ7uMybQ4xVeSTbksRxVJbMbt6seehPSnM+wYY727+9MCdpeCQMVCZcnqP8Kg808jBx2xUZb1GfrSAvI+MDdkdzWN45kB8FeIAP8AoH3A/wDITVooRjngVj+N3H/CF6+ABj+z7gcf9c2qrdgPngKBgc5HSpIWwTk06VSvB9aSHBOCa8lu6PZS1NK3Y8AfrVgZPYk+gqpF6gnPerkbBjjJx7da5ZHREY/Q+vpWdqkJkiI257itVgVB64qrcAsuBz711YDEewrRm9hTXMrHKSxnbhelViCW2gc1qzKI5yucYqtgG5GAMk191hszjRpOMVddDxq+H5pJ3KF0pjm2kYOBTrNv9IGK0dbt/wBwsqj5lOCPasyzP78Z6V83Vm5ycnuypR5HYddtumGf71LqvyzIP9mknP8ApKcdWqTW8edFj+7zWKfvIT2Zn55pcjHuaYOvSrF3AYTG3/LOUblP9K1b6Ga2G26q0yCRiseeSOtPnYeZgEkY4PtVfOOhpWb1pphfQ6Tw+vn20rY+6wH6VoNbgdqPC1pJDpjNcIVMr7lB64x1rVMa9BXj16v7x2O2EPdVzGaD1qJoTxwa22hqN7fNSqw3A9I+ChKeGtTXof7Qbp/1xir0ZXO0fIenrXnXwgRl0bVCB8o1A8/9sYa79WfaMKcY9a9ilrBM8+ekmfMUg/eMfc0n40S/6xz7mk9zXUtTJFnTf+P+L3OKlvZlljMYTDIzbjnryarWbn7ZERx81WZ4/wB3cP8A9NSMZqb2YyjCCJM9ulTSZUk4IHTmooz+8BqRg4U7+cngUtGUtCROU3Y6enepIW+Usz7cn5c1ABhg2SeOlPjVCilgCUFRJJspNjNyr8zg4zjioZcc/wBanCsoKddx6dTW7a+DdQvYPOkkii3H/V53P+VHMkJplTwd4Vv/ABZqP2exAjgjwZ7l/uRD+p9BX0d4Y0Gw8O6VHY6ZHtjX5pJW+/M3qx/p2rM8H6ZBoHh+2sLcDjl27ySHqx/l+FdMocbApye/tUTm5bCijQiIjXpip1bgEcj1psUYj5GSSO/NSZqojGODjvzVeaPnBz6irbHjFQNlsk9uKBnGeI5DGWQnC9D9a81vNKTUtRaADbM5wG9Pr7V6d4pOJQ+M8jOPauf8qOyuGnTH7wcH2rOSTjqJmhY6PbxaNFZ24AEQ+U+p7k1i3tik6GKZCCD1xzW5aagNgBYDnn2qHVNc0+3cExieX3rLRi2MXT4Rpc7SruEbDHzcZqvq2unOI3J7cf0rK8Q+IJr9zwFReiL0FYiMzcv+lJvlVkJmzFeTzOMSYB71v2sZ+ykBvNP3txP3TXJRE4AX6VoWk8tuCEfCmnGS2A9MttVSXTodgBcDawqKSXecnAIFcZoepNCZIIlBZ+QT61sRT3AB+0LyevvWqfcLmhJcbT1/EVH5xGc5qBpAqggAgntVc3KBiCMqew70dANWCQtjnr0zVHxmQPBWvccnT7jn/tm1RRSjI+cAA1H4vlD+DNdCjAFhP3zn921NMDxa8QM3ydh1FVIxg81fwN2DULxAkkV4sZdGe+46ixtg4BIFW4XDLwAKqgY6jPHepUKq3H5elRLUaZcYZ5LcfSqsucnHJqwCGAAwRUco+8amLsy3qc9rMRj2yAH0NZ9mxadSfWuhvolki2sAc+tYbRiJyo6ivfwk/aRPPqxalc17mNZbd1IB3CuXtTtnAI6Vv284aEqzcqM5rngf9KY9smiaszOs07NEsvzXEZGOtGrvmdR6CmuMzR8d+lGqjE4JxyKzW6MJbMp12OkiObTUSZEkQdmFcd3zXW6IwNivNZYv4SqG5W1rTrRIA8MPluXA+U8Y+lTaFYWiwieWPfMHIG/kDB9KfrB/cwgf89RT9N/48+e8j/zrncpOlubKKUtjXM47mjzvWs9iaaXIxzzXNyXNOY1BKCTzzS+YDzkVlCUj2NH2g+uKXsn0DnPWvhROE0PVQP8AoIk/X9xDXcrK20cDp61558HU8/Q9Sfbn/iYNz/2xir0NYQFAI7V7NJPkivI8+b95nzTDa3F7e/Z7OCSed2ISONck12Gm/C/xDdANdrBYoRkec+T+QzWr8Jbm209r65kA8+STyw57L6fnXrdtfxXCZzxWk566GaR8/at4J17QphNdWhmt0OTPb/vFA9TjkfjWdIyuk6oMs0pbI6YxX02ORmMjHp7VyXiLwNpuoCaWzjWxu5FOXRfkJPcr2/Cp5+4W7Hz/AAsN56DAqTIJ5rU17wrrHh2ZjqFsTbdBcR/NG349vxqhY2F/qLbdPtZpye6qT+vStFbqNMiQ4bBxT2JUheAre3Suhh8IToofVb22sV7jdvb8hxUm7wzpq7Ujl1KYDGZT8ufoP8aJWQcxleH4xcatGwG6OIFsgZGe1egeHEabXIBztXLN74rmrjVtUmgUWthFY2Z+6XUIv17Vq/Dt2l1+Z7m6E7pEeFHAyeorGabsFz1OBJJb6MICYkGcAd/euliQLJ8uckc55NZWmoo2MN2W5J9u1a6AeZknHNEV1KRfToB0pchRTFdFBZ2CovJLHArKbxNppuDDDKZnzj5BwPxrRy1CxqtKc4AH4dqoX15LGMKAPepYLyKVNwXDHnGRWfeyJNLsU4YDOD1/Km+wjG1WCS73JnljxzWB4kt2s4rNd2485x0FdZAdytuPzDg1meLLfMEDKudqk57VjPYLnCzXboCyng8CsS6uWlducmtO6BZtqj14rOeHg5Bz7VnJN7CKO0sxZuOPyqaPAxxmpxaknAH4+tTx2QCj+VQoytqAWyk4wBVkxFuBTkQRDoAfSnxMrE5wK1gtLCJLOH7IRMT+8ByMVuvcPcBSEwuORjis+3eJlO8jCrnkVasboNZndtCjpnriqStpcCRpMIcjgenWq0TLIuCMHJINVpbnMwAxmrUS5OTwT0xTfkAnnbflPAzzxVTxJcK3hTXFDfN9hn/9FtVq6QA71FZHilSPDGqup4NnNn/vg0+oHngOw/dzmkJHAx1psi/vM7jj0prNjgZ+teKlc+gHknOCaQN7ZqNScAipB69cUWsIswP0A7VYkXehGP8A69U42+bHPtVpGAHcms5blp3RTmTj1xWLqEYDbsexxW9MM7gDWTfr+6bjnvXoYKpyuxjXjdGWrmNWI6kdKzIz+9J9a0HPyt9Kz4MeZ0rvnuedPoTcCRMetP1jHnJ64ppwHTI4pNUYNKOO1ZL4kRLYp8cV0mjOfsg6VzWQB05rpNDXNpn36VOI+EdHck1KTcLcZ/5aiptPcC0X/eb+dQakNr2wPQyU6zX/AERM8df51zNL2aN/tFwyL1pjEE+1RMcZphY9+azUQuSs3HvTHOckYpm80xpM8GrURXPX/gnP5Xh7UV45v2P/AJCir0QT5A4rzD4NOo0K/wA/8/5/9FR16SrrtHK9PSvQh8KOOW7PGvBuDZ3Q/wCmx/lXVWV9PakbHOAemetcn4HbdFeJ1PmZx7V0qjPBPIqKi5ZXZC1Ou0nxEDxLhW9DXTWl/DcqFyCcZry6NGyOBV21u7i2dSjEj0NTdlHpkkCyRsPlZG4KsMgj6VzPiLw01/aNFpt0+nS4wBGv7s/Vf8KTS/EWdomytdLBew3Cjdj+tVdMZ4Lr3ha70NfP1z7bfoed1sP3Q9i56H8KyYdTaDA0y2trMY++q+Y//fTf0r6YNsJI3ZGQoBlg2On0PWuK8Q+FtMWC4u9MtbeO/A3hdvyPjtjsatSZLR4vcC9nUz3Aml9HkyR+tdF8NgyavOfMRt0WAFOcc96p3n9pakpXMjR9CoG1RVz4fWD2XiVwzKC0RGBzzS501cWzPeNNXKqd2TjjNR6trMWnZjWKW7vGGY7eBdzH3PoPeqdzqMsM0Gm6TGs2pSqD833IV7s/+HetWytv7OhaOAtLcSfNNOw+aRvX2HoKTvJWiWcXe6f4s1+UNdwC2gzxG8m1R+HU1qWXhNbWNVubyIHuEBPNdA8Ur8zz+WvoOtKhjjyIF5xy7cmqStqxEVnptvahSqyzNnjPArRmjVYpJ3CmSJC27HC8dqgjcRy+Tu3SkbmJ5wKk1qUQaNOOhkUoKq6SbYHnnhrWHS4liumILMWBbvk11l4sd3akKQeOK4rXdPPlLLAdrr3HrVHTfFEtvuiuRkrxzXOmla4iDVbeS3vWVgQrVUKhuR9DU+saql/KCGApkMibeWXrxVRe4MVYDwAvJ5qVYyq5IOcU8Txbc55p3mqcYIPbNN73EV5I9zYwST0qtcwyx/cHucVoO6AZL5HbFOTbInyENnrn0pNX1GY8krOEjORvOD64FX4BJNKEjPBG3GarTov2pmXG1BjI9ak06UxS4bgdvY00mnZgb9vov2bD3IG76066VE+50FVLnUZZo0YHI6GnIzXEeWYj1FadNBE0ZRxlyduOcc81jeJo3h8Na2V5jaxm/wDRbVqQyDeIGXCdqg8XJs8I60qL0spufbY1TuB46024Y3ZxSoxOO+f1qh52G9fSpVkwc9a832dj3Oe5aRsM2chfSpo2GecmqqNk5zVhGWs5IpMnjA3Z7dqnHHc5PPFVUZcdR9Ke0hwOeOtZNalJjps4NUJ4yykngE1cJ3DP5VC/3MYyAa1pvlegpao5uddjOpOMZrPt/wDWGtXVUKuzDgEVlwffr1VK6ueXUVpWJJMbhz7/AEpt6SW5pW5cCkvQQ1C3IezKvWul8PHNuw965vHNdH4eP+jN65rPEfAFH4iXV/v2g/2z/KrFgB9ggz/d/rVfVeZ7T6sf0qzYDFjB/uCuSWlNHQviFZB69O9RNHxweast65ph61CY7FR0we+KgcdQPwq63WoZMHtWsZEtHonwlLHQr0Dp9tb/ANFx16Itu20fvB09a8/+EUanRL/PQXrf+io69Kj8ny1z1wK9GPwo4pbs86i0W10ectsmEIkyJScjdjjNbCBXAZNpVu4PFbMX3+gIz0IzVe40eJmaSyf7LN1wBlGPuv8AUVhO8kJMzwg2nHTpRtIIzz9KJvNtWEd7EYifuyA5jb6Ht+NSD5uTjHapi0BHgAknqOcjoKs2d9Nbt8rMV96iCnqBzSMCB7+lNPoB09tr0ix7tqk44PpWJqGsSNM5zkk9u9JDzGBjHHJrJvDmYnHtVrRAym8ru0m4kDOQKTw7Mtvr7TEA+VC7YqnPcMs0kbDjPY81H4dje51+GBc4uA0Rx1AI5NEprTQR6T4DuLhLBtSf557slgT3Ga6gajPKcEhfYVXsdNKRQwQII4YkCDPoPataC2t7Y79u+T+8aqCaSRRHBBNMct+7T1PWrkEaL8qcqv8AEe5qN5JJB8vAJwDUu7ywFQcetXFK4HOW2pL/AMJdeWrsMrtAB+lbfiYbtPBB5FeYa9NNb+JLnUIW+ZJiD9B2rr7nxHb6jpVsqSAuxG71HtWMZpxaApzqJYzG2MY6+lcVrenEuzovzKeQO9drAgZsk1Q1a3Hmbh0YfrUv3o6iPNXEkbEHhu2RTftEin5SQa6y/wBNWYZZSCO/esafSBk7HPHtWaTiw3M9b2XHXk1LDfv/ABHHvUj6U/OHHHekOmHs2armk1ogJYrmSTIBpFmuI2ZgTwORmoDbTwMSucdAcVO8olhRGXDswXpUqb2YFqyLNbKX5ZvmPvT2B45+YdKfGoXAA46VM0DsMgE1rq1qBcskOSONrjcPSrkbmIMqnOaqWyyC3XK/dbBz6Gpkw0mF6+prRXegiwkZZQQMY7moPFb7/ButA4yLGfp3/dtV5CVXaVyazvFDAeEtcHrYT9f+ubUlZOwzwlUOBtGefypE3L749auonI96c8QI6c1xe0R7PIV1ZsetW4iWAyOKi8vC8dakiPQHis5O60BaE6IzY2rUixuD6HPehDno2DT2clQQM+tYtmqEIJJDEBR0IqFxjgnipmVg3tTHHOCcD+dOLGzM1ODzbZwBluornYRls/hXWOBXNTp5V3Ig6ZyBXfRldWODER1uM6yjv60uoAhh7imoMyrT9SGCvXpW3VHM9mUscj0rpPDg/cNmua9M10Xh4nyW5/OoxC9wKPxFjVs/abT2Vz+lXbND9jg7fIKztWbNzB7Rua07Qj7LCB2QD9K456U4nQt2DKRnHJ9aiarLHjGaryEevFZxZTK75/8Ar1BIeCBipJs44qq56810QRmz0z4USEaJfLnB+2Mf/IcdegpIxUcjp6ivMvhlLt0e9HUm7bA/7Zx13CSPsXg9K9GC91HFL4mX48byOOvX0qwjgY5yKrnO49cgntUiAj+En8Ky3FctAq4KHa6sMFSMg/hWbPo6hi+nyCE94m5Qn29Kupux0IP0/WpskDGDUtKwznHDwyCO6VopG6Bvut7g9DUV9OtpB5jklMhQAetdU6rNGUmi3oeqsMisbUNHk2kWi74D9+GU/wDoJ/xpKNloA21IaFWQllYZBHpWbdgGc7Rz0q3HOIYxHJBLCQMBSh6exqrM0ksn7uJyPVhgVUGriMq4sRKxkH3m9e1aXhm3/sWWbUWAacKY4gexPUijy1jVvMyJj93A+WruoRSRJFbbeYkBI/2jyaU31Y0aPhnW76419VnlZ0cHIPavQo83MoAIAAyxHYV5p4LtmbUJZiCdi4HHcmu3tNQaUPBApXDkO3c47VcWtwubDyohJA6DAHoKqyXKwo8r/dUZqLDnkg+9Y2vzsXS2XJAG9+Kpt2uBzMyfaZrhivLuzY981zVz5llL5sZbZu+bHY108TOoYFGxnjis+7tyzOWT5XHQiue11ZCLeiawsgAYn866GYpcWuP4hyD615pNDNY3AZQxiJyMjpXR6Pq7kAOGOeMYoi7r3hmi67s1XeADkdz1qw0u5wVU4PTj9KXluoOPftTSsIy5LfH3R09ajZCue+PetQxknIHB6cVE9qZB9zg89KbV9gIbdUcfP1PT6Vl3Nsj3ZliHyR5A9zV25hlVxBGGBPVgOgqwlpLIixxRkKBxxSa5tBmTGcOB71rW5VAGbn14pzaLPsLkEMPaoJN8YMZVi2Pzq4+6xFuOWJzIi/xL+oogYZycdKpWtvcmcSBSBnv6VYUvG/lkMSDnpT33A0EbedxOMc+1ZHi9yPC2sAAYNnOOB/0zatONZSOnJ7Y7Ul5bedBJFKgdHBVkZchgRyCPQ0Na3A8PiGOeMZp7AdRzXq8XhrRMBjo+m49DaJz+lbOmeGvDkpUvoWlk+hso/wDCub6rd/Ed/wBe/u/ieEZHGaacbjzxX0ivhXwsuA3h7R/r9hj/APiaY/h3wqrEf8I9ouPX7DF/8TVfVvMTxnkfPULkgc1ajYKD0z7V7o+i+EE4bQNFB/68ov8A4mq72HgqL7+haNx/04xf/E1Dwd/tFLG2+z+J4mxAT6dqqyP8x+le6x23gpyQPD+ig+9hF/8AE1ci8PeFbhf3fh/RRn0sYv8A4mmsGl9oPr390+d3bqelYd+QbwnPOK+objwp4ZjUt/YGkk+gs4//AImuV13Q9GJ22+habHz/AA2kY/pW0KHJ1MamJ51ax8/xnEwzTtQcNjFe02nhjShJvuNNstvp9nXH8qvroeis2E0XTiP+vRP8K1cLasx9p0Pnmuh0DAgbpXsN1pGiQJhdE053x/z6J/hWYNE0+aUY0exUZ6C2T/CpqRU1y3CE+V3seZ6rj7VH/wBcmrRhwLeL/cFem23hjSlG6bSbD6fZl/wq0vh7Qx97RtPIx/z6p/hWUsPdKNy1Xs72PKnfA5qvNICc16pNoejBcro2nnPpaJ/hUQ8PaWwP/EmsB3/49U/wpLCpdR/WPI8mkfJx0qFq9bm0HR4zzpNiR7Wy8/pVR9F0wsSNIsgB6Wyf4VfsVHS5PtvIzvhuwXR7z1+1n/0XHXcxyL5a/MOg71z9napaDy7a2jgiJ3ERRhBn1wK1U80opEZ6f3a2UmlZGTd3c//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Applanation tonometry calculates intraocular pressure indirectly by measuring the force required to flatten (applanate) a constant area of the cornea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8979=[""].join("\n");
var outline_f8_49_8979=null;
var title_f8_49_8980="Arterial supply of the spinal cord";
var content_f8_49_8980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F62845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F62845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arterial supply of the spinal cord",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Prasad S, Price RS, Kranick SM, et al. Clinical Reasoning: A 59-year-old woman with acute paraplegia. Neurology 2007; 69:E41. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8980=[""].join("\n");
var outline_f8_49_8980=null;
var title_f8_49_8981="Ring removal techniques";
var content_f8_49_8981=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ring removal techniques",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     Joan Bothner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     Anne M Stack, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     Allan B Wolfson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?8/49/8981/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?8/49/8981/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients commonly present to emergency departments with rings that they are unable to remove from their fingers; often they have tried multiple removal techniques before presenting for care. In addition to rings, children may place metal washers or nuts over their fingers or toes, and teenage and adult males may place various constriction devices around their penis or scrotum to maintain or enhance erection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/1\">",
"     1",
"    </a>",
"    ]. Etiologies for swelling include trauma, dependent extremity positioning, allergic angioedema, or placement of a ring that is too small for the digit.",
"   </p>",
"   <p>",
"    Techniques for removing a constricting ring from a finger, toe, or penis are reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ring should be removed as rapidly as possible if the patient has signs of vascular compromise (eg, mottling, absent capillary refill, or gray color).",
"   </p>",
"   <p>",
"    In addition, removal of rings prior to swelling and entrapment is good basic first aid practice in patients with extremity trauma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS AND PRECAUTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no absolute contraindications to ring removal.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Appropriate analgesia and, if needed, sedation should be provided prior to attempted removal.",
"     </li>",
"     <li>",
"      The clinician should avoid damage to underlying skin and overheating of the metal ring during removal. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ring cutting'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H11\">",
"       'Electric cutting devices'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Males with penile constriction devices and signs of penile ischemia warrant urologic consultation prior to removal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Key interventions prior to ring removal include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain control &ndash; Regional infiltrative anesthesia by digital block or dorsal penile block (",
"      <a class=\"graphic graphic_figure graphicRef69794 \" href=\"mobipreview.htm?8/44/8896\">",
"       figure 1",
"      </a>",
"      ) suffices for most cooperative adolescents and adults. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23703?source=see_link\">",
"       \"Digital nerve block\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33689?source=see_link\">",
"       \"Infiltration of local anesthetics\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30100?source=see_link&amp;anchor=H2311462#H2311462\">",
"       \"Management of zipper injuries\", section on 'Dorsal penile block'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Young children are frequently uncooperative and often require procedural sedation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/23/43384?source=see_link\">",
"       \"Procedural sedation in children outside of the operating room\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      However, with careful explanation of the procedure to the child and the cooperation of the parents, the clinician may be able to make one attempt at manual removal of a ring from a finger or toe without anesthesia.",
"      <br/>",
"      <br/>",
"      One disadvantage of regional anesthesia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      procedural sedation is that the patient cannot provide feedback regarding overheating of the ring or trauma to underlying tissues during removal.",
"     </li>",
"     <li>",
"      Prepare the wound &ndash; Before the ring is removed, clean the surrounding skin with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/0/32768?source=see_link\">",
"       povidone iodine",
"      </a>",
"      or similar antiseptic solution [",
"      <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/2\">",
"       2",
"      </a>",
"      ]. Verify tetanus status and give prophylaxis when indicated (",
"      <a class=\"graphic graphic_table graphicRef61087 \" href=\"mobipreview.htm?7/52/8013\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/11/7353?source=see_link\">",
"       \"Tetanus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reduce&nbsp;swelling &ndash; Apply ice and elevate the extremity to increase the success of ring removal techniques. Elastic bands (eg, Penrose drain, or phlebotomy tourniquet) may reduce edema enough to allow for manual removal. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Manual removal'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Lubricate the ring &ndash; Apply soap or water-soluble lubricant liberally to the entrapped digit or penis prior to attempting manual removal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RING REMOVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several techniques for removal of rings have been described but have not been evaluated in controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. Ring cutters have been used successfully for thin bands of metal and the string wrap technique has been used for thicker or longer metallic rings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Many techniques used for digital ring removal can also be used in patients with penile rings or other constricting devices.",
"   </p>",
"   <p>",
"    The choice of technique varies depending upon the presence of neurovascular compromise, the ability of the patient to cooperate, the presence of distal trauma, and the ring's value and thickness.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Remove the ring as rapidly as possible if the patient has signs of vascular compromise (eg, mottling, absent capillary refill, or gray color).",
"     </li>",
"     <li>",
"      Cut off inexpensive, thin rings.",
"     </li>",
"     <li>",
"      Use one of the string techniques or an electric cutting device to remove thick, broad bands. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'String wrap technique'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H8\">",
"       'String or elastic pull technique'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H11\">",
"       'Electric cutting devices'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Manual removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two methods have been described that markedly reduce digital swelling. These techniques may permit manual removal when the ring is valuable or cannot be easily cut off. They may also permit use of the string pull or string wrap method when swelling does not allow for passage of a string or other ligature beneath the ring. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'String or elastic pull technique'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H9\">",
"     'String wrap technique'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Double Penrose drain method &ndash; In a case series of 12 patients, the double Penrose drain technique led to successful manual ring removal in all patients, including those with digital trauma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/7\">",
"       7",
"      </a>",
"      ]. To perform this procedure, apply one Penrose drain just distal to the proximal interphalangeal (PIP) joint. Tightly wrap a second Penrose drain, starting at the first one and extending back to the incarcerated ring. Repeat as necessary until the edema is sufficiently reduced to allow manual removal. Once the ring passes the PIP joint, remove the first Penrose drain.",
"     </li>",
"     <li>",
"      Elastic tape method &ndash; Apply a blood pressure cuff to the affected extremity and inflate it to the patient's systolic blood pressure plus 100 mmHg. Then tightly wrap a Penrose drain or 1 inch elastic band (intravenous tourniquet) from the tip of the digit proximally and elevate the extremity above the heart for 10 to 15 minutes (",
"      <a class=\"graphic graphic_figure graphicRef56186 \" href=\"mobipreview.htm?20/29/20959\">",
"       figure 2",
"      </a>",
"      ). Assess for reduction of edema and reapply the elastic wrap, if necessary. Keep the blood pressure cuff inflated while attempting manual removal, but remember that total tourniquet time should not exceed two hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ring cutting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Manual and electrically powered ring cutters are commonly available. Use ring cutters with care in patients with lacerations because metal filings from cutting the ring have been reported to cause a foreign body reaction and chronic synovitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/9\">",
"     9",
"    </a>",
"    ]. Before each use, check the saw blade of the ring cutter to ensure that is it sharp and clean. Show the patient how the guard prevents cutting of the finger. Standard ring cutters are usually not effective for removing hardened steel rings (eg, steel nuts, steel washers). The procedural steps are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Place the guard of the ring cutter under the ring on the palmar aspect of the hand or the plantar aspect of the foot.",
"     </li>",
"     <li>",
"      If possible, rotate the ring so that the thinnest part of the band is located under the saw blade.",
"     </li>",
"     <li>",
"      Apply the saw blade wheel to the ring and turn it (",
"      <a class=\"graphic graphic_figure graphicRef53966 \" href=\"mobipreview.htm?18/51/19249\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The friction of the ring cutting process generates heat. Interrupt the procedure periodically to allow the ring to cool. If necessary, immerse the digit and ring in ice water to hasten the cooling process.",
"     </li>",
"     <li>",
"      Cut the ring in two places to permit removal. When making the second cut, protect the finger from sharp edges at the first cut by placing gauze under the cut ring.",
"     </li>",
"     <li>",
"      Once the ring is cut, remove it from the finger by pulling it apart with hemostats. Rings that have been removed with a ring cutter usually can be repaired by a jeweler.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     String or elastic pull technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Do not attempt this technique if the patient has an open wound, fracture, or dislocation distal to the ring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, if the digit or penis appears mottled or pale, cut the ring as quickly as possible. The steps for the string pull method are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lubricate the digit or penis with water-soluble lubricant.",
"     </li>",
"     <li>",
"      Pass one end of a 20-inch length of 2.0 or 3.0 silk, umbilical tape, or elastic band (eg, phlebotomy tourniquet, Penrose drain, or rubber band) under the ring and pull the two ends until they are of equal length. Grasp the string from underneath the proximal edge of the ring with a hemostat to pull it through.",
"     </li>",
"     <li>",
"      Grasp the string or band 5 to 10 cm from the ring and pull distally in a circular fashion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Move the string or elastic band to different areas of the ring and pull it along the axis of the finger or penis, permitting the ring to be gradually removed (",
"      <a class=\"graphic graphic_picture graphicRef68736 \" href=\"mobipreview.htm?14/12/14543\">",
"       picture 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/4,10,11\">",
"       4,10,11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     String wrap technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Do not attempt this technique if the patient has an open wound, fracture, or dislocation distal to the ring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, if the digit or penis appears mottled or pale, cut the ring off as quickly as possible. This procedure can be painful, so use regional anesthesia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    procedural sedation if necessary to achieve adequate pain control. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23703?source=see_link\">",
"     \"Digital nerve block\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Place one end of 2.0 or 3.0 suture, Penrose drain, or umbilical tape 20 to 25 inches (0.5 to 0.6 m) in length under the ring from the proximal to the distal side with 5 inches (12.5 cm) of material remaining proximally [",
"      <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/4,11,12\">",
"       4,11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Wrap the suture material tightly around the digit or penis beginning at the distal aspect of the ring. Overlap the wrappings so that no tissue is visible (",
"      <a class=\"graphic graphic_figure graphicRef53497 \" href=\"mobipreview.htm?32/56/33668\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef69794 \" href=\"mobipreview.htm?8/44/8896\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Continue wrapping beyond the proximal interphalangeal joint of the digit or beyond the coronal sulcus of the penis (",
"      <a class=\"graphic graphic_figure graphicRef76391 \" href=\"mobipreview.htm?19/0/19462\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Once the wrapping is complete, pull on the proximal end of the wrapping material so that the ring is removed from the finger or penis (",
"      <a class=\"graphic graphic_figure graphicRef53497 \" href=\"mobipreview.htm?32/56/33668\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef69794 \" href=\"mobipreview.htm?8/44/8896\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The success of this technique depends upon tight, close wrapping of the finger or penis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/4,11\">",
"     4,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Surgical glove technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;This technique has the advantage of causing minimal additional pain, and can be used with finger fractures or soft tissue injuries and lacerations (",
"    <a class=\"graphic graphic_figure graphicRef62819 \" href=\"mobipreview.htm?25/25/26002\">",
"     figure 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cut one finger from a surgical glove to form a cylindrical sleeve.",
"     </li>",
"     <li>",
"      Place this sleeve on the involved digit and slip the proximal end circumferentially under the ring using a hemostat.",
"     </li>",
"     <li>",
"      Once in place, pull the proximal end back over the ring and toward the tip of the digit in a twisting motion, advancing the ring distally. Avoid pulling so hard that the glove rips or pulls out from under the ring.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Electric cutting devices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various cutting devices may be used to remove hard metal rings, including dental drills, diamond drills, Dremel saws, and air driven grinders if other techniques fail [",
"    <a class=\"abstract\" href=\"mobipreview.htm?8/49/8981/abstract/1\">",
"     1",
"    </a>",
"    ]. Two cuts, 180 degrees apart, are typically required. Dentists, firemen, machinists, or other aid personnel may have greater proficiency with the safe use of these devices and may assist in the removal of hard metal rings.",
"   </p>",
"   <p>",
"    Take the following precautions to avoid patient and operator injury:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Provide industrial eye protection for the patient and all other personnel present for the procedure.",
"     </li>",
"     <li>",
"      Cover the patient's exposed skin with damp gauze to protect it from sparks and metal filings.",
"     </li>",
"     <li>",
"      Insert a metal barrier between the metal ring and the digit or penis (eg, laryngoscope blade or malleable retractor).",
"     </li>",
"     <li>",
"      Cool the ring and the drill (or saw) with ice prior to the procedure and continue dripping ice water over the cutting site during the procedure. Interrupt frequently to assess for overheating of the ring.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     POST-PROCEDURAL CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal of a ring can cause soft tissue trauma, including bruising or small cuts. After the ring is removed, clean the finger and dress it with antibiotic ointment if necessary. Reevaluate perfusion after the procedure. Consult a hand surgeon if the finger remains mottled or poorly perfused after the ring has been removed. Consult a urologist if the patient is unable to void or has penile infarction after ring removal. Advise the patient that pain and swelling should be completely resolved before he or she returns to wearing rings on the affected finger.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Remove the ring as rapidly as possible if the patient has signs of vascular compromise (eg, mottling, absent capillary refill, or gray color). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ring removal is often painful, so use regional anesthesia and procedural sedation if necessary, especially in children. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Before performing the procedure, prepare the wound, reduce swelling, and lubricate the digit or penis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Choose the best technique depending upon a variety of factors (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Ring removal'",
"      </a>",
"      above):",
"     </li>",
"     <li>",
"      Inexpensive rings are typically removed with a ring cutter (",
"      <a class=\"graphic graphic_figure graphicRef53966 \" href=\"mobipreview.htm?18/51/19249\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Valuable or hard metal rings may be amenable to manual removal after using elastic tape or double Penrose wrapping to reduce swelling. Alternatively, the string or elastic pull technique or string wrap technique may employed (",
"      <a class=\"graphic graphic_figure graphicRef69794 \" href=\"mobipreview.htm?8/44/8896\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef68736 \" href=\"mobipreview.htm?14/12/14543\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53497 \" href=\"mobipreview.htm?32/56/33668\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53966 \" href=\"mobipreview.htm?18/51/19249\">",
"       figure 3",
"      </a>",
"      ). In some instances, electric cutting devices (eg, Dremel saw) may be required.",
"     </li>",
"     <li>",
"      Many of the techniques described for digital ring removal also work for the removal of penile constriction devices. Consult a urologist if the patient has penile ischemia.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/1\">",
"      Silberstein J, Grabowski J, Lakin C, Goldstein I. Penile constriction devices: case report, review of the literature, and recommendations for extrication. J Sex Med 2008; 5:1747.",
"     </a>",
"    </li>",
"    <li>",
"     Ruddy, RM. Illustrated techniques of pediatric emergency procedures. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher, GR, Ludwig, S, Henretig, FM (Eds), Lippincott, Williams, &amp; Wilkins, Philadelphia 2006. p.1861.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/3\">",
"      Baker A, Rylance K, Giles S. The occasional ring removal. Can J Rural Med 2010; 15:26.",
"     </a>",
"    </li>",
"    <li>",
"     Fuchs, SM. Ring removal. In: Textbook of Pediatric Emergency Procedures, 2nd, Henretig, FM, King, C (Eds), Lippincott, Williams, &amp; Wilkins, Philadelphia 2008. p.1107.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/5\">",
"      Greenspan L. Tourniquet syndrome caused by metallic bands: a new tool for removal. Ann Emerg Med 1982; 11:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/6\">",
"      Schuster G, Stockmal P. Genital incarceration with metal rings: their safe removal. Tech Urol 1999; 5:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/7\">",
"      Chiu TF, Chu SJ, Chen SG, et al. Use of a Penrose drain to remove an entrapped ring from a finger under emergent conditions. Am J Emerg Med 2007; 25:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/8\">",
"      Cresap CR. Removal of a hardened steel ring from an extremely swollen finger. Am J Emerg Med 1995; 13:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/9\">",
"      Fasano FJ Jr, Hansen RH. Foreign body granuloma and synovitis of the finger: a hazard of ring removal by the sawing technique. J Hand Surg Am 1987; 12:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/10\">",
"      McElfresh EC, Peterson-Elijah RC. Removal of a tight ring by the rubber band. J Hand Surg Br 1991; 16:225.",
"     </a>",
"    </li>",
"    <li>",
"     Stone, DB, Levine, MR. Foreign body removal. In: Roberts and Hedges Clinical Procedures in Emergency Medicine, 5th, Roberts, JR, Hedges, JR (Eds), WB Saunders Company, Philadelphia 2010. p.650.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/12\">",
"      Belliappa PP. A technique for removal of a tight ring. J Hand Surg Br 1989; 14:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?8/49/8981/abstract/13\">",
"      Inoue S, Akazawa S, Fukuda H, Shimizu R. Another simple method for ring removal. Anesthesiology 1995; 83:1133.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6332 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-4874105216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8981=[""].join("\n");
var outline_f8_49_8981=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONTRAINDICATIONS AND PRECAUTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RING REMOVAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Manual removal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ring cutting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      String or elastic pull technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      String wrap technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Surgical glove technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Electric cutting devices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      POST-PROCEDURAL CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6332\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6332|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/44/8896\" title=\"figure 1\">",
"      The string wrap technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/29/20959\" title=\"figure 2\">",
"      Elastic tape method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/51/19249\" title=\"figure 3\">",
"      Ring cutter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/56/33668\" title=\"figure 4\">",
"      Wrap technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/0/19462\" title=\"figure 5\">",
"      Penis anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/25/26002\" title=\"figure 6\">",
"      Glove technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6332|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/12/14543\" title=\"picture 1\">",
"      String pull technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6332|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/52/8013\" title=\"table 1\">",
"      Tetanus prophylaxis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/9/23703?source=related_link\">",
"      Digital nerve block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/57/33689?source=related_link\">",
"      Infiltration of local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/25/30100?source=related_link\">",
"      Management of zipper injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/11/7353?source=related_link\">",
"      Tetanus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_49_8982="Tranexamic acid: Pediatric drug information";
var content_f8_49_8982=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tranexamic acid: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?13/58/14248?source=see_link\">",
"    see \"Tranexamic acid: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10037?source=see_link\">",
"    see \"Tranexamic acid: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cyklokapron&reg;;",
"     </li>",
"     <li>",
"      Lysteda&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F229861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cyklokapron&reg;;",
"     </li>",
"     <li>",
"      Tranexamic Acid Injection BP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antifibrinolytic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihemophilic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hemostatic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12675770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Limited data available: Surgery for congenital diaphragmatic hernia during ECMO (bleeding reduction): 4 mg/kg as a single dose 30 minutes before repair, followed by a continuous infusion of 1 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     for 24 hours, was reported to reduce blood loss and hemorrhagic complications in neonates (van der Staak, 1997)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/58/14248?source=see_link\">",
"      see \"Tranexamic acid: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tooth extraction in patients with hemophilia (in combination with replacement therapy): 10 mg/kg immediately before surgery, then 10 mg/kg/dose 3-4 times/day; may be used for 2-8 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Surgery for congenital heart disease (to reduce perioperative blood loss and need for transfusions): Infants and Children 2 months to 15 years: Limited data available; dose not established: Reported dosing regimens variable; ideal dose-response not established: Loading dose: 10 mg/kg, priming dose: 10 mg/kg and 10 mg/kg after protamine (Chauhan, 2004; Chauhan, 2004; Eaton, 2008); also reported: Loading dose: 100 mg/kg, followed by 10 mg/kg/hour infusion (continued until ICU transport) and 100 mg/kg priming dose when by-pass initiated (Reid, 1997)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Surgery for scoliosis (to reduce perioperative blood loss and need for transfusions): Children and Adolescents 8-18 years: Limited data available; dose not established: Reported dosing regimens variable; ideal dose-response not established: Loading dose: 100 mg/kg, followed by infusion: 10 mg/kg/hour until skin closure (Sethna, 2005; Shapiro 2007). Other regimens reported with positive results:  Loading dose: 20 mg/kg, followed by 10 mg/kg/hour infusion (Grant, 2009) or loading dose: 10 mg/kg and 1 mg/kg/hour infusion (Grant, 2009; Neilipovitz, 2001)",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V.: Tooth extraction in patients with hemophilia (in combination with replacement therapy): 10 mg/kg immediately before surgery, then 10 mg/kg/dose 3-4 times/day; may be used for 2-8 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral: Menorrhagia: 1300 mg 3 times daily (3900 mg/day) for up to 5 days during monthly menstruation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Adults: See table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"175\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Serum Creatinine",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mg/dL)",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         I.V. Dose",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         1.36-2.83",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         10 mg/kg twice daily",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;2.83-5.66",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         10 mg/kg once daily",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;5.66",
"        </p>",
"       </td>",
"       <td align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         10 mg/kg every 48 h",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         or",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         5 mg/kg every 24 h",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:0em;\">",
"     Oral: Adult:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Serum creatinine &gt;1.4-2.8 mg/dL: 1300 mg twice daily (2600 mg/day) for up to 5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Serum creatinine 2.9-5.7 mg/dL: 1300 mg once daily for up to 5 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Serum creatinine &gt;5.7 mg/dL: 650 mg once daily for up to 5 days",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F229847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 100 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cyklokapron&reg;: 100 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lysteda&trade;: 650 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F229834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Oral: Administer without regard to meals. Should be swallowed whole; do not break, chew, or crush.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Parenteral: May be administered by direct I.V. injection at a maximum rate of 100 mg/minute (1 mL/minute); in pediatric scoliosis studies, loading dose infused over 15 minutes",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F229905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Compatible with dextrose, saline, electrolyte, amino acid, or dextran solutions, heparin;",
"     <b>",
"      incompatible",
"     </b>",
"     with solutions containing penicillin.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1062676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Prepare on same day as infusion. Incompatible with solutions containing penicillin; compatible with dextrose, saline, and heparin, as well as with electrolyte, amino acid, or dextran solutions",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Injection: Short-term use (2-8 days) in hemophilia patients to reduce or prevent hemorrhage and reduce need for blood factor replacement therapy during and following tooth extraction [FDA approved in pediatric patients (age not specified) and adults]; primary menorrhagia; prevention of GI hemorrhage and hemorrhage following ocular trauma; recurrent epistaxis; hereditary angioneurotic edema; prophylactic use to decrease perioperative blood loss and the need for transfusion in patients undergoing congenital heart disease or scoliosis-related surgery",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Tablet: Treatment of cyclic heavy menstrual bleeding (FDA approved in postmenarcheal women &gt;18 years)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F229906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cyklokapron&reg; may be confused with cycloSPORINE",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F229904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Injection:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (with rapid I.V. injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Giddiness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Allergic dermatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Unusual menstrual discomfort",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Fatigue, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Hematologic: Anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, muscle cramps/spasms, muscle pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Respiratory: Nasal/sinus symptoms",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      All formulations:",
"     </b>",
"     Rare but important or life-threatening: Allergic skin reaction, anaphylactic shock, anaphylactoid reactions, cerebral thrombosis, deep vein thrombosis (DVT), diarrhea, dizziness, nausea, pulmonary embolism, renal cortical necrosis, retinal artery/vein obstruction, seizure, ureteral obstruction, visual disturbances (including impaired color vision and loss), vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tranexamic acid or any component; subarachnoid hemorrhage; acquired defective color vision, active intravascular clotting process; active thromboembolic disease (eg, cerebral thrombosis, DVT, or PE); history of thrombosis or thromboembolism, including retinal vein or retinal artery occlusion; intrinsic risk of thrombosis or thromboembolism (eg, hypercoagulopathy, thrombogenic cardiac rhythm disease, thrombogenic valvular disease)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage modification required in patients with renal impairment; use with caution in patients with cardiovascular, renal, cerebrovascular disease, or transurethral prostatectomy. Use with caution in patients with upper urinary tract bleeding; ureteral obstruction due to clot formation has been reported. Use with extreme caution in patients with DIC requiring antifibrinolytic therapy; patients should be under strict supervision of a physician experienced in treating this disorder. Use with caution with concurrent tretinoin use; may exacerbate procoagulant effects.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not administer concomitantly with factor IX complex concentrates or anti-inhibitor coagulant concentrates due to increased risk of thrombosis. Concomitant use with combination hormonal contraception may further increase risk of thromboembolism; patients taking hormonal contraceptives were excluded from clinical trials. Visual defects (eg, color vision change, visual loss), and retinal venous and arterial occlusions have been reported; discontinue treatment if changes in vision occur; prompt ophthalmic examination should be performed by an ophthalmologist. Avoid use in patients with acquired defective color vision since this would prohibit monitoring one endpoint as a measure of ophthalmic toxicity. Ligneous conjunctivitis has been reported with the tablet, but usually resolves upon discontinuation of therapy. Severe hypersensitivity reactions have been reported rarely. Seizures have been reported with use; most often with intraoperative use (eg, open chamber cardiac surgery) and in older patients (Murkin, 2010). The mechanism by which tranexamic acid use results in seizures may be secondary to neuronal gamma aminobutyric acid (GABA) inhibition.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F229842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-inhibitor Coagulant Complex: Antifibrinolytic Agents may enhance the thrombogenic effect of Anti-inhibitor Coagulant Complex.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): May enhance the thrombogenic effect of Tranexamic Acid. Management: Ensure that the potential benefits of concurrent therapy outweigh the increased risk of potential thrombosis that accompanies use of tranexamic acid with hormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): May enhance the thrombogenic effect of Tranexamic Acid. Management: Ensure that the potential benefits of concurrent therapy outweigh the increased risk of potential thrombosis that accompanies use of tranexamic acid with hormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fibrinogen Concentrate (Human): Antifibrinolytic Agents may enhance the adverse/toxic effect of Fibrinogen Concentrate (Human). Specifically, the risk for thrombosis may be increased. Fibrinogen Concentrate (Human) may enhance the adverse/toxic effect of Antifibrinolytic Agents. Specifically, the risk for thrombosis may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tretinoin (Systemic): May enhance the thrombogenic effect of Antifibrinolytic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F229843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F7679524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. There are no adequate and well-controlled studies in pregnant women. Tranexamic acid crosses the placenta and concentrations within cord blood are similar to maternal concentrations. Use only if the potential benefit justifies the potential risk to the fetus. Lysteda&trade; is not indicated for use in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmologic exams (baseline and at regular intervals) of chronic therapy",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1062681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     5-10 mcg/mL is required to decrease fibrinolysis",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Forms a reversible complex that displaces plasminogen from fibrin resulting in inhibition of fibrinolysis; it also inhibits the proteolytic activity of plasmin",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Breast milk levels are 1% of serum; CSF levels are 10% of plasma",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : Adults: 9-27 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 3%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: I.M.: 100%; oral: ~45%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: ~3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Elimination characteristics differ by route of administration: after I.V. administration 95% excreted as unchanged drug in urine vs 39% after oral administration",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F10224228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10037?source=see_link\">",
"      see \"Tranexamic acid: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Report any unusual bruising, bleeding, sudden change in vision, eye pain or irritation, or rash to your physician.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F12808160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 5% (50 mg/mL) oral solution may be prepared by diluting 5 mL of 10% (100 mg/mL) tranexamic acid injection with 5 mL sterile water. Label &ldquo;refrigerate&rdquo;. Stable for 5 days refrigerated.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 25 mg/mL oral suspension may be prepared with tablets. Place one 500 mg tablet (strength not available in U.S.) into 20 mL water and let stand ~2-5 minutes. Begin stirring and continue until the tablet is completely disintegrated, forming a fine particulate suspension (dispersion time for each 500 mg tablet is ~2-5 minutes). Administer immediately after preparation.",
"    </p>",
"    <div class=\"reference\">",
"     Lam MS, \"Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs,\"",
"     <i>",
"      Pharmacotherapy",
"     </i>",
"     , 2011, 31(2):164-92.",
"     <span class=\"pubmed-id\">",
"      21275495",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Chauhan S, Bisoi A, Kumar N, et al, \"Dose Comparison of Tranexamic Acid in Pediatric Cardiac Surgery,\"",
"      <i>",
"       Asian Cardiovasc Thorac Ann",
"      </i>",
"      , 2004, 12(2):121-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/15213077 /pubmed\" id=\"15213077 \" target=\"_blank\">",
"        15213077",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chauhan S, Das SN, Bisoi A, et al, \"Comparison of Epsilon Aminocaproic Acid and Tranexamic Acid in Pediatric Cardiac Surgery,\"",
"      <i>",
"       J Cardiothorac Vasc Anesth",
"      </i>",
"      , 2004, 18(2):141-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/15073700/pubmed\" id=\"15073700\" target=\"_blank\">",
"        15073700",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eaton MP, \"Antifibrinolytic Therapy in Surgery for Congenital Heart Disease,\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2008, 106(4):1087-100.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/18349177/pubmed\" id=\"18349177\" target=\"_blank\">",
"        18349177",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grant JA, Howard J, Luntley J, et al, \"Perioperative Blood Transfusion Requirements in Pediatric Scoliosis Surgery: The Efficacy of Tranexamic Acid,\"",
"      <i>",
"       J Pediatr Orthop",
"      </i>",
"      , 2009, 29(3):300-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/19305284/pubmed\" id=\"19305284\" target=\"_blank\">",
"        19305284",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levin E, Wu J, Devine DV, et al, \"Hemostatic Parameters and Platelet Activation Marker Expression in Cyanotic and Acyanotic Pediatric Patients Undergoing Cardiac Surgery in the Presence of Tranexamic Acid,\"",
"      <i>",
"       Thromb Haemost",
"      </i>",
"      , 2000, 83(1):54-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/10669155/pubmed\" id=\"10669155\" target=\"_blank\">",
"        10669155",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Murkin JM, Falter F, Granton J, et al, \"High-Dose Tranexamic Acid Is Associated With Nonischemic Clinical Seizures in Cardiac Surgical Patients,\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2010, 110(2):350-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/19996135/pubmed\" id=\"19996135\" target=\"_blank\">",
"        19996135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neilipovitz DT, Murto K, Hall L, et al, \"A Randomized Trial of Tranexamic Acid to Reduce Blood Transfusion for Scoliosis Surgery,\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2001, 93(1):82-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/11429344/pubmed\" id=\"11429344\" target=\"_blank\">",
"        11429344",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reid RW, Zimmerman AA, Laussen PC, et al, \"The Efficacy of Tranexamic Acid Versus Placebo in Decreasing Blood Loss in Pediatric Patients Undergoing Repeat Cardiac Surgery,\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1997, 84(5):990-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/9141920/pubmed\" id=\"9141920\" target=\"_blank\">",
"        9141920",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sethna NF, Zurakowski D, Brustowicz RM, et al, \"Tranexamic Acid Reduces Intraoperative Blood Loss in Pediatric Patients Undergoing Scoliosis Surgery,\"",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 2005, 102(4):727-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/15791100/pubmed\" id=\"15791100\" target=\"_blank\">",
"        15791100",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shapiro F, Zurakowski D, and Sethna NF, \"Tranexamic Acid Diminishes Intraoperative Blood Loss and Transfusion in Spinal Fusions for Duchenne Muscular Dystrophy Scoliosis,\"",
"      <i>",
"       Spine (Phila Pa 1976)",
"      </i>",
"      , 2007, 32(20):2278-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/17873823/pubmed\" id=\"17873823\" target=\"_blank\">",
"        17873823",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van der Staak FH, de Haan AF, Geven WB, et al, \"Surgical Repair of Congenital Diaphragmatic Hernia During Extracorporeal Membrane Oxygenation: Hemorrhagic Complications and the Effect of Tranexamic Acid,\"",
"      <i>",
"       J Pediatr Surg",
"      </i>",
"      , 1997, 32(4):594-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/9126762/pubmed\" id=\"9126762\" target=\"_blank\">",
"        9126762",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zonis Z, Seear M, Reichert C, et al, \"The Effect of Preoperative Tranexamic Acid on Blood Loss After Cardiac Operations in Children,\"",
"      <i>",
"       J Thorac Cardiovasc Surg",
"      </i>",
"      , 1996, 111(5):982-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8982/abstract-text/8622323/pubmed\" id=\"8622323\" target=\"_blank\">",
"        8622323",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12854 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-7719C8D6E9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8982=[""].join("\n");
var outline_f8_49_8982=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229860\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229861\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062679\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12675770\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062673\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229847\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229834\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062683\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229905\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062676\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062682\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229906\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229904\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062686\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062672\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062671\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300160\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229842\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229843\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7679524\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062678\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062681\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062670\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062685\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10224228\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12808160\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12854\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12854|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/58/14248?source=related_link\">",
"      Tranexamic acid: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10037?source=related_link\">",
"      Tranexamic acid: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_49_8983="TEE contrast atrial septal aneurysm and defect";
var content_f8_49_8983=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/67067/teeasanc_conv.mp4?title=TEE+contrast+atrial+septal+aneurysm+and+defect\" style=\"width:324px;height:236px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Atrial septal aneurysm and defect",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 419px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transesophageal echocardiogram was performed with contrast. Panel A shows an aneurysm of the atrial septum. Immediately after the injection of agitated saline, contrast (yellow arrow) can be seen in the right atrium (RA) (panel B). With complete filling of the RA, a small amount of contrast is seen entering the left atrium (LA) as a result of a right to left shunt through an atrial septal defect (panel C). The contrast is then seen diffusely within the LA (panel D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8983=[""].join("\n");
var outline_f8_49_8983=null;
var title_f8_49_8984="Systemic AL amyloidosis purpura";
var content_f8_49_8984=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77887&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77887&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Systemic AL amyloidosis - periorbital purpura",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 533px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple periorbital purpuric macules are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8984=[""].join("\n");
var outline_f8_49_8984=null;
var title_f8_49_8985="Polyarteritis nodosa (light micrograph)";
var content_f8_49_8985=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F74893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F74893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Polyarteritis nodosa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a small muscular renal artery in polyarteritis nodosa. There is diffuse inflammation of the adventitia and marked thickening of the inner layers by loose connective tissue (arrows). The lumen (L) is significantly narrowed. Involvement of a vessel this large would be unusual in microscopic polyarteritis or granulomatosis with polyangiitis (Wegener&rsquo;s).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8985=[""].join("\n");
var outline_f8_49_8985=null;
var title_f8_49_8986="Propranolol: Drug information";
var content_f8_49_8986=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Propranolol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/4/43077?source=see_link\">",
"    see \"Propranolol: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/62/36840?source=see_link\">",
"    see \"Propranolol: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F7254284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F214907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Inderal&reg; LA;",
"     </li>",
"     <li>",
"      InnoPran XL&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F214908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Propranolol&reg;;",
"     </li>",
"     <li>",
"      Dom-Propranolol;",
"     </li>",
"     <li>",
"      Inderal&reg;;",
"     </li>",
"     <li>",
"      Inderal&reg; LA;",
"     </li>",
"     <li>",
"      Novo-Pranol;",
"     </li>",
"     <li>",
"      Nu-Propranolol;",
"     </li>",
"     <li>",
"      PMS-Propranolol;",
"     </li>",
"     <li>",
"      Propranolol Hydrochloride Injection, USP;",
"     </li>",
"     <li>",
"      Teva-Propranolol",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F214939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antianginal Agent;",
"     </li>",
"     <li>",
"      Antiarrhythmic Agent, Class II;",
"     </li>",
"     <li>",
"      Beta-Blocker, Nonselective",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F214911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Akathisia (unlabeled use):",
"     </b>",
"     Oral: 30-120 mg/day in 2-3 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Essential tremor:",
"     </b>",
"     Oral: 40 mg twice daily initially; maintenance doses: Usually 120-320 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"     Initial: Oral: 40 mg twice daily; increase dosage every 3-7 days; usual dose: 120-240 mg divided in 2-3 doses/day; maximum daily dose: 640 mg; usual dosage range (JNC 7): 40-160 mg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Extended release formulations:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Inderal&reg; LA: Initial: 80 mg once daily; usual maintenance: 120-160 mg once daily; maximum daily dose: 640 mg; usual dosage range (JNC 7): 60-180 mg/day once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     InnoPran XL&reg;: Initial: 80 mg once daily at bedtime; if initial response is inadequate, may be increased at 2-3 week intervals to a maximum dose of 120 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypertrophic subaortic stenosis:",
"     </b>",
"     Oral: 20-40 mg 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Inderal&reg; LA: 80-160 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Migraine headache prophylaxis:",
"     </b>",
"     Oral: Initial: 80 mg/day divided every 6-8 hours; increase by 20-40 mg/dose every 3-4 weeks to a maximum of 160-240 mg/day given in divided doses every 6-8 hours; if satisfactory response not achieved within 6 weeks of starting therapy, drug should be withdrawn gradually over several weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Inderal&reg; LA: Initial: 80 mg once daily; effective dose range: 160-240 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pheochromocytoma:",
"     </b>",
"     Oral: 30-60 mg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Post-MI mortality reduction:",
"     </b>",
"     Oral: 180-240 mg/day in 3-4 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Stable angina:",
"     </b>",
"     Oral: 80-320 mg/day in doses divided 2-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Inderal&reg; LA: Initial: 80 mg once daily; maximum dose: 320 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tachyarrhythmias:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 10-30 mg/dose every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 1-3 mg/dose slow IVP; repeat every 2-5 minutes up to a total of 5 mg; titrate initial dose to desired response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     0.5-1 mg over 1 minute; may repeat, if necessary, up to a total maximum dose of 0.1 mg/kg (ACLS guidelines, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Once response achieved or maximum dose administered, additional doses should not be given for at least 4 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Thyroid storm (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 60-80 mg every 4 hours; may consider the use of an intravenous shorter-acting beta-blocker (ie, esmolol) (Bahn, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 0.5-1 mg administered over 10 minutes every 3 hours (Gardner, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Thyrotoxicosis (unlabeled use):",
"     </b>",
"     Oral: 10-40 mg/dose every 6-8 hours; may also consider administering extended or sustained release formulations (Bahn, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Variceal hemorrhage prophylaxis (unlabeled use)",
"     </b>",
"     (Garcia-Tsao, 2007): Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Primary prophylaxis: Initial: 20 mg twice daily; adjust to maximal tolerated dose.",
"     <b>",
"      Note:",
"     </b>",
"     Risk factors for hemorrhage include Child-Pugh class B/C or variceal red wale markings on endoscopy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Secondary prophylaxis: Initial: 20 mg twice daily; adjust to maximal tolerated dose",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F214926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/62/36840?source=see_link\">",
"      see \"Propranolol: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypertension (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Initial: 0.5-1 mg/kg/day in divided doses every 6-12 hours; increase gradually every 5-7 days; maximum: 16 mg/kg/24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Migraine headache prophylaxis (unlabeled use):",
"     </b>",
"     Oral: Initial: 2-4 mg/kg/day",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &le;35 kg: 10-20 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;35 kg: 20-40 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tachyarrhythmias (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Initial: 0.5-1 mg/kg/day in divided doses every 6-8 hours; titrate dosage upward every 3-7 days; usual dose: 2-6 mg/kg/day; higher doses may be needed; do not exceed 16 mg/kg/day or 60 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 0.01-0.1 mg/kg/dose slow IVP over 10 minutes; maximum dose: 1 mg for infants; 3 mg for children",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Thyroid storm (unlabeled use):",
"     </b>",
"     Oral: Children: 0.5 mg/kg/dose every 4-8 hours;  titrate to effective dose (Eyal, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Thyrotoxicosis (unlabeled use):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 10-40 mg every 6 hours; titrate to effective dose (Eyal, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypercyanotic spells (TOF) (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: Palliation: Initial: 1 mg/kg/day every 6 hours; if ineffective, may increase dose after 1 week by 1 mg/kg/day to a maximum of 5 mg/kg/day, if patient becomes refractory, may increase slowly to a maximum of 10-15 mg/kg/day. Allow 24 hours between dosing changes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 0.01-0.2 mg/kg/dose infused over 10 minutes; maximum dose: 5 mg",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F214912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Use caution; initiate at lower end of the dosing range.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hypertension: Consider lower initial doses and titrate to response (Aronow, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tachyarrhythmias: Initial: 10 mg twice daily; increase dosage every 3-7 days; usual dose range: 10-320 mg/day given in 1-2 divided doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Refer to adult dosing for additional uses.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F214913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Not dialyzable (0% to 5%); supplemental dose is not necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peritoneal dialysis effects: Supplemental dose is not necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F214914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Marked slowing of heart rate may occur in chronic liver disease with conventional doses; low initial dose and regular heart rate monitoring.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F214877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, extended release, oral, as hydrochloride: 60 mg, 80 mg, 120 mg, 160 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     InnoPran XL&reg;: 80 mg, 120 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, sustained release, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Inderal&reg; LA: 60 mg, 80 mg, 120 mg, 160 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 1 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 1 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral, as hydrochloride: 4 mg/mL (500 mL); 8 mg/mL (500 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 10 mg, 20 mg, 40 mg, 60 mg, 80 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F214862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F214882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V. dose is much smaller than oral dose. When administered acutely for cardiac treatment, monitor ECG and blood pressure. May administer by rapid infusion (I.V. push) at a rate of 1 mg/minute or by slow infusion over ~30 minutes. Necessary monitoring for surgical patients who are unable to take oral beta-blockers (prolonged ileus) has not been defined. Some institutions require monitoring of baseline and postinfusion heart rate and blood pressure when a patient's response to beta-blockade has not been characterized (ie, the patient's initial dose or following a change in dose). Consult individual institutional policies and procedures. Do not crush long-acting oral forms.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F214946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Alteplase, fenoldopam, heparin, hydrocortisone sodium succinate, inamrinone, linezolid, meperidine, milrinone, morphine, nesiritide, potassium chloride, propofol, tacrolimus, tirofiban, vitamin B complex with C.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, pantoprazole.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Inamrinone, milrinone.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Pantoprazole.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F214881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of hypertension; angina pectoris; pheochromocytoma; essential tremor; supraventricular arrhythmias (such as atrial fibrillation and flutter, AV nodal re-entrant tachycardias), ventricular tachycardias (catecholamine-induced arrhythmias, digoxin toxicity); prevention of myocardial infarction; migraine headache prophylaxis; symptomatic treatment of hypertrophic subaortic stenosis (hypertrophic obstructive cardiomyopathy)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F214936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tremor due to Parkinson's disease; aggressive behavior (not recommended for dementia-associated aggression), anxiety, schizophrenia; antipsychotic-induced akathisia; primary and secondary prophylaxis of variceal hemorrhage; acute panic; thyrotoxicosis; tetralogy of Fallot (TOF) hypercyanotic spells",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F214948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Propranolol may be confused with prasugrel, Pravachol&reg;, Propulsid&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Inderal&reg; may be confused with Adderall&reg;, Enduron, Imdur&reg;, Imuran&reg;, Inderide, Isordil&reg;, Toradol&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Significant differences exist between oral and I.V. dosing. Use caution when converting from one route of administration to another.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Inderal [Canada and multiple international markets] and Inderal LA [U.S.] may be confused with Indiaral brand name for loperamide [France]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F214937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Angina, arterial insufficiency, AV conduction disturbance increased, bradycardia, cardiogenic shock, CHF, hypotension, impaired myocardial contractility, mesenteric arterial thrombosis (rare), Raynaud's syndrome, syncope",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Amnesia, catatonia, cognitive dysfunction, confusion, depression, dizziness, emotional lability, fatigue, hallucinations, hypersomnolence, insomnia, lethargy, lightheadedness, psychosis, vertigo, vivid dreams",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, contact dermatitis, cutaneous ulcers, eczematous eruptions, erythema multiforme, exfoliative dermatitis, hyperkeratosis, nail changes, oculomucocutaneous reactions, pruritus, psoriasiform eruptions, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, ulcers, ulcerative lichenoid, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyper-/hypoglycemia, hyperkalemia, hyperlipidemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, cramping, constipation, diarrhea, ischemic colitis, nausea, stomach discomfort, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence, interstitial nephritis (rare), oliguria (rare), Peyronie's disease, proteinuria (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, nonthrombocytopenic purpura, thrombocytopenia, thrombocytopenic purpura",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthropathy, carpal tunnel syndrome (rare), myotonus, paresthesia, polyarthritis, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Hyperemia of the conjunctiva, mydriasis, visual acuity decreased, visual disturbances, xerophthalmia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, dyspnea, laryngospasm, pharyngitis, pulmonary edema, respiratory distress, wheezing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylactic/anaphylactoid allergic reaction, cold extremities, lupus-like syndrome (rare)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F214885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to propranolol, beta-blockers, or any component of the formulation; uncompensated congestive heart failure (unless the failure is due to tachyarrhythmias being treated with propranolol), cardiogenic shock, severe sinus bradycardia or heart block greater than first-degree (except in patients with a functioning artificial pacemaker), severe hyperactive airway disease (asthma or COPD)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F214866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse events:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactic reactions: Use caution with history of severe anaphylaxis to allergens; patients taking beta-blockers may become more sensitive to repeated challenges. Treatment of anaphylaxis (eg, epinephrine) in patients taking beta-blockers may be ineffective or promote undesirable effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bronchospastic disease: In general, patients with bronchospastic disease should not receive beta-blockers; if used at all, should be used cautiously with close monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Conduction abnormality: Consider pre-existing conditions such as sick sinus syndrome before initiating.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; may potentiate hypoglycemia and/or mask signs and symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heart failure (HF): Use with caution in patients with compensated HF and monitor for a worsening of the condition (efficacy of propranolol in HF has not been demonstrated).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; dosage adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peripheral vascular disease (PVD) and Raynaud's disease: Can precipitate or aggravate symptoms of arterial insufficiency in patients with PVD and Raynaud's disease. Use with caution and monitor for progression of arterial obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pheochromocytoma (untreated): Adequate alpha-blockade is required prior to use of any beta-blocker.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psoriasis: Beta-blocker use has been associated with induction or exacerbation of psoriasis, but cause and effect have not been firmly established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychiatric disease: Use with caution in patients with a history of psychiatric illness; may cause or exacerbate CNS depression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; may have increased side effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid disease: May mask signs of hyperthyroidism (eg, tachycardia). If thyrotoxicosis is suspected, carefully manage and monitor; abrupt withdrawal may exacerbate symptoms of hyperthyroidism or precipitate thyroid storm. Alterations in thyroid function tests may be observed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Calcium channel blockers (nondihydropyridines): Use with caution in patients on concurrent verapamil or diltiazem; bradycardia or heart block can occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac glycosides: Use with caution in patients receiving digoxin; bradycardia or heart block can occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Inhaled anesthetic agents: Use with caution in patients receiving inhaled anesthetic agents known to depress myocardial contractility.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Bradycardia may be observed more frequently in elderly patients (&gt;65 years of age); dosage reductions may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abrupt withdrawal:",
"     <b>",
"      [U.S. Boxed Warning]: Beta-blocker therapy should not be withdrawn abruptly (particularly in patients with CAD), but gradually tapered to avoid acute tachycardia, hypertension, and/or ischemia.",
"     </b>",
"     Severe exacerbation of angina, ventricular arrhythmias, and myocardial infarction (MI) have been reported following abrupt withdrawal of beta-blocker therapy. Temporary but prompt resumption of beta-blocker therapy may be indicated with worsening of angina or acute coronary insufficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Major surgery: Chronic beta-blocker therapy should not be routinely withdrawn prior to major surgery.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F214934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP2C19 (minor), CYP2D6 (major), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2D6 (weak), P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F214871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May decrease the serum concentration of Propranolol. Alcohol (Ethyl) may increase the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): Beta-Blockers may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting). Epinephrine used as a local anesthetic for dental procedures will not likely cause clinically relevant problems.  Management: Cardioselective beta-blockers and lower doses of epinephrine may confer a more limited risk. Patients who may require acute subcutaneous epinephrine (e.g., bee sting kits) should probably avoid beta blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: Beta-Blockers may enhance the orthostatic hypotensive effect of Alpha1-Blockers. The risk associated with ophthalmic products is probably less than systemic products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists: May enhance the AV-blocking effect of Beta-Blockers. Sinus node dysfunction may also be enhanced. Beta-Blockers may enhance the rebound hypertensive effect of Alpha2-Agonists. This effect can occur when the alpha",
"     <sub>",
"      2",
"     </sub>",
"     -agonist is abruptly withdrawn. Management: Closely monitor heart rate during treatment with a beta blocker and clonidine. Withdraw beta blockers several days before clonidine withdrawal when possible, and monitor blood pressure closely. Recommendations for other alpha2-agonists are unavailable.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Apraclonidine; Brimonidine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoquinolines (Antimalarial): May decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: May enhance the bradycardic effect of Beta-Blockers. Possibly to the point of cardiac arrest. Amiodarone may increase the serum concentration of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the bradycardic effect of Beta-Blockers. Anilidopiperidine Opioids may enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Beta-Blockers. Beta-Blockers may decrease the metabolism of Antipsychotic Agents (Phenothiazines). Antipsychotic Agents (Phenothiazines) may decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May decrease the serum concentration of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: Beta-Blockers (Nonselective) may diminish the bronchodilatory effect of Beta2-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bupivacaine: Beta-Blockers may increase the serum concentration of Bupivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Beta-Blockers may enhance the bradycardic effect of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Beta-Blockers may enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction.  Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Dabigatran dose reductions may be needed.  Specific recommendations vary considerably according to US vs Canadian labeling, specific P-gp inhibitor, renal function, and indication for dabigatran treatment.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: May enhance the bradycardic effect of Beta-Blockers. Dronedarone may increase the serum concentration of Beta-Blockers. This likely applies only to those agents that are metabolized by CYP2D6. Management: Use lower initial beta-blocker doses; adequate tolerance of the combination, based on ECG findings, should be confirmed prior to any increase in beta-blocker dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: Beta-Blockers may enhance the vasoconstricting effect of Ergot Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: Beta-Blockers may enhance the bradycardic effect of Fingolimod.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Beta-Blockers.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FluvoxaMINE: May increase the serum concentration of Propranolol. Management: Use a lower initial propranolol dose and be cautious with propranolol dose titration.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Insulin: Beta-Blockers may enhance the hypoglycemic effect of Insulin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lacidipine: May enhance the hypotensive effect of Propranolol. Lacidipine may increase the serum concentration of Propranolol. Propranolol may decrease the serum concentration of Lacidipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Systemic): Beta-Blockers may increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Topical): Beta-Blockers may increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mepivacaine: Beta-Blockers may increase the serum concentration of Mepivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methacholine: Beta-Blockers may enhance the adverse/toxic effect of Methacholine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Midodrine: Beta-Blockers may enhance the bradycardic effect of Midodrine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the antihypertensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: May decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reserpine: May enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Rifabutin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rizatriptan: Propranolol may increase the serum concentration of Rizatriptan.  Management: Rizatriptan adult dose should be reduced to 5 mg in patients who are also being treated with propranolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May increase the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Citalopram; Escitalopram; FluvoxaMINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Beta-Blockers may enhance the hypoglycemic effect of Sulfonylureas. Cardioselective beta-blockers (eg, acebutolol, atenolol, metoprolol, and penbutolol) may be safer than nonselective beta-blockers. All beta-blockers appear to mask tachycardia as an initial symptom of hypoglycemia. Ophthalmic beta-blockers are probably associated with lower risk than systemic agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Beta-Blockers (Nonselective) may diminish the bronchodilatory effect of Theophylline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zileuton: May increase the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ZOLMitriptan: Propranolol may increase the serum concentration of ZOLMitriptan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F214902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cigarette: Smoking may decrease plasma levels of propranolol by increasing metabolism. Management: Avoid smoking.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Ethanol may increase or decrease plasma levels of propranolol. Reports are variable and have shown both enhanced as well as inhibited hepatic metabolism (of propranolol). Management: Caution advised with consumption of ethanol and monitor for heart rate and/or blood pressure changes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Propranolol serum levels may be increased if taken with food. Protein-rich foods may increase bioavailability; a change in diet from high carbohydrate/low protein to low carbohydrate/high protein may result in increased oral clearance. Management: Tablets (immediate release) should be taken on an empty stomach. Capsules (extended release) may be taken with or without food, but be consistent with regard to food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Dong quai has estrogenic activity. Some herbal medications may worsen hypertension (eg, licorice); others may enhance the antihypertensive effect of propranolol (eg, shepherd's purse). Management: Avoid dong quai if using for hypertension. Avoid bayberry, blue cohosh, cayenne, ephedra, ginger, ginseng (American), gotu kola, licorice, and yohimbe. Avoid black cohosh, california poppy, coleus, garlic, golden seal, hawthorn, mistletoe, periwinkle, quinine, and shepherd's purse.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F214873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F214888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies; therefore, the manufacturer classifies propranolol as pregnancy category C. Propranolol crosses the placenta and is measurable in the newborn serum following maternal use during pregnancy. In a cohort study, an increased risk of cardiovascular defects was observed following maternal use of beta-blockers during pregnancy. Intrauterine growth restriction (IUGR), small placentas, as well as fetal/neonatal bradycardia, hypoglycemia, and/or respiratory depression have been observed following",
"     <i>",
"      in utero",
"     </i>",
"     exposure to beta-blockers as a class. Adequate facilities for monitoring infants at birth should be available. Untreated chronic maternal hypertension and pre-eclampsia are also associated with adverse events in the fetus, infant, and mother. The peak maternal serum concentrations of propranolol and the active metabolite 4-hydroxypropranolol do not change during pregnancy; peak serum concentrations of naphthoxylactic acid are lower in the third trimester when compared to postpartum. Propranolol is recommended for use in the management of thyrotoxicosis in pregnancy. Propranolol has been evaluated for the treatment of hypertension in pregnancy, but other agents may be more appropriate for use. Propranolol has also been used in the management of hypertrophic obstructive cardiomyopathy in pregnancy and has been studied for use as an adjunctive agent in the management of dysfunctional labor (dystocia).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F214918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F214889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Propranolol is excreted into breast milk with peak concentrations occurring ~2-3 hours after an oral dose. The inactive metabolites of propranolol have also been detected in breast milk. The manufacturer recommends that caution be exercised when administering propranolol to nursing women. Due to immature hepatic metabolism in newborns, breast-feeding infants should be monitored for adverse events.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F214890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablets (immediate release) should be taken on an empty stomach; capsules (extended release) may be taken with or without food, but should always be taken consistently (with food or on an empty stomach)",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F214887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, 24-hour",
"     </b>",
"     (Inderal LA Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $949.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (100): $1109.33",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     120 mg (100): $1376.05",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     160 mg (100): $1801.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, 24-hour",
"     </b>",
"     (InnoPran XL Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (30): $361.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     120 mg (30): $361.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsule, 24-hour",
"     </b>",
"     (Propranolol HCl ER Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $132.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (100): $154.89",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     120 mg (100): $192.09",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     160 mg (100): $251.47",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Propranolol HCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg/mL (1 mL): $9.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Propranolol HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/5 mL (500 mL): $48.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/5 mL (500 mL): $69.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Propranolol HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $33.53",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $36.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (100): $69.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $121.83",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (100): $63.39",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F214875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Acute cardiac treatment: Monitor ECG, heart rate, and blood pressure with I.V. administration; heart rate and blood pressure with oral administration",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F214878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Therapeutic: 50-100 ng/mL (SI: 190-390 nmol/L) at end of dose interval",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F214891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anaprilan (RU);",
"     </li>",
"     <li>",
"      Angilol (IE);",
"     </li>",
"     <li>",
"      Apsolol (GB);",
"     </li>",
"     <li>",
"      Atensin (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Avlocardyl (FR);",
"     </li>",
"     <li>",
"      Bai Er Luo (CL);",
"     </li>",
"     <li>",
"      Bedranol (BB, BF, BJ, BM, BS, BZ, CI, ET, GH, GM, GN, GY, JM, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, SR, TN, TT, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Berkolol (HK);",
"     </li>",
"     <li>",
"      Beta-Timelets (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Betalol (TH);",
"     </li>",
"     <li>",
"      Betascan (TW);",
"     </li>",
"     <li>",
"      Cardiblok (ZA);",
"     </li>",
"     <li>",
"      Cardinol (NZ);",
"     </li>",
"     <li>",
"      Cardinol LA (NZ);",
"     </li>",
"     <li>",
"      Cardispare (ZA);",
"     </li>",
"     <li>",
"      Cardolol (TW);",
"     </li>",
"     <li>",
"      Ciplar (IN);",
"     </li>",
"     <li>",
"      Colliprol (MX);",
"     </li>",
"     <li>",
"      Corbeta (IN);",
"     </li>",
"     <li>",
"      Coriodal (CN);",
"     </li>",
"     <li>",
"      Deralin (AU, IL);",
"     </li>",
"     <li>",
"      Dideral (TR);",
"     </li>",
"     <li>",
"      Dociton (DE);",
"     </li>",
"     <li>",
"      Duranol (PH);",
"     </li>",
"     <li>",
"      Farmadral (ID);",
"     </li>",
"     <li>",
"      Frina (GR);",
"     </li>",
"     <li>",
"      Hipranol (MY);",
"     </li>",
"     <li>",
"      Indenol (KP);",
"     </li>",
"     <li>",
"      Inderal (AE, AR, AT, AU, BB, BE, BF, BG, BH, BJ, BM, BR, BS, BZ, CH, CI, CO, CY, DK, EC, EG, ET, GH, GM, GN, GR, GY, HN, IE, IQ, IR, IT, JM, JO, KE, KP, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, MY, NE, NG, NL, NO, OM, PE, PH, PK, PT, PY, QA, SA, SC, SD, SE, SG, SL, SN, SR, SY, TN, TT, TW, TZ, UG, UY, VE, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Inderal LA (AE, BB, BF, BH, BJ, BM, BS, BZ, CI, CY, EG, ET, GB, GH, GM, GN, GY, IE, IQ, IR, JM, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, PE, PT, QA, SA, SC, SD, SL, SN, SR, SY, TN, TT, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Inderalici (MX);",
"     </li>",
"     <li>",
"      Indesol (KP);",
"     </li>",
"     <li>",
"      Indicardin (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Inpanol (HK);",
"     </li>",
"     <li>",
"      Laining (TW);",
"     </li>",
"     <li>",
"      MIDDLEEAST (IL);",
"     </li>",
"     <li>",
"      Normpress (TH);",
"     </li>",
"     <li>",
"      Oposim (AR);",
"     </li>",
"     <li>",
"      Palon (TH);",
"     </li>",
"     <li>",
"      Pranidol (MX);",
"     </li>",
"     <li>",
"      Prestoral (ID);",
"     </li>",
"     <li>",
"      Prolol (IL);",
"     </li>",
"     <li>",
"      Propalong (AR);",
"     </li>",
"     <li>",
"      Propayerst (AR);",
"     </li>",
"     <li>",
"      Propra (EE);",
"     </li>",
"     <li>",
"      Propra-Ratiopharm (PL);",
"     </li>",
"     <li>",
"      Propral (FI);",
"     </li>",
"     <li>",
"      Propranolol Eurogenerics (LU);",
"     </li>",
"     <li>",
"      Pu Le Xin (CL);",
"     </li>",
"     <li>",
"      Purbloka (ZA);",
"     </li>",
"     <li>",
"      Rebaten LA (BR);",
"     </li>",
"     <li>",
"      Rexigen (ZA);",
"     </li>",
"     <li>",
"      Sawatal (JP);",
"     </li>",
"     <li>",
"      Slow Deralin (IL);",
"     </li>",
"     <li>",
"      Sumial (ES);",
"     </li>",
"     <li>",
"      Tenomal (GR);",
"     </li>",
"     <li>",
"      Waucoton (GR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F214865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nonselective beta-adrenergic blocker (class II antiarrhythmic); competitively blocks response to beta",
"     <sub>",
"      1",
"     </sub>",
"     - and beta",
"     <sub>",
"      2",
"     </sub>",
"     -adrenergic stimulation which results in decreases in heart rate, myocardial contractility, blood pressure, and myocardial oxygen demand. Nonselective beta-adrenergic blockers (propranolol, nadolol) reduce portal pressure by producing splanchnic vasoconstriction (beta",
"     <sub>",
"      2",
"     </sub>",
"     effect) thereby reducing portal blood flow.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F214884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Beta-blockade: Oral: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Immediate release: 6-12 hours; Extended-release formulations: ~24-27 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid and complete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 4 L/kg in adults",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Newborns: 68%; Adults: ~90% (S-isomer primarily to alpha",
"     <sub>",
"      1",
"     </sub>",
"     -acid glycoprotein; R-isomer primarily to albumin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP2D6, and CYP1A2 to 4-hydroxypropranolol (active) and inactive compounds; extensive first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~25% reaches systemic circulation due to high first-pass metabolism; protein-rich foods increase bioavailability by ~50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Neonates and Infants: Possible increased half-life; Children: 3.9-6.4 hours; Adults: Immediate release formulation: 3-6 hours; Extended-release formulations: 8-10 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Immediate release: 1-4 hours; Extended-release formulations: ~6-14 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Metabolites are excreted primarily in urine (96% to 99%); &lt;1% excreted in urine as unchanged drug",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Adler LA, Peselow E, Rosenthal M, et al, &ldquo;A Controlled Comparison of the Effects of Propranolol, Benztropine, and Placebo on Akathisia: An Interim Analysis,&rdquo;",
"      <i>",
"       Psychopharmacol Bull",
"      </i>",
"      , 1993, 29(2):283-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/8290678/pubmed\" id=\"8290678\" target=\"_blank\">",
"        8290678",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/11533352 /pubmed\" id=\"11533352 \" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anderson JL, Adams CD, Antman EM, et al, \"2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 123(18):e426-579.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/21444888/pubmed\" id=\"21444888\" target=\"_blank\">",
"        21444888",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Annequin D, Tourniaire B, Massiou H, et al, &ldquo;Migraine and Headache in Childhood and Adolescence,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 2000, 47(3):617-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/10835994/pubmed\" id=\"10835994\" target=\"_blank\">",
"        10835994",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Anbe DT, Armstrong PW, et al, &ldquo;ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(9):e82-292.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/15339869/pubmed\" id=\"15339869\" target=\"_blank\">",
"        15339869",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Hand M, Armstrong PW, et al, &ldquo;2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2008, 51(2):210-49.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/18191746/pubmed\" id=\"18191746\" target=\"_blank\">",
"        18191746",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronow WS, Fleg JL, Pepine CJ, et al, &ldquo;ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 123(21):2434-506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/21518977/pubmed\" id=\"21518977\" target=\"_blank\">",
"        21518977",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bahn RS (Chair), Burch HB, Cooper DS, et al, &ldquo;Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists,&rdquo;",
"      <i>",
"       Thyroid",
"      </i>",
"      , 2011, 21(6):593-646.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/ 21510801/pubmed\" id=\" 21510801\" target=\"_blank\">",
"        21510801",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bartosh S and Aronson A, &ldquo;Childhood Hypertension. An Update on Etiology, Diagnosis and Treatment,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1999, 46(2):235-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/10218072/pubmed\" id=\"10218072\" target=\"_blank\">",
"        10218072",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bille B, Ludvigsson J, and Sanner G. &ldquo;Prophylaxis of Migraine in Children,&rdquo;",
"      <i>",
"       Headache",
"      </i>",
"      , 1977, 17(2):61-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/324951/pubmed\" id=\"324951\" target=\"_blank\">",
"        324951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Blomstr&ouml;m-Lundqvist C, Scheinman MM, Aliot EM, et al, &ldquo;ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2003, 108(15):1871-909.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/14557344/pubmed\" id=\"14557344\" target=\"_blank\">",
"        14557344",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brauchli YB, Jick SS, Curtin F, et al, &ldquo;Association Between Beta-Blockers, Other Antihypertensive Drugs and Psoriasis: Population-Based Case-Control Study,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 2008, 158(6):1299-307.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/18410416/pubmed\" id=\"18410416\" target=\"_blank\">",
"        18410416",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, &ldquo;The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/12748199/pubmed\" id=\"12748199\" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cumming GR and Carr W, &ldquo;Hemodynamic Effects of Propranolol in Patients With Fallot&rsquo;s Tetralogy,&rdquo;",
"      <i>",
"       Am Heart J",
"      </i>",
"      , 1967, 74(1):29-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/6027567/pubmed\" id=\"6027567\" target=\"_blank\">",
"        6027567",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cumming GR, &ldquo;Propranolol in Tetralogy of Fallot,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      ,  1970, 41(1):13-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/5420625/pubmed\" id=\"5420625\" target=\"_blank\">",
"        5420625",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Pediatric Emergencies. Committee on Drugs, Committee on Drugs, 1996 to 1997, Liaison Representatives, and AAP Section Liaisons,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1998, 101(1):E13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/9734990/pubmed\" id=\"9734990\" target=\"_blank\">",
"        9734990",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eades SK, &ldquo;Pharmacotherapy of Congenital Heart Defects,&rdquo;",
"      <i>",
"       J Pediatr Pharm Prac",
"      </i>",
"      , 2000, 5(1):15-34.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eyal O and Rose SR, &ldquo;Thyroid Disease,&rdquo; in",
"      <i>",
"       Roger&rsquo;s Textbook of Pediatric Intensive Care",
"      </i>",
"      , 4th ed, David G Nichols, ed, Philadelphia, PA: Lippincott, Williams, &amp; Wilkins, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Farine M and Arbus G, &ldquo;Management of Hypertensive Emergencies in Children,&rdquo;",
"      <i>",
"       Pediatr Emerg Care",
"      </i>",
"      , 1989, 5(1):51-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/2652097/pubmed\" id=\"2652097\" target=\"_blank\">",
"        2652097",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Field JM, Hazinski MF, Sayre MR, et al, &ldquo;Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122 (18 Suppl 3):640-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/20956217/pubmed\" id=\"20956217\" target=\"_blank\">",
"        20956217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fihn SD, Gardin JM, Abrams J, et al, &ldquo;2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(25):3097-137.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/23166211/pubmed\" id=\"23166211\" target=\"_blank\">",
"        23166211",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fleisher LA, Beckman JA, Brown KA, et al, &ldquo;2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2009, 54(22):e13-118.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/19926002/pubmed\" id=\"19926002\" target=\"_blank\">",
"        19926002",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fuster V, Ryden LE, Cannom DS, et al, &ldquo;ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2006, 48(4):854-906.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/16904574 /pubmed\" id=\"16904574 \" target=\"_blank\">",
"        16904574",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garcia-Tsao G, Sanyal AJ, Grace ND, et al, &ldquo;Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis,&rdquo;",
"      <i>",
"       Hepatology",
"      </i>",
"      , 2007, 46(3):922-38.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/17879356/pubmed\" id=\"17879356\" target=\"_blank\">",
"        17879356",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gardner DG, &ldquo;Endocrine Emergencies,&rdquo; in",
"      <i>",
"       Greenspan&rsquo;s Basic &amp; Clinical Endocrinology",
"      </i>",
"      , 9th ed, Gardner DG and Shoback D eds, The McGraw-Hill Companies Inc, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garson A Jr, Gillette PC, and McNamara DG, &ldquo;Propranolol: The Preferred Palliation for Tetralogy of Fallot,&rdquo;",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 1981, 47(5):1098-104.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/6164284/pubmed\" id=\"6164284\" target=\"_blank\">",
"        6164284",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Geffner DL and Hershman JM, &ldquo;beta-Adrenergic Blockade for the Treatment of Hyperthyroidism,&rdquo;",
"      <i>",
"       Am J Med",
"      </i>",
"      , 1992, 93(1):61-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/1352658/pubmed\" id=\"1352658\" target=\"_blank\">",
"        1352658",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hillis LD, Smith PK, Anderson JL, et al, &ldquo;2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):2610-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/22064600/pubmed\" id=\"22064600\" target=\"_blank\">",
"        22064600",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hirsch AT, Haskal ZJ, Hertzer NR, et al, &ldquo;ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). A Collaborative Report of the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2006, 113(11):e463-654.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/16549646/pubmed\" id=\"16549646\" target=\"_blank\">",
"        16549646",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Juul AB, Wetterslev J, Gluud C, et al, &ldquo;Effect of Perioperative Beta Blockade in Patients With Diabetes Undergoing Major Non-Cardiac Surgery: Randomized Placebo Controlled, Blinded Multicentre Trial. DIPOM Trial Group,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 2006, 332(7556):1482.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/16793810/pubmed\" id=\"16793810\" target=\"_blank\">",
"        16793810",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lang DM, &ldquo;Anaphylactoid and Anaphylactic Reactions. Hazards of Beta-Blockers,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1995, 12(5):299-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/7669259/pubmed\" id=\"7669259\" target=\"_blank\">",
"        7669259",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lindenauer PK, Pekow P, Wang K, et al, \"Perioperative Beta-Blocker Therapy and Mortality After Major Noncardiac Surgery,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2005, 353(4):349-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/16049209/pubmed\" id=\"16049209\" target=\"_blank\">",
"        16049209",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Luedtke S, Kuhn R, and McCaffrey F, &ldquo;Pharmacologic Management of Supraventricular Tachycardias in Children. Part 2: Atrial flutter, Atrial Fibrillation, and Junctional and Atrial Ectopic Tachycardia,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1997, 31(11):1347-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/9391691/pubmed\" id=\"9391691\" target=\"_blank\">",
"        9391691",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, &ldquo;The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2004, 114(2 Suppl):555-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/15286277/pubmed\" id=\"15286277\" target=\"_blank\">",
"        15286277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neumar RW, Otto CW, Link MS, et al, &ldquo;Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):729-67.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      O'Gara PT, Kushner FG, Ascheim DD, et al, \"2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 127(4):e362-425.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/3247304/pubmed\" id=\"3247304\" target=\"_blank\">",
"        3247304",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pickoff AS, Zies L, Ferrer PL, et al, &ldquo;High-dose Propranolol Therapy in the Management of Supraventricular Tachycardia,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1979, 94(1):144-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/758396/pubmed\" id=\"758396\" target=\"_blank\">",
"        758396",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      POISE Study Group, Devereaux PJ, Yang H, et al, &ldquo;Effects of Extended-Release Metoprolol Succinate in Patients Undergoing Non-Cardiac Surgery (POISE Trial): A Randomised Controlled Trial,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2008, 371(9627):1839-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/18479744/pubmed\" id=\"18479744\" target=\"_blank\">",
"        18479744",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.  Available at file://psychiatryonline.org/guidelines.aspx",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Radack K and Deck C, &ldquo;Beta-Adrenergic Blocker Therapy Does Not Worsen Intermittent Claudication in Subjects With Peripheral Arterial Disease. A Meta-Analysis of Randomized Controlled Trials,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1991, 151(9):1769-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/1679624/pubmed\" id=\"1679624\" target=\"_blank\">",
"        1679624",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Redelmeier D, Scales D, and Kopp A, &ldquo;Beta Blockers for Elective Surgery in Elderly Patients: Population Based, Retrospective Cohort Study,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 2005, 331(7522):932.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/16210252/pubmed\" id=\"16210252\" target=\"_blank\">",
"        16210252",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sch&ouml;n MP and Boehncke WH, &ldquo;Psoriasis,&rdquo;",
"      <i>",
"       N Eng J Med",
"      </i>",
"      , 2005, 352(18):1899-1912.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/15872205/pubmed\" id=\"15872205\" target=\"_blank\">",
"        15872205",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shah PM and Kidd L, &ldquo;Circulatory Effects of Propranolol in Children With Fallot&rsquo;s Tetralogy,&rdquo;",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 1967, 19(5):653-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/6024709/pubmed\" id=\"6024709\" target=\"_blank\">",
"        6024709",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shanks RG, Hadden DR, Lowe DC, et al, &ldquo;Controlled Trial of Propranolol in Thyrotoxicosis,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1969, 1(7603):993-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/4181181/pubmed\" id=\"4181181\" target=\"_blank\">",
"        4181181",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Skanes AC, Healey JS, Cairns JA, et al, &ldquo;Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control,&rdquo;",
"      <i>",
"       Can J Cardiol",
"      </i>",
"      , 2012, 28(2):125-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/22433576/pubmed\" id=\"22433576\" target=\"_blank\">",
"        22433576",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith SC Jr, Benjamin EJ, Bonow RO, et al, &ldquo;AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(22):2458-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/22052934/pubmed\" id=\"22052934\" target=\"_blank\">",
"        22052934",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith CS and Howard NJ, &ldquo;Propranolol in Treatment of Neonatal Thyrotoxicosis,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1973, 83:1046.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/4757519/pubmed\" id=\"4757519\" target=\"_blank\">",
"        4757519",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Strasburger JF, \"Cardiac Arrhythmias in Childhood. Diagnostic Considerations and Treatment,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 1991, 42(6):974-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/1724643/pubmed\" id=\"1724643\" target=\"_blank\">",
"        1724643",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      UK Prospective Diabetes Study Group, &ldquo;Efficacy of Atenolol and Captopril in Reducing Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 39,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 1998, 317(7160):713-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/9732338/pubmed\" id=\"9732338\" target=\"_blank\">",
"        9732338",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wann SL, Curtis AB, January CT, et al, &ldquo;2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 123 (1):104-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/21173346/pubmed\" id=\"21173346\" target=\"_blank\">",
"        21173346",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wensley DF, Karl T, Deanfield JE, et al, &ldquo;Assessment of Residual Right Ventricular Outflow Tract Obstruction Following Surgery Using the Response to Intravenous Propranolol,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 1987, 44(6):633-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/3689047/pubmed\" id=\"3689047\" target=\"_blank\">",
"        3689047",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yang H, Raymer K, Butler R, et al, &ldquo;The Effects of Perioperative Beta-Blockade: Results of the Metoprolol After Vascular Surgery (MaVS) Study, a Randomized Controlled Trial,&rdquo;",
"      <i>",
"       Am Hear J",
"      </i>",
"      , 2006, 152(5):983-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?8/49/8986/abstract-text/17070177/pubmed\" id=\"17070177\" target=\"_blank\">",
"        17070177",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9829 Version 51.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-C88E1676B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8986=[""].join("\n");
var outline_f8_49_8986=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7254284\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214907\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214908\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214939\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214911\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214926\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214912\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214913\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214914\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214877\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214862\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214882\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214946\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214881\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214936\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214948\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214937\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214885\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214866\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214934\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214871\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214902\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214873\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214888\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214918\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214889\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214890\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214887\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214875\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214878\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214891\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214865\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F214884\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9829\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9829|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/4/43077?source=related_link\">",
"      Propranolol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/62/36840?source=related_link\">",
"      Propranolol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_49_8987="DX probable MSA";
var content_f8_49_8987=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F61013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F61013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for the diagnosis of probable MSA",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       A sporadic, progressive, adult (&gt;30 y)-onset disease characterized by:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Autonomic failure involving urinary incontinence (inability to control the release of urine from the bladder, with erectile dysfunction in males) or an orthostatic decrease of blood pressure within 3 min of standing by at least 30 mm Hg systolic or 15 mm Hg diastolic",
"       <strong>",
"        and",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Poorly levodopa-responsive parkinsonism (bradykinesia with rigidity, tremor, or postural instability)",
"       <strong>",
"        or",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       A cerebellar syndrome (gait ataxia with cerebellar dysarthria, limb ataxia, or cerebellar oculomotor dysfunction)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MSA: multiple system atrophy; y: year.",
"    </div>",
"    <div class=\"reference\">",
"     Gilman, S, Wenning, GK, Low, PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71:670.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8987=[""].join("\n");
var outline_f8_49_8987=null;
var title_f8_49_8988="LV dose adjustment";
var content_f8_49_8988=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for dose adjustment of leucovorin (d,l-racemic mixture) for prolonged methotrexate excretion*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Plasma methotrexate (MTX) level",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dose and/or schedule adjustment for leucovorin (d,l-leucovorin)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       24 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &gt;1-5 micromolar",
"      </td>",
"      <td>",
"       25-50 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       every 6 hours IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &ge;10 micromolar",
"      </td>",
"      <td>",
"       50-100 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       q 6 hours IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &ge;100 micromolar",
"      </td>",
"      <td>",
"       1000 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       q 6 hours IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       48 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &ge;1 micromolar",
"      </td>",
"      <td>",
"       50-100 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       q 6 hours IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &ge;10 micromolar",
"      </td>",
"      <td>",
"       100-200 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       q 3-4 hours IV&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       72 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       0.1-0.9 micromolar",
"      </td>",
"      <td>",
"       50-100 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       every 6 hours IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &ge;1 micromolar",
"      </td>",
"      <td>",
"       50-100 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       q 3-4 hours IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       &ge;10 micromolar",
"      </td>",
"      <td>",
"       100-1000 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       q 3-4 hours&bull;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * This table is for general use only, local hospital practice and specific protocol predefined leucovorin dose adjustments should supercede use of this table for clinical practice.",
"     <br>",
"      &bull; Consider adjunctive means of lowering methotrexate (MTX) levels (see section on \"Adjuctive rescue techniques\").",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8988=[""].join("\n");
var outline_f8_49_8988=null;
var title_f8_49_8989="Fetal alcohol syndrome - Diagnostic criteria";
var content_f8_49_8989=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fetal alcohol syndrome - Diagnostic criteria",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Facial dysmorphia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Based on racial norms, individual exhibits all three characteristic facial features:",
"        <br/>",
"        <ul>",
"         <li>",
"          Smooth philtrum (University of Washington Lip-Philtrum Guide rank 4 or 5)",
"         </li>",
"         <li>",
"          Thin vermillion border (University of Washington Lip-Philtrum Guide rank 4 or 5)",
"         </li>",
"         <li>",
"          Small palpebral fissures (at or below 10",
"          <sup>",
"           th",
"          </sup>",
"          percentile)",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Growth problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confirmed prenatal or postnatal height or weight, or both, at or below the 10",
"        <sup>",
"         th",
"        </sup>",
"        percentile, documented at any one point in time (adjusted for age, sex, gestational age, and race or ethnicity)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Central nervous system abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Structural",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Head circumference (OFC) at or below the 10",
"        <sup>",
"         th",
"        </sup>",
"        percentile adjusted for age and sex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clinically significant brain abnormalities observable through imaging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Neurological",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neurological problems not due to a postnatal insult or fever, or other soft neurological signs outside normal limits",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Functional",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Performance substantially below that expected for an individual's age, schooling, or circumstances, as evidenced by:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        1. Global cognitive or intellectual deficits representing multiple domains of deficit (or significant developmental delay in younger children) with performance below the 3",
"        <sup>",
"         rd",
"        </sup>",
"        percentile (two standard deviations below the mean for standardized testing)",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        2. Functional deficits below the 16",
"        <sup>",
"         th",
"        </sup>",
"        percentile (one standard deviation below the mean for standardized testing) in at least three of the following domains:",
"        <br/>",
"        <ul>",
"         <li>",
"          Cognitive or developmental deficits or discrepancies",
"         </li>",
"         <li>",
"          Executive functioning deficits",
"         </li>",
"         <li>",
"          Motor functioning delays",
"         </li>",
"         <li>",
"          Problems with attention or hyperactivity",
"         </li>",
"         <li>",
"          Social skills",
"         </li>",
"         <li>",
"          Other, such as sensory problems, pragmatic language problems, memory deficits, etc",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Maternal alcohol exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confirmed prenatal alcohol exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unknown prenatal alcohol exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Criteria for fetal alcohol syndrome diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Requires all three of the following findings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Documentation of all three facial abnormalities (smooth philtrum, thin vermillion border, and small palpebral fissures)",
"         </li>",
"         <li>",
"          Documentation of growth deficits",
"         </li>",
"         <li>",
"          Documentation of central nervous system (CNS) abnormality",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: The National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis. Full report available at: file://www.cdc.gov/ncbddd/fasd/documents/FAS_guidelines_accessible.pdf. (Accessed on July 11, 2011).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8989=[""].join("\n");
var outline_f8_49_8989=null;
var title_f8_49_8990="ASCO larynx CA Rx guidelines";
var content_f8_49_8990=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72929&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72929&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of laryngeal cancer-I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Type of cancer",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Organ-preservation strategy",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Basis for recommendation",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Quality of evidence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Recommended",
"       </td>",
"       <td class=\"subtitle2\">",
"        Other options",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        T1 cancer of the glottis:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         T1 - tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility",
"        </p>",
"        <p>",
"         T1a - tumor limited to one vocal cord",
"        </p>",
"        <p>",
"         T1b - tumor involves both vocal cords",
"        </p>",
"       </td>",
"       <td>",
"        Endoscopic resection (selected patients) OR radiation therapy",
"       </td>",
"       <td>",
"        Open organ-preservation surgery",
"       </td>",
"       <td>",
"        High local control rates and quality of voice after endoscopic resection compared with radiation therapy; possible cost savings; ability to reserve radiation for possible second primary cancers of the upper aerodigestive tract; however, not suitable for all patients",
"       </td>",
"       <td>",
"        Comparison of outcomes from case series/prospective single-arm studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        T2 cancer of the glottis, favorable*:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         T2 - tumor extends to supraglottis and/or subglottis, or with impaired vocal cord mobility",
"        </p>",
"       </td>",
"       <td>",
"        Open organ-preservation surgery OR radiation therapy",
"       </td>",
"       <td>",
"        Endoscopic resection (selected patients)",
"       </td>",
"       <td>",
"        Open organ-preservation surgery is associated with highest local control rates; however, leads to permanent hoarseness; local control rates after radiation therapy are also high, and functional outcomes  may be better",
"       </td>",
"       <td>",
"        Comparison of outcomes from case series/prospective single-arm studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        T2 cancer of the glottis, unfavorable*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Open organ-preservation surgery OR concurrent chemoradiation therapy (selected patients with node-positive disease)",
"       </td>",
"       <td>",
"        <p>",
"         Radiation therapy",
"        </p>",
"        <p>",
"         Endoscopic resection (selected patients)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Higher local control rates after surgery compared with radiation therapy alone; quality of voice after therapy of less concern if vocal chord function is irreversibly compromised by tumor invasion; endoscopic surgery requires careful patient selection",
"        </p>",
"        <p>",
"         For patients with T2 N+ disease, evidence from randomized trials supports concurrent chemoradiation therapy as an organ-preservation option",
"        </p>",
"       </td>",
"       <td>",
"        Comparison of outcomes from case series/prospective single-arm studies; randomized controlled clinical trials comparing concurrent chemoradiation therapy and/or induction chemotherapy followed by radiation, and/or radiation therapy alone, and/or surgery followed by radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        T1 - T2 cancer of the supraglottis, favorable*:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         T1 - tumor limited to one subsite of supraglottis with normal vocal cord mobility",
"        </p>",
"        <p>",
"         T2 - tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (eg, mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx",
"        </p>",
"       </td>",
"       <td>",
"        Open organ-preservation surgery OR radiation therapy",
"       </td>",
"       <td>",
"        Endoscopic resection (selected patients)",
"       </td>",
"       <td>",
"        Open organ-preservation surgery associated with highest local control rates; however, requires temporary tracheostomy and may lead to increased rick of aspiration after therapy; local control rates after radiation therapy are also high, and functional outcomes may be better",
"       </td>",
"       <td>",
"        Comparison of outcomes from case series/prospective single-arm studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        T2 cancer of supraglottis, unfavorable*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Open organ-preservation surgery OR concurrent chemoradiation therapy (selected patients with node-positive disease)",
"       </td>",
"       <td>",
"        <p>",
"         Radiation therapy",
"        </p>",
"        <p>",
"         Endoscopic resection (selected patients)",
"        </p>",
"       </td>",
"       <td>",
"        Open organ-preservation surgery is more likely to yield higher local control rates than radiation therapy; for patients with T2 N+ disease, evidence from randomized trials supports concurrent chemoradiation therapy as an organ-preservation option",
"       </td>",
"       <td>",
"        Comparison of outcomes from case series/prospective single-arm studies; randomized controlled clinical trials comparing concurrent chemoradiation therapy and/or induction chemotherapy followed by radiation and/or radiation therapy alone, and/or surgery followed by radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        T3 - T4 cancers of the glottis or supraglottis:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         T3 glottis - tumor limited to the larynx with vocal cord fixation, and/or invades paraglottic space, and/or minor thyroid cartilage erosion (eg, inner cortex)",
"        </p>",
"        <p>",
"         T3 supraglottis - tumor limited to larynx with vocal cord fixation, and/or invades any of the following: postcricoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (eg, inner cortex)",
"        </p>",
"        <p>",
"         T4a - glottis or supraglottis - tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus)",
"        </p>",
"        <p>",
"         T4b glottis or supraglottis - tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures",
"        </p>",
"       </td>",
"       <td>",
"        Concurrent chemoradiation therapy OR open organ-preservation surgery (in highly selected patients)",
"       </td>",
"       <td>",
"        Radiation therapy",
"       </td>",
"       <td>",
"        Highest rate of larynx preservation is associated with concurrent chemoradiation therapy compared with other radiation-based approaches, at the cost of higher acute toxicities but with more long-term difficulties in speech and swallowing; when salvage total laryngectomy incorporated, no difference in overall survival; organ preservation surgery is an option in highly selected patients (eg, there are patients with T3 supraglottic cancers that have minimal or moderate pre-epiglottic invasion and are candidates for organ preserving surgery)",
"       </td>",
"       <td>",
"        Randomized controlled clinical trials comparing concurrent chemoradiation therapy, and/or induction chemotherapy followed by radiation, and/or radiation therapy alone; and/or surgery followed by radiation; comparison of outcomes from case series/prospective single-arm studies",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * A favorable T2 glottic lesion is defined as a superficial tumor, on radiographic imaging, with normal cord mobility. An unfavorable T2 glottic lesion is defined as a deeply invasive tumor on radiographic imaging, with or without subglottic extension, with impaired cord mobility (indicating deeper invasion). A favorable supraglottic lesion is defined as a T1 or T2 tumor with superficial invasion on radiographic imaging and preserved cord mobility, and/or tumor of the aryepiglottic fold with minimal involvement of the medial wall of the pyriform sinus. More locally advanced invasive T2 suproglottic lesions are considered unfavorable.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: American Society of Clinical Oncology. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006; 24:3693. Copyright &copy; 2006 the American Society of Clinical Oncology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8990=[""].join("\n");
var outline_f8_49_8990=null;
var title_f8_49_8991="Neuromuscular respir failure";
var content_f8_49_8991=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 597px\">",
"   <div class=\"ttl\">",
"    Pathophysiology of neuromuscular respiratory failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 577px; height: 319px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     V/Q: ventilation/perfusion; VC: vital capacity; TV: tidal volume.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_49_8991=[""].join("\n");
var outline_f8_49_8991=null;
